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ABSTRACT 
 
 Research in the last twenty years has transformed the role of hydrogen sulfide 
(H2S) being perceived from a toxic gas to a gaso-transmitter with diverse physiological 
and pathological significance. Cystathionine gamma-lyase (CSE) is the major enzyme 
responsible for the endogenous production of H2S in pancreatic β cells and liver cells, 
which are two key types of cells to regulate glucose level. The hallmarks of type 2 
diabetes mellitus consist of insulin resistance, pancreatic β-cell dysfunction, and 
increased endogenous glucose production by liver. Pathophysiological implications of the 
CSE/H2S system in both type 1 and type 2 diabetes as well as diabetic complications 
have been reported before. 
 Previous studies in our laboratory have shown that endogenous H2S mainly 
produced from CSE inhibited insulin release via activating KATP channels and decreased 
H2S production was observed after exposure to elevated glucose level in pancreatic β 
cells. However, the effect of glucose on CSE gene expression in pancreatic β cells and 
the underlying mechanism have not been thoroughly explored. Liver, an important organ 
to control glucose level, has relatively high amount of H2S production compared to other 
organs and CSE has been reported to be the major enzyme responsible for it. The aim of 
the current study was to investigate the effect of glucose on CSE expression in INS-1E 
cells (insulin-secreting β cells) and the role of H2S on basal and insulin-stimulated 
glucose uptake, glycogen synthesis and gluconeogenesis in human hepatoma HepG2 cells 
as well as the underlying mechanisms.  
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 In the present study, a significant decrease of CSE mRNA and protein expression 
by high glucose was observed in INS-1E cells and freshly isolated rat pancreatic islets. 
This regulation required Sp1 (specific protein-1) and p38 MAPK phosphorylation. 
Glucose stimulated the phosphorylation of Sp1 via p38 MAPK activation, which led to 
decreased CSE promoter activity and subsequent downregulation of CSE gene expression.  
Diminished H2S production through altered CSE activity and expression by high glucose 
may be involved in the fine control of glucose stimulated insulin secretion.  
 Besides insulin secretion, insulin actions through adipose tissues, skeletal muscle 
and liver are also critical for blood glucose control. In liver cells, incubation with NaHS 
(a H2S donor) significantly impaired basal and insulin-stimulated glucose uptake and 
glycogen storage in HepG2 cells. DL-propargylglycine (PPG), as an irreversible inhibitor 
of the H2S synthesizing enzyme CSE, significantly improved glycogen storage in HepG2 
cells. These impairing effects of H2S did not appear to be due to loss of cell viability, but 
were mediated by AMPK inhibition. We also found that H2S increased gluconeogenesis 
in HepG2 cells with pyruvate and lactate as substrate in association with increased 
phosphoenolpyruvate carboxykinase (PEPCK) activity. Decreased glucokinase activity 
and enhanced glycogenolysis were also observed when the cells were treated with NaHS. 
Moreover, adenovirus-mediated CSE overexpression had similar effects as that of low 
dose of exogenous H2S (below 100 μM) on glycogen storage. These data suggest that 
CSE/H2S system in the liver is an important potential target for regulating insulin 
sensitivity and glucose metabolism. A detailed understanding of the mechanisms 
correlating CSE/H2S system and insulin secretion, insulin action as well as glucose 
homeostasis under physiological or diabetes like conditions may help develop improved 
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treatment strategies for diabetes, considering the importance of these events within the 
context of pancreatic β cell function and liver function. 
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REVIEW 
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INTRODUCTION 
 
1 Hydrogen sulphide (H2S) as a gasotransmitter 
1.1 Biochemistry and physiological production of H2S 
Gasotransmitters are important endogenous signalling molecules with 
multifaceted physiological significance (Wang, 2002). Gasotransmitters play a major role 
in physiological and pathological processes such as blood pressure regulation, 
neurotransmitter release, inflammatory processes, longevity and so on (Szabó, 2007). It 
was a great surprise for the scientific world when they found nitric oxide (NO), a simple 
inorganic molecule, functions as an important vertebrate biological messenger (Culotta, 
et al., 1992). Following the identification of NO and carbon monoxide (CO) as 
gasotransmitters, mounting evidence has demonstrated H2S being the third one. The 
advances in H2S researches may revolutionize many conventional doctrines in the 
biomedical field. 
H2S is a colorless, flammable, water-soluble and foul-smelling gas with an odour 
resembling that of rotten eggs. Its molecular weight is 34.08 and vapor density is 1.19, 
heavier than air (d=1). H2S is the sulfur analog of water molecule, and can be oxidized 
into different forms such as SO2, sulfates and elemental sulfur. It has a boiling point of -
60.3 °C, melting point -82.3 °C, and freezing point of -86 °C (Wang, 2012). This “swamp 
gas” is generally associated with decaying vegetation, sewers and noxious industrial 
emissions. Its toxic effect has been known for at least 300 years (Beauchamp, et al., 
1984). H2S can cause a series of deleterious effects in humans and animals when inhaled 
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above safe levels, such as anxiety, irritation to eyes and respiratory tract, fatigue, 
headache, even death if above 1000 ppm.  
Around 1990, a turning point came for H2S. Endogenous “sulphide” was reported 
to exist in rat brain tissues and in normal human post-mortem brainstem (Warenycia, et 
al., 1989; Goodwin, et al., 1989). It is now established that H2S is produced endogenously 
in mammals in the brain, blood vessels, liver and kidneys. H2S is thought to be implicated 
in various physiological and pathological processes in our body like the other two 
gasotransmitters: NO and CO. As the most recently discovered gasotransmitter, H2S has 
attracted a great deal of attention as well as controversy over the past few years. Ample 
evidence points to an important cell signalling role of H2S that may be of fundamental 
importance for cellular functions.  
In vitro, H2S can be hydrolyzed to hydrosulfide and sulfide ions in the following 
sequential reactions:  
H2S             H
+ + HS-                  2H+ + S2- 
 Even in aqueous solutions, about one third of H2S remains undissociated at pH 
7.4, which is close to the physiological environment. The other two thirds dissociate into 
H+ and HS-, which subsequently decompose to H+ and S2-. However, the latter reaction 
occurs only at high pH, thus S2- does not occur in vivo substantially. Sodium hydrosulfide 
(NaHS) is commonly used as an H2S donor since it dissociates into Na
+ and HS-; the 
latter can partially binds H+ to form undissociated H2S (Wang, 2002). 
 Table 1-1. summarize the pharmacology and biology of H2S in mammalian 
tissues. 
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Table1-1. 
Pharmacology and biology of H2S 
Environmental sources 
Organic: toxic gas originating from sewers, 
septic tanks, swamps, water treatment 
plants and putrefaction (Lederer, et al., 
1913). 
Inorganic: natural gas, petroleum refinery, 
paper and pulp mill plant (Haahatela, et al., 
1992), sulfur deposits, sulfur springs. 
Endogenous sources 
Synthesized in various tissues from L-
cysteine by cystathionine-beta-synthase 
(CBS) (Jhee, et al., 2005), cystathionine-
gamma-lyase (CSE) (Zhao, et al., 2001), 
and 3-mercaptopyruvate sulfurtransferase 
(MST) (Kuo, et al., 1983) with cysteine 
aminotransferase (CAT) (EC 2.6.1.75) 
(Shibuya, et al., 2009a; Shibuya, et al., 
2009b). 
Pharmacological inhibitors 
CSE inhibitors: (1) D,L-propargylglycine 
(PPG)(selective and specific effects are 
concentration dependent) (Whiteman, et 
al., 2011) (2) beta-cyanoalanine (BCA) 
(limited selectivity, unspecific side-effects) 
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(Pfeffer, et al., 1967; Zhao, et al., 2001; 
Mok, et al., 2004) 
CBS inhibitors: (1) aminooxyacetate 
(AOA) (unspecific, inhibiting 
aminotranferase generally) (Rej, 1977); 
 (2) hydroxylamine (HA) (Kimura, 2002) 
 
Elimination kinetics 
Half-life within minutes; metabolites 
comprise thiosulfate, sulfite, and sulfate 
(Wang,  2002) 
Receptors and targets 
ATP-dependent potassium channels (KATP 
channels); cytochrome c oxidase (Zhao, et 
al., 2001; Yang,  et al., 2005) 
Cardiovascular effects 
(1) Chronotropic and inotropic effects on 
heart (Xu, et al., 2008) 
(2) Vasodilation or vasoconstriction 
(depending on local oxygen concentration) 
(Zhao, et al., 2001; Koenitzer, et al., 2007) 
Biological effects 
Radical scavenging, upregulation of heme 
oxygenase-1(HO-1), involving in long term 
synaptic potentiation in the hippocampus 
(Abe, et al., 1996) 
Toxicology: pulmonary irritant,  
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damaging to mitochondrial by binding to 
cytochrome c oxidase 
(Wang, 2002; Khan, et al., 1990; Dorman, 
et al., 2002) 
Inflammatory effects 
Dose-dependent proinflammatory or anti-
inflammatory effects 
(Yang, et al., 2007) 
 
1.2 Endogenous generation and metabolism of H2S  
Physiological importance of H2S emerged in the mid-1990s. It can be produced in 
mammals including humans, and it can be detected in significant amounts (Figure 1-1) 
(Yang G, et al., 2007a). The production of H2S in mammalian tissues has been mainly 
attributed to two key enzymes responsible for metabolizing L-cysteine: CBS (EC 4.2.1.22) 
and CSE (EC 4.4.1.1). CBS and CSE are heme-containing enzymes whose activity 
depends on the cofactor pyridoxal 5′-phosphate (P5P). The substrate of CBS and CSE, L-
cysteine, can be derived from alimentary sources or can be liberated from endogenous 
proteins.  
It can also be synthesized endogenously from L-methionine through the trans-
sulphuration pathway, with homocysteine being an intermediate in the process. In tissue 
homogenates, rates of sulphide production are in the range of 1–10 pmoles per second per 
mg protein (Doeller, et al., 2005). This results in low micromolar extracellular 
concentrations of sulfide. Sulfide can be rapidly consumed and degraded by various 
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mammalian tissues. H2S cannot accumulate in the body and is rapidly metabolized. 
Sulphate is the major end product and is excreted through urine. Thiosulphate, another 
by-product of H2S metabolism, is also excreted in urine and present in low concentrations. 
Thiosulphate serves as the marker of H2S metabolism (Belardinelli, et al., 2001). 
 
 
  
Figure 1-1. Schematic representation of the metabolic pathways involved in    
         production of H2S from cysteine in mammalian cells  
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A recent report proposed the existence of pyridoxal-phosphate (PLP)-independent 
pathway in neuronal tissue and endothelial cells from rodent large vessel (thoracic aorta) 
via utilizing the desulfuration of 3-mercaptopyruvate by MST (3-mercaptopyruvate 
sulfurtransferase; EC 2.8.1.2) with CAT (cysteine aminotransferase; EC 2.6.1.75) 
(Shibuya, et al., 2009a; Shibuya, et al., 2009b). However, the importance of this third 
pathway is not as clarified as CSE and CBS, and its role in generating H2S in human 
tissues remains unknown. 
The tissue-specific production of H2S was determined both in vivo and in vitro 
using different pharmacological manipulations (Zhao, et al., 2003). The organ-specific 
expression and molecular regulation of CBS and CSE have been characterized by 
multiple groups in rodents before. The distributions of CBS and CSE were reported to 
vary from tissue to tissue. However, with more investigations researching on the role of 
H2S in their specific system, the marked tissue specificity is not clear any more. The 
current literature agree that CBS is the predominant H2S-producing enzyme in the central 
nervous system, highly concentrated in cerebellar purkinje and hippocampal neurons and 
is also densely expressed in liver and kidney. In comparison, CSE is mainly expressed in 
the liver and in vasculature (e.g.smooth muscle and endothelium) and non-vascular 
smooth muscle. CSE is also detected in the small intestine and stomach of rodents 
(Fiorucci, et al., 2006). It is important to note that substantial differences exist between 
the human and the mouse CBS and CSE enzymes (Fiorucci, et al., 2006; Miles, et al., 
2004). The distributions of CSE and CBS are assumed to be much more widespread in 
humans, and the expressions of CSE, CBS, CAT and MST would be more similar in 
humans, highlighting the significance of H2S synthesis in a variety of tissues. For 
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example, CSE has also been known to express in human brain including astrocytes (Lee, 
et al., 2009), pre-central cortex (Lee, et al., 2009), pyramidal neurons of CA3 and granule 
cell layer of dentate gyrus, and reticular neurons in midbrain (Diwakar, et al., 2007). CSE 
mRNA expression and catalytic activity was also detected in cerebellar and granule and 
Perkinje cells in human brain (Diwakar, et al., 2007).  
Three pathways of H2S degradation have been demonstrated: (1) mitochondrial 
oxidation to thiosulfate, which is further converted to sulfite and sulfate; (2) cytosolic 
methylation by thiol S-methyltransferase (TSMT) (EC 2.1.1.9) to methanethiol (CH3SH) 
and dimethylsulfide (CH3SCH3); and (3) sulfhemoglobin formation after binding to 
hemoglobin (Wang, 2002). Similar to NO and CO, H2S can also bind to hemoglobin. 
Hemoglobin was therefore termed the common sink for the three gaseous transmitters 
(Penney, et al., 1991). If this sink is filled with one gas, this binding might lead to 
enhanced plasma concentrations and, subsequently, the biological effects of the other 
gases (Wang, 2002). Nevertheless these biochemical means are available for H2S 
catabolism. H2S, as a powerful reducing agent, is likely to be consumed by endogenous 
oxidant species in the vasculature, such as peroxynitrite (Whiteman, et al., 2004), 
superoxide (Chang, et al., 2008), and hydrogen peroxide (Geng, et al., 2004). 
1.2.1 Cystathionine gamma-lyase (CSE) 
Cystahionine gamma-lyase (EC 4.4.1.1) has been conventionally abbreviated as 
CSE, CGL, or CTH. It is also known as gamma-cystathionase, cysteine lyase, cysteine 
desulfhydrase, cystathionase, cystathioninase, homoserine deaminase, or homoserine 
dehydratase, which catalyses the second step of transsulfuration: cleavage of the 
cystathionine C-gamma-S bond yielding L-cysteine, alpha-ketobutyrate (also called 2-
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oxobutanoate, 2-ketobutyrate, and alpha-oxobutyrate), and ammonia. The rat CSE 
enzyme was reported to catalyze the formation of two gases, H2S and NH3 as well as 
pyruvate from L-cysteine (Braunstein, et al., 1984; Matsuo, et al., 1958). The trans-
sulfuration pathway is critical for a sufficient supply of cysteine in in vitro culture of rat 
hepatocytes (Reed, et al., 1977; Rao, et al., 1990). Besides as an amino acid component 
of polypeptide chains, cysteine is necessary for synthesis of glutathione (GSH), a major 
intracellular antioxidant. Determination of CSE crystal structure has revealed that both 
yeast and human CSE are almost identical in their active sites to cystathionine gamma 
synthase (CGS) from Escherichia coli (Messerschmidt, et al., 2003).  
Similar to CBS, CSE has been found to be exclusively localized in the cytosol 
(Ogasawara, et al., 1994). In the study of Ogasawara et al., rat liver and kidney tissues 
have been used to test the subcellular distribution of CSE. CSE activities and sulfide 
production capacity from cysteine were mainly detected in the cytosolic fractions of these 
tisseus. 
In human beings, there are two forms of CSE mRNA, of which the shorter form 
has an internal deletion of 132 bp, probably due to being products of different genes or 
splice variants. It was hypothesized that the subunit composition of the tetrameric CSE 
modulates the activity, and that the developmental changes in CSE activity are attributed 
to an alternation in relative expression of these two isoforms (Levonen, et al., 2000). It 
has been reported that CSE activity (Sturman, et al., 1970) as well as immunoreactive 
protein (Gaull, et al., 1972) is absent from human fetal liver. In rat liver, CSE activity is 
low during fetal development but increases rapidly during the last 3 days of gestation 
(Heinonen, et al., 1973). The rate of GSH synthesis from methionine is six times lower in 
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fetal than in adult rat hepatocytes, and the difference was concluded as a result of low 
CSE activity (Pallardo, et al., 1991). Genetic CSE deficiency in human beings has been 
associated with cystathioninuria, hypercystathioninemia and increased risk of developing 
atherosclerosis and bladder cancer (Renga, 2011). Regulation of CSE expression and 
activity has been elaborated in Section 1.4. 
 The fact that CSE expression and activity gradually increased in liver tissues 
during development has been observed before (Ishii, et al., 2004). CSE expression 
emerged after birth at very low levels at embryonic stage and gradually increased until 21 
days postnatal (weaning age) and maintained this level at least until 84 days postnatal in 
mouse liver tissues, suggesting that CSE gene may involve in liver function after 
maturation. Indeed, CSE activity is vitamine B6 dependent, considering all three forms of 
vitamin B6 are precursors of pyridoxal 5'-phosphate (PLP), which is the co-factor of CSE 
and CBS. When rats are fed a vitamin B6-deficient diet, they have a lower level of blood 
glucose compared to fed controls (Beaton, et al., 1954; Huber, et al.,  1964).  
1.2.2. Cystathionine beta synthase (CBS) 
 CBS (EC 4.2.1.22) is a member of the beta family of PLP-dependent enzymes. It 
is the enzyme to catalyze the first irreversible step of the transsulfuration pathway, from 
homocysteine to cystathionine: 
 L-serine + L-homocysteine              L-cystathionine + H2O  
 Cystathionine is further converted to cysteine by CSE. Alternatively, CBS is 
involved in the condensation of cysteine with homocysteine forming cystathionine and 
H2S (Jhee, et al., 2005). CBS enzyme activity can be allosterically regulated by S-
adenosyl-L-methionine (SAM). 
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 In mammals, CBS contains a heme cofactor to modulate its enzyme activity in 
response to changes in the redox potential (Banerjee, et al., 2005). CBS is a multidomain 
enzyme composed of an N-terminal heme domain followed by two CBS domain in the 
regulatory C-terminal region. The activity of CBS is regulated presumably at the 
transcriptional level by glucocorticoids and cyclic AMP. The activity of CBS can also be 
directly inhibited by NO and CO (Puranik, et al., 2006). It can be activated by the NO 
donor sodium nitroprusside in a manner that paradoxically does not involve NO, but 
involves a chemical modification of the enzyme (Eto, et al., 2002). The regulation of 
CBS has been reviewed elsewhere (Miles, et al., 2004). 
1.3. Mechanism of H2S effect       
 H2S exerts its various effects in biological systems through a variety of 
interconnected mechanisms (Szabó, et al., 2007). H2S promotes numbers of cellular 
signals which regulate metabolism, cardiac function and cell survival. Previous studies 
have demonstrated that both CSE and CBS are critical for the maintenance of 
cardiovascular function and that treatment of animals with exogenous forms of H2S has 
demonstrated very robust protection to various organs in a variety of cardiovascular 
diseases including: ischemia-reperfusion injury, various forms of shock, stroke, 
inflammatory disorders and models of ischemia-induced angiogenesis (Mok, et al., 2004; 
Elrod, et al., 2007; Szabó, et al., 2007; Kimura, et al., 2006; Jha, et al., 2008). H2S is also 
a regulator of the N-methyl-D-aspartate (NMDA) receptor and may be central in long-
term potentiation of neuronal circuitry for learning and memory (Kimura, et al., 2000; 
Boehning, et al., 2003). 
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 Until now, the knowledge we gain about biology of H2S largely derives from in 
vitro studies from different cell lines and isolated organ systems, either using CSE 
inhibitors such as PPG and BCA, or application of H2S gas or H2S donors such as sodium 
disulfide (Na2S) or sodium hydrosulfide (NaHS). Applying H2S in a high (micromolar to 
millimolar) concentration even for a short time can invariably cause cytotoxic 
consequences (Cheung, et al., 2007), which is the result of blockage of mitochondrial 
oxidative phosphorylation (Reiffenstein, et al., 1992). H2S at low concentration has been 
shown to exert either cytoprotective (antinecrotic or antiapoptotic) effects (Elrod, et al., 
2007; Sodha, et al., 2008; Jha, et al., 2008) or proapoptotic effects (Cao, et al., 2006; 
Baskar, et al., 2007; Adhikari, et al., 2008), depending on the cell type and experimental 
conditions.  
 Cytochrome c oxidase, or called Complex IV as a large transmembrane protein 
complex which can be found in bacteria and the mitochondrion at the end of the 
respiratory electron transport chain and it is also an intracellular target of H2S (Khan, et 
al., 1990; Dorman, et al., 2002). Inhibition of this enzyme would lead to termination of 
oxidative phosphorylation, a major source of adenosine triphosphate (ATP) synthesis. 
The toxic effects of H2S and the induction of a so-called “suspended animation” 
(Blackstone, et al., 2005; Roth, et al., 2005) are both referred to derive from this 
inhibition of mitochondrial respiration (Hill, et al., 1984; Cooper, et al., 2008), and 
therefore may underlie a potential mechanism for the regulation of cellular oxygen 
consumption (Leschelle, et al., 2005). The hypothesis that H2S may be an oxygen-sensing 
molecule (Olson, et al., 2010), if confirmed, would fill up a major gap in our 
understanding on how the oxygen-sensing cells sense oxygen level change and then 
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initiates corresponding reactions to regain a desirable oxygen level. Chemoreceptors and 
chromaffin cells are well-known oxygen-sensing cells in vertebrate cardio-respiratory 
systems. It is speculated that oxidation of endogenously produced H2S triggers the 
cardiorespiratory reflexes and relaxes smooth muscles to increase local blood perfusion 
and/or ventilation. Though this theory is not mature, lines of evidence have been 
amounted to support.  
Activation of ATP-sensitive potassium channels (KATP channels) is another major 
mechanism underlying H2S effect, which has been introduced as the molecular basis for 
vasodilation, preconditioning against ischemia/reperfusion injury, myocardial protection 
(Zhang Z, et al., 2007) and insulin release inhibition (Wu L, et al., 2009) (it will be 
discussed in detail later). Various findings support this notion (Szabo, et al., 2007; 
Lowicka, et al., 2007; Pryor, et al., 2006). KATP channel blockers (sulfonylurea derivates 
–such as glibenclamide) attenuated the H2S-induced vasodilation both in vivo and in vitro 
(Tang, et al., 2005; Zhao, et al., 2001), and stimulation of KATP by H2S was proved in the 
myocardium, pancreatic β cells, neurons and the carotid sinus (Lowicka, et al., 2007). 
Moreover, glibenclamide reversed the otherwise significant H2S-induced hepatic arterial 
buffer response counteracting the reduction of portal venous flow, whereas inhibition of 
CSE by PPG decreased this compensatory mechanism (Siebert, et al., 2008). 
Apart from the role of H2S to open KATP channels, H2S has a wide interaction with 
various ion channels to exert specific functions. In summary, H2S regulated intracellular 
Ca2+ levels by inhibiting L-type Ca2+ channels in cardiomyocytes but activated the same 
channel in neurons. H2S stimulated small and medium conductance KCa channels in 
peripheral resistance vessel - mesentery artery beds (Cheng, et al., 2004) to exert its 
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vasorelaxant effect. In addition, the activation of transient receptor potential vanilloid 1 
(TRPV1, also called capsaicin receptor) and transient receptor potential ankyrin 
1(TRPA1) by H2S is believed to be responsible for the contraction of nonvascular smooth 
muscles and increased colonic luminal Cl− secretion. H2S-induced hyperalgesia and pro-
nociception is known to be associated with the activation of T-type Ca2+ channels and 
TRPV1 channels respectively. Application of H2S donor activates TRPV1 ion channels in 
the gastrointestinal tract, airway, pancreas and the urinary bladder, leading to colonic 
mucosal Cl− secretion, gut motility, airway constriction, acute pancreatitis, detrusor 
muscle contraction and bladder contractility response respectively (Patacchini, et al., 
2005;  Bhatia, et al., 2005; Bhatia, et al., 2005; Streng, et al., 2008; Trevisani, et al., 
2005). Activation of Cl− channel by H2S has been suggested to protect neurons from 
oxidative stress (Kimura, et al., 2006).  
The evidence that H2S acts on small to medium conductance KCa channels in 
endothelial cells points to the role of H2S as an endothelium-derived hyperpolarizing 
factor (EDHF)  (Wang, 2009). H2S fits the principal criteria as an EDRF in many ways 
(Yang, et al., 2008). As the major enzyme to produce H2S in the vascular tissues, CSE is 
selectively located in the endothelium of blood vessels. It is further demonstrated that 
endothelial CSE is activated in a calcium/calmodulin dependent manner (Yang, et al., 
2008). Methacholine induced relaxation of the mesenteric artery is largely reduced in 
CSE knockout vessels and about half in heterozygotes, establishing H2S as a major 
physiological EDRF. Eventually, CSE knockout mice developed hypertension with age, 
which largely reflects the gradually impaired endothelium-dependent vasorelaxation in 
these mice (Yang, et al., 2008; Wang, 2009). 
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H2S is also a reducing agent and can interact with oxidative species. It was 
reported that H2S significantly inhibited HOCl-mediated toxicity at physiological 
relevant concentrations in the brain (Whiteman, et al., 2005). Direct scavenge of 
peroxynitrate and inhibition of peroxynitrate-mediated processes by H2S has been 
reported (Whiteman, et al., 2004). Its antioxidant capacity for peroxynitrate scavenging is 
comparable to that of GSH (Beckman, et al., 1994; Whiteman, et al., 1996). 
A novel posttranslational modification mechanism, called S-sulfhydration, has 
been proposed by Mustafa et al., which has potential to alter the activity or function of 
numerous signalling proteins (Mustafa, et al., 2009). It is well known that S-nitrosylation 
is a process to transfer a nitric oxide (NO) group to a cysteine residue. In contrast, S-
sulfhydration is a covalent modification by a sulfhydryl group, which is transferred to the 
cysteine residue of a protein. The outcome will be the formation of a hydropersulfide 
moiety (–SSH). It is demonstrated that H2S appears to signal predominantly through S-
sulfhydration of cysteines in its target proteins, which is comparable to S-nitrosylation by 
NO (Mustafa, et al., 2009). Even though S-nitrosylation usually inhibits enzyme activities, 
S-sulfhydration in most cases stimulates it. Intriguingly, the existence of endogenous 
desulfhydration molecules has not been confirmed. It is hypothesized that H2S itself may 
function such a role due to its reducing property, whereas other strong endogenous 
reducing molecules cannot be excluded (Wang, 2012). 
1.4 Regulation of CSE gene expression and activity 
In recent years, there has been more and more understanding about how CSE can 
be regulated. Specifically, rodent CSE gene regulation has been well characterized. Zhao, 
et al. discovered that NO enhanced CSE activity in rat vascular tissues (Zhao, et al., 2001) 
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via two possible mechanisms. It is hypothesized that NO increases the activity of cGMP-
dependent protein kinase, further stimulates CSE; or alternatively NO may directly act 
upon CSE protein. Additionally, NO-induced H2S production also depended on 
upregulated CSE expression. In Zhao et al., study, incubation of cultured vascular SMCs 
with NO donor (S-nitroso-N-Acetylpenicillamine, abbreviated as SNAP) for 6 hour 
markedly increased the transcription level of CSE (Zhao, et al., 2001). In summary, their 
study for the first time demonstrated that NO might be a physiological modulator of the 
endogenous production of H2S by increasing the CSE expression and activity. 
Conceivably, the interaction of NO and H2S may act as a molecular switch for regulating 
vascular tone. In another study, NO increased the production of hydrogen sulphide in rat 
fetal membranes. The augmentation of hydrogen sulphide production in human 
intrauterine tissues in a low oxygen environment could have a role in pathophysiology of 
pregnancy (Patel, et al., 2009). 
There is evidence that myeloid zinc finger 1 (MZF1) and specificity protein 1 
(Sp1; also known as Sp1 transcription factor) play roles in the basal transcriptional 
activity of mouse CSE gene (Ishii, et al., 2004). Exposure to nonsteroidal anti-
inflammatory drug (NSAIDs) inhibited CSE expression (mRNA and protein) and activity 
in the rat gastric mucosa by reduced Sp1 binding to CSE promoter (Fiorucci, et al., 
2005a). As to the human counterpart, there are less reports regarding the regulation of 
CSE expression and enzyme activity compared to rodent CSE. CSE protein expression 
and activity can be up-regulated by butyrate in WiDr cells, a human colon carcinoma cell 
line (Cao, et al., 2004). Recently it has been demonstrated that liver CSE transcription is 
upregulated by bile acid mediated by the nuclear receptor Farnesoid X Receptor (FXR) in 
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human hepatoma HepG2 cells (Renga, 2009), which is a potential protective mechanism 
against portal hypertension and endothelial dysfunction in livers. A very recent finding 
has indicated that PI3K/Akt elevated the expression of CSE at transcription level via Sp1 
in human hepatoma cell lines, which is of potential importance to understand the effect of 
PI3K/Akt and CSE/H2S system on tumorigenesis (Yin, et al., 2012).  
2. General overview of insulin secretion, glucose homeostasis and diabetes 
2.1 Insulin secretion 
2.1.1 Biosynthesis of insulin 
 In mammals, insulin is synthesized in large quantities solely in pancreatic β cells 
of the islets of Langerhans. Around one to three million islets of Langerhans (pancreatic 
islets) distributed throughout the organ form the endocrine part of the pancreas in a 
healthy adult human, which occupies only 2% of the total mass of the pancreas (Saito, et 
al., 1978). Within the pancreatic islets, β cells constitute 60–80% of all the cells. The 
other cells include glucagon-producing α (alpha) cells, somatostatin-generating δ (delta) 
cells, pancreatic polypeptide-producing PP cells, and ghrelin-producing ε (epsilon) cells 
(Elayat, et al., 1995). 
 The insulin mRNA is translated into a single chain peptide named preproinsulin, 
and excision of its signal peptide generates proinsulin in the endoplasmic reticulum (Bell, 
et al., 1980). After folding and disulfide bond oxidizing, proinsulin is transported to the 
Golgi apparatus. The proteolysis of the prohormone starts there and the mature hormone 
is concentrated, sorted and packed into secretory granules, ready for extracellular release. 
Inside the endoplasmic reticulum, proinsulin is exposed to several specific proteases 
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which excise the C peptide, and generate mature insulin. Insulin and free C peptide are 
separately packaged in the Golgi as secretory granules and accumulate in the cytoplasm. 
When the β cell is stimulated, insulin is secreted from the cell through exocytosis and 
diffuses into islet capillary blood. Meanwhile, C peptide is also released into the blood, 
but has no known biological activity (Guest, et al., 1991; Davidson, 2004). 
 To be specific, unless “human” β cells were mentioned, most of the studies cited 
in this thesis have utlilized rat-, mouse- or hamster-derived insulinoma β-cell lines to 
study function in vitro, a small proportion of studies are using rodent islets. It is due to 
the inherent difficulty in maintaining primary rodent islet β-cell mass and function for 
more than a few days in vitro and also due to the scarcity of human islets for research 
purposes. As yet, no suitable human β-cell lines are available for unrestricted in vitro 
studies. Prevalent use of the major rodent β-cell lines have provided substantial data and 
insights into β cell function in physiological or pathogenic conditions.  
2.1.2 Regulation and mechanism of insulin secretion 
 Pancreatic β cells in the islets release insulin in two distinct phases. The first 
phase release is triggered by elevated blood glucose levels within 10 minutes. In this 
phase, β cells discharge an immediately releasable pool of insulin granules which 
comprises the first phase of glucose stimulated insulin secretion (GSIS). The rate-limiting 
step for this process lies between Ca2+ sensing and exocytosis. The second phase is a 
stable, slow release of newly formed vesicles which lasts between one and three hours. 
Glucose-stimulated biphasic insulin secretion has drawn researchers and clinicians’ 
attention since the phenomenon was first observed (Porte, et al., 1969). The major 
differences between two phases of insulin secretion are that the first phase represents 
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insulin release from a population of secretory vesicles which are “docked” and “primed” 
at the β-cell membrane and awaiting a glucose-dependent calcium signal for immediate 
release. The second phase represents replenishment of exocytosis-competent secretory 
vesicles. In fact, it is rare under physiological conditions because an abrupt increase of 
blood glucose level is mandatory to elicit the response—but such an increase does not 
normally occur following a meal (Ashcroft, et al., 1984). 
Insulin is secreted largely in response to elevated blood glucose. Glucose is 
transported into the β cells by facilitated diffusion through GLUT2 transporter; elevated 
glucose concentrations in extracellular fluid thus permeate into the β cell. The increase of 
glucose metabolism via glycolysis and the Krebs cycle (also known as TCA cycle) where 
multiple high-energy ATP molecules are produced can lead to higher intracellular 
[ATP]/[ADP] ratio, closure of KATP channels, and membrane depolarization. 
Depolarization results in increased Ca2+ influx through voltage-dependent Ca2+ channels 
(VDCC), the increase in [Ca2+]i eventually leads to insulin release (Hohmeier, et al., 
2000; Antunes, et al., 2000). Thus, the KATP channel becomes the bridge between glucose 
metabolism and the stimulation of insulin secretion. This pathway is presently known as 
the KATP channel-dependent pathway (Rorsman, et al., 1985; Santos, et al., 1991; Koster, 
et al., 2005). It is now recognized as the major mechanism to stimulate insulin secretion. 
Another glucose-signalling pathway that augments the secretory response to increased 
[Ca2+]i was discovered more than 10 years ago (Aizawa, et al., 1998; Komatsu, et al., 
2001). This is currently called the KATP channel–independent augmentation pathway 
which is mainly responsible for the second phase of GSIS. Nevertheless, when the clonal 
β cell lines-HIT-TI5, INS-1, and βHC9 were examined for presence of the KATP channel–
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independent pathway, it was concluded that this pathway did not exist in these cells 
(Straub, et al., 2002). 
 Many diabetic drugs target on KATP channels to exert its therapeutic benefit.  
Opening of this channel is predicted to dampen the electrical trigger of insulin secretion. 
Sulfonylurea drugs promote, but diazoxide represses insulin secretion by binding to the 
regulatory sulfonylurea receptor-1 (SUR1) subunit to inhibit or activate KATP channel 
current, respectively (Bryan, et al., 2005).  
2.1.2.1 The importance of KATP channel and voltage-dependent calcium channels (VDCC) 
in insulin secretion 
Ion channels in pancreatic β cells modulate secretory activity triggered by 
metabolic, pharmacologic, or neural signals via controlling the electrical activity of ion 
channels, specifically permeability to K+ and Ca2+.  KATP channels are a small family of 
potassium selective ion channels assembled of four inward rectifier pore-forming 
subunits, Kir6.x, paired with four sulfonylurea receptors (SURs) which are members of 
the ATP-binding cassette superfamily. This name is being called because the activity of 
these channels can be gated by the ratio of ADP to ATP, which is driven by cell 
metabolism. In this way, it provides a connection to link membrane electrical activity 
with metabolism. Apart from vascular smooth muscle cells and cardiomyocytes, KATP 
channels are abundantly expressed in insulin-secreting pancreatic β cells. In contrast to 
vascular KATP channels which consist of Kir 6.2 and sulfonylurea receptor SUR2B, 
pancreatic KATP channels contain Kir 6.2 and SUR1 (Ashcroft, et al., 1989). Pancreatic 
KATP channel plays a major role in the regulation of insulin secretion (see Figure 1-2).  
 

23 
 
The α1 subunit is the pore forming subunit while the associated subunits modulate the 
activity of gating. VDCCs are normally closed at resting membrane potential. They can 
only be activated at depolarized membrane potentials, and this is why it’s termed 
“voltage-dependent channels” (Yang SN, et al., 2006). Activation of particular VDCCs 
allows Ca2+ flux into the cell. Depending on the cell type, it leads to muscular contraction, 
excitation of neurons, up-regulation of gene expression, etc. In pancreatic β cells 
particularly, activation of VDCC results in release of insulin. 
In summary, the KATP channels act as a switch in response to fuel secretagogues 
or sulfonylureas to initiate depolarization. VDCC is opened consequently by 
depolarization to increase the free cytosolic Ca2+ levels ([Ca2+]i), then trigger exocytosis 
of insulin. In contrast, hyperpolarization of the β cell or any receptor-mediated, G-
protein-coupled effects to decrease VDCC activity will inhibit insulin secretion. 
Membrane potential is recovered by repolarization which is initiated by voltage- and 
Ca2+-activated K+ channels. Both KATP channel and VDCC play critical roles in the 
regulation of insulin secretion in normal and diabetic β cells (Drews, et al., 2010). 
Understanding the regulatory mechanism of them should provide insight into the β cell 
metabolism and insulin secretion, which is fundamental for treating diabetes. 
2.1.2.2 Regulators of insulin secretion 
 Insulin release from β cells is elegantly regulated by an interconnected network of 
factors, including hormones, autacoids, neurotransmitters, and nutrients. Most of them 
function by modulating the levels of their relevant intracellular signalling molecules to 
enhance insulin release. In our study, H2S is demonstrated to be a physiological inhibitor 
of insulin secretion.  
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 Nutrients regulate insulin secretion via various mechanisms. For instances, 
glucose induces insulin secretion through its oxidation by glycolysis and TCA cycle, 
further leading to increased ATP/ADP ratio and closure of the KATP channels. The 
presence of some fatty acids in pancreatic β-cells is necessary for glucose-stimulated 
insulin secretion; fatty acids also have enormous capacity to amplify glucose-stimulated 
insulin secretion, which becomes more important in situations of β-cell compensation for 
insulin resistance. Fatty acids stimulate exocytosis of insulin vesicles via generating acyl-
CoA, which leads to acylation of proteins (Nolan, et al., 2006). Amino acids provide 
anaplerotic substrates to TCA cycle that increase ATP/ADP ratio, further resulting in an 
increase of insulin secretion. Nutrients may stimulate release of the incretins GIP and 
GLP-1 from the gut to induce insulin secretion (Drucker, et al., 2006). As to the 
mechanisms, GIP activates voltage-gated Ca2+ channel in β-cells via cAMP. GLP-1 
mediates insulin transcription via PI3-K (Baggio, et al., 2007). However, glucagon and 
ghrelin prevent insulin gene transcription and insulin exocytosis, respectively (Torres, et 
al, 2009). 
 Some amino acids such as leucine and glutamine provide anaplerotic substrates to 
the TCA cycle which can increase ATP/ADP ratio and induce insulin secretion (Sener A, 
et al., 1980). Other amino acids such as alanine (Dunne MJ, et al., 1990; McClenaghan 
NH, et al., 1998) and arginine (Sener A, et al., 2000) are cotransported with Na+ into the 
β‐cell provoking a membrane depolarization to activate voltage‐gated Ca2+ channels, 
further leading to insulin vesicles exocytosis.  
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 Regulating factors of insulin release including carbohydrate nutrients, 
noncarbohydrate nutrients, hormonal factors and neural factors are listed in the following 
table (See Table 1-2). 
 
Table 1-2. Regulators of insulin release 
Stimulants of insulin release Inhibitors of insulin release 
Sugar: glucose, mannose; 
Fatty acids (Nolan, et al., 2006) 
Amino acids: leucine, glutamine (Torres, et 
al, 2009) 
Vagus nerve stimulation 
Sulfonylureas, KCl, leptin 
Neural: alpha-adrenergic effect of 
catecholamines (epinephrine, 
norepinephrine) 
Humoral: somatostatin (paracrine action), 
ghrelin (Egido, et al., 2002), 
prostaglandins (Robertson, et al., 1983), 
cytokines (IL-1β) (Tran, et al., 1999) 
Gasotransmitter: H2S (Yang, et al., 2005) 
Amplifiers of glucose induced insulin release 
Enteric hormones: Eg., gastrin,secretin, cholecystokinin (Kahil, et al., 1970) 
Neural amplifiers: β-adrenergic effect of catecholamine; 
Amino acids: alanine and arginine Torres, et al, 2009) 
Incretins: glucose-dependent insulinotropic peptide (GIP) 
                glucagon-like peptide-1 (GLP-1) (Drucker, et al., 2006) 
 
2.2 Insulin action. 
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 Insulin is a highly pleiotropic hormone which plays a pivotal role in the regulation 
of energy expenditure and glucose metabolism in the body by direct and indirect actions. 
Its anabolic action is mediated through a tightly regulated signalling cascade in a variety 
of tissues including kidney, muscle, and adipose tissue (O'Brien, et al., 1991). The 
signalling pathways downstream of binding of insulin to its receptor regulate a wide 
spectrum of biological events which are essential for cell survival, normal growth and 
development, and for glucose homeostasis, fat and protein metabolism. The signalling 
pathway involves a complex cascade of protein kinases and regulatory proteins, of which 
insulin receptor substrate (IRS)-1 and IRS-2 are the most important. Insulin promotes 
glucose transport and glycogen synthesis in the liver and skeletal muscle; thereby glucose 
is stored as glycogen in these tissues. Selectivity of final responses to insulin derives both 
from cell-specific expression of effector proteins and by activation of different signalling 
pathways.  
 The final outcomes can be summarized as follows: 
 Insulin causes (1) suppression of glucose release from liver and kidney (Woods, 
et al., 1979), (2) translocation of glucose transporters in muscle and adipose tissue to 
increase their glucose uptake (Sipols, et al., 1995) and (3) inhibition of release of FFA 
into the circulation due to suppression of the activity of hormone-sensitive lipase and a 
simultaneous increase in their clearance from the circulation (Schwartz, et al., 1991). 
2.2.1 PI3-K signalling pathway activated by insulin 
  When insulin binds the insulin receptor, insulin action is initiated. The insulin 
receptor belongs to a family of receptor tyrosine kinases (RTKs) and is a heterotetrameric 
glycoprotein with two α-subunits (135 kDa) as the binding site and two β-subunits (95 
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kDa) as the tyrosine kinase. The receptor increases its kinase activity via 
autophosphorylation. IRS proteins are then phosphorylated by activated insulin receptor, 
leading to activation of PI3-K (Dupont, et al., 2001). Activation of PI3-K can recruit PI3-
K dependent kinase and Akt from the cytoplasm to the plasma membrane. In this way, 
conformational changes occur in Akt, which allows the phosphorylation of Thr308 and 
Ser473 of AKT by PI3-K-dependent kinase. The final outcome of activation of Akt is the 
activation of glycogen synthesis and the translocation of GLUT 4 to the cell membrane 
for glucose transport (Tremblay, et al., 2001). The status of phosphorylation or 
dephosphorylation of these signal proteins, including the insulin receptor and many 
downstream signal proteins such as Akt, may alter insulin function. As a matter of fact, 
insulin resistance has been associated with impaired Akt activation (Tomás, et al., 2002). 
2.2.2 Insulin and carbohydrate metabolism 
 Glucose is usually obtained from disaccharides like starch or sucrose in the diet. 
By hydrolysis in the small intestine, these disaccharides are then absorbed into the 
bloodstream as glucose. Elevated levels of blood glucose stimulate insulin release, and 
insulin then acts on target cells to promote glucose uptake, utilization and storage into 
glycogen. Insulin exerts tissue specific effects on glucose metabolism, which can be 
briefly divided into two important effects:   
 1. Insulin facilitates glucose uptake into muscle, adipose and several other tissues. 
The only mechanism of glucose uptake is by facilitated diffusion through a family of 
GLUT transporters. Muscle - being a case in point - the major transporter used for 
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glucose uptake (called GLUT4) is translocated into the plasma membrane through the 
action of insulin (Olson, et al., 1996).  
GLUT4 transporters are mainly present in intracellular vesicles in muscle and 
adipose cells when insulin concentrations are low. Insulin action on these cells leads to 
rapid fusion of those vesicles with the plasma membrane and insertion of the glucose 
transporters, thereby making the cell available for taking up glucose. Under the condition 
when insulin level decreases and insulin receptors are free from binding, the glucose 
transporters are recycled back into the cytoplasm.  
2. In liver tissues, insulin prompts the storage of glucose in the form of glycogen. 
A large portion of glucose absorbed from the small intestine is utilized by hepatocytes to 
convert into the storage of polymer glycogen. 
2.3 Insulin resistance  
Insulin resistance (IR) generally refers to a condition in which normal amount of 
insulin cannot produce adequate metabolic effects of insulin, including the suppressive 
effects of insulin on endogenous glucose production, the stimulatory effects of insulin on 
peripheral (predominantly skeletal muscle) glucose uptake and glycogen synthesis, and 
the inhibitory effects of insulin on adipose tissue lipolysis. Insulin resistance has been 
frequently linked to a number of diseases, including chronic infection, human obesity, 
and type 2 diabetes (Virkamäki, et al., 1999). 
Insulin resistance in liver cells is featured by impaired glycogen synthesis and a 
failure to suppress glucose production. Hyperglycemia and hyperinsulinemia due to IR is 
considered to be the cause of metabolic syndrome and type 2 diabetes. To alleviate 
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insulin resistance by increasing insulin sensitivity is still one of the key avenues to cure 
type 2 diabetes (Le Roith, et al., 2001; Gillies CL, et al., 2007). 
2.4 Glucose homeostasis 
Glucose metabolism is adjusted for the maintenance of blood glucose levels 
within a normal range. The stable status of glucose level is called glucose homeostasis. 
Arterial plasma glucose values during a 24-h period average around 5 mM, with a 
maximum not exceeding 9.17 mM such as after meal (Rizza, et al., 1980) and staying 
above 3.05 mM after exercise (Wahren, et al., 1978) or fasting for 60 h (Consoli, et al., 
1987). This relative stability is in contrasts to the case of other physiological substrates 
such as glycerol, lactate, free fatty acids, and ketone bodies which have much wider 
fluctuations (Gerich, et al., 1993). 
Glucose homeostasis is so critical because glucose is the obligate metabolic fuel 
for the brain under normal conditions, whereas free fatty acids are the main fuel for most 
other organs. This is because of low circulating levels of other possible alternative 
substrates (e.g., ketone bodies) or because of limitations of transport across the blood-
brain barriers (e.g., free fatty acids). After prolonged fasting, a rise in ketone bodies in the 
circulation contributes to brain energy to a large extent. 
Glucose homeostasis is accomplished via highly complicated mechanisms 
involving the anabolic hormone insulin, several insulin-like growth factors and multiple 
organs and cell types (i.e., cells in the liver, pancreas, muscle, adipose tissues, brain and 
gut). Delicate signalling network including nutrient, hormone, neurotransmitter and 
specialized cell types have evolved to orchestrate a whole-body response to glucose level. 
Many catabolic hormones (glucagon, catecholamine, cortisol, and growth hormone) exert 
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catecholamines are involved in the regulation of hepatic glucose metabolism. The key 
role of liver in glucose homeostasis is partially due to its central location, ideally fit to 
control systemic supply of nutrients. Another reason, it’s one of only two organs that can 
both consume and produce glucose. Numerous evidence now established the fact that the 
liver takes up 1/3 of an oral glucose load, skeletal muscle and adipose tissue extract 
around 1/3, and the non-insulin-dependent tissues take up one-third (Meyer, et al., 2002). 
Glucose enters hepatocytes by facilitated diffusion in an insulin independent way 
via GLUT2 transporters, which is in contrast to adipocyte and muscle cells through 
GLUT4 transporters (Pessin, et al., 1992). In the liver, the production of G-6-P is 
mediated by glucokinase (GK), a low affinity enzyme specifically expressed in liver and 
pancreas (HK type IV). Because GK activity rises rapidly as the glucose concentration 
elevates, it functions as a metabolic switch to shift hepatic glucose metabolism between 
fed and fasting states. G-6-P can then be stored as glycogen or metabolized in glycolytic 
or pentose phosphate pathway (Antoine, et al., 1997).  
Glucose output predominantly occurs in the liver from glycogen breakdown. The 
biochemical and central anatomical location of the liver is adapted to release glucose in 
response to decrease in plasma glucose level and is modulated by various hormones. 
Hepatic glucose production (HGP) is an essential mechanism for the maintenance of 
circulating blood glucose levels and supply of glucose to the brain in fasting conditions 
and is delicately controlled to manage whole body homeostasis. HGP is suppressed 
primarily by insulin through modulation of glycogen metabolism, leading to increased 
glycogen synthesis and decreased glycogen breakdown (Ramnanan, et al., 2010). 
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However, glucose homeostasis is disrupted in diabetic condition, and the blood 
glucose is elevated due to unregulated HGP in the fasting state and impaired suppression 
of HGP in the feeding state (Agius, et al., 2007; Boden, et al., 2001). Specifically 
speaking, alterations in glycogenolysis and gluconeogenesis were observed in type-2 
diabetic patients (Baynes, et al., 2004; Atkinson, et al., 1994). The consequence of 
glucose and fatty acids overproduction in liver is further stimulation of insulin secretion 
from the pancreatic β cells, and further peripheral insulin resistance, thereby becoming a 
vicious circle.  
2.4.2 Gluconeogenesis 
Gluconeogenesis is the process of glucose generation especially in the liver from 
non-carbohydrate carbon substrates. When the glucose level drops (hypoglycemia), 
glycogen is mobilized and degraded (glycogenolysis) immediately to supplement 
endogenous glucose. This supply is complemented by gluconeogenesis, the other source 
of endogenous glucose. In animals, gluconeogenesis takes place mainly in the liver with 
the cortex of kidneys contributing to a lesser extent (only after prolonged fasting) (Gerich, 
et al., 2001). 
 The substrates for gluconeogenesis include lactate, glucogenic amino acids and 
glycerol, which originate from anaerobic glycolysis in the skeletal muscle (lactate), the 
breakdown of either muscle protein (alanine) or adipose tissue triglycerides (glycerol). In 
big contrast to liver, muscle does not have glucose-6-phosphatase (G-6-Pase) thus cannot 
release free glucose into the circulation. Instead, glycogen is used as an important fuel for 
contracting skeletal muscle during prolonged strenuous exercise. However, muscle 
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contributes to endogenous glucose production by releasing lactate, which can be 
transported to the liver as substrate for gluconeogenesis (Nurjhan, et al., 1992).  
Most of the enzymes required for gluconeogenesis can be found in the cytoplasm;  
pyruvate carboxylase (PC) and PEPCK being an exception. The former solely exists in 
mitochondrial and the latter acts as an isozyme distributed in both the mitochondrion and 
the cytosol (Chakravarty, et al., 2005). The rate of gluconeogenesis is ultimately 
controlled by the action of two enzyme, fructose-1,6-bisphosphatase and G-6-Pase.  
Increased rates of endogenous glucose production due to increased rates of 
gluconeogenesis have been observed in patients with poorly controlled type 2 diabetes. 
Hence, gluconeogenesis is a therapeutic target for type II diabetes. Indeed, metformin, a 
widely used drug for type 2 diabetes, is known to exert its function primarily by 
inhibiting hepatic gluconeogenesis (Hundal, et al., 2000).  
2.4.3 Glycogenolysis 
Glycogenolysis (also known as “Glycogenlysis”) is the catabolism of glycogen 
polymers into glucose monomers by removal of a glucose monomer through cleavage 
with inorganic phosphate to produce glucose-1-phosphate (G-1-P), which is then 
converted to glucose-6-phosphate (G-6-P), an intermediate in glycolysis. Glycogen 
phosphorylase catalyzes the rate-limiting step in glycogenolysis by catalyzing the 
phosphorylytic cleavage of the 1-4 linkages of glycogen to yield G-1-P. Glycogenolysis 
occurs in the liver and muscle tissue, where glycogen is stored as energy and broken 
down into glucose in response to a hormonal stimulant like epinephrine (e.g., adrenergic 
stimulation) and/or glucagon. The combined action of phosphorylase and other enzymes 
leads to the complete breakdown of glycogen. The reaction catalyzed by 
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phosphoglucomutase is reversible, so that G-6-P can be formed from G-1-P. In liver and 
kidney, but not in muscle, G-6-Pase hydrolyzes G-6-P, exports free glucose into the 
bloodstream. Muscle cells cannot release glucose, instead use G-6-P in glycolysis (Bollen, 
et al., 1998; Ramnanan, et al., 2011).  
Glycogenolysis occupies a large proportion of glucose output at the beginning of 
an overnight fast, but it is gradually replaced by gluconeogenesis with fasting goes on: 
The proportion of glycogenolysis contributing to the overall glucose release into the 
circulation was estimated to be about 45% in overnight-fasted humans, whereas that of 
gluconeogenesis around 55% (Gay, et al., 1994). 
2.4.4 Glucokinase 
Glucokinase (GK) is a type IV isoenzyme which is a member of family of 
hexokinases (ATP: D-hexose 6-phosphotransferase; EC 2.7.1.1), but is a distinct form of 
hexokinase mainly expressed in liver and pancreatic β cells. It facilitates the formation of 
G-6-P in eukaryotic cells. This isoenzyme (Dipietro, et al., 1962) has a molecular mass of 
52 kDa and low affinity for glucose than the other hexokinases. It is not regulated by 
negative feedback by G-6-P as a product, which allows continued signal output (e.g., to 
trigger insulin release) and product formation. GK activity is localized in multiple tissues, 
including liver (Printz, et al., 1993), pancreatic islets of Langerhans (Matschinsky, et al., 
1968), jejunal enterocytes, neuroendocrine cells, and brain of humans and most other 
vertebrates  (Jetton, et al., 1994; Navarro, et al., 1996; Roncero, et al., 2004).  
Mutations of the gene of this enzyme can cause specific forms of diabetes or 
hypoglycemia. For example, maturity onset diabetes of the young 2 (MODY2) is 
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associated with GK mutations (Fajans, et al., 2001). GK mutations that decreased its 
activity have deleterious effects on insulin secretion and hepatic glucose metabolism. 
Increased GK in the hepatocyte was shown to be glycogenic, because only G-6-P 
produced by GK promoted the activation of glycogen synthase. 
GK is encoded by a single gene in the rat, but the alternative promoters allow this 
protein to be expressed in various types of cells with differential regulation. Thus, due to 
tissue specific promoter expression, liver GK is regulated by insulin (Printz, et al., 1993), 
whereas the pancreatic enzyme seems to be controlled posttranslationally by glucose 
levels (Magnuson, et al., 1989). In the liver, GK is found exclusively in hepatocytes, 
which are the predominant cells in liver tissues. GK is demonstrated to be key and rate-
limiting enzyme in the regulation of glucose utilization by hepatocytes.  
2.4.5 Phosphoenolpyruvate carboxykinase (PEPCK) and its relationship to diabetes 
 PEPCK (EC 4.1.1.32) converts oxaloacetate into phosphoenolpyruvate (PEP) and 
carbon dioxide and has been found in two forms: cytosolic and mitochondrial. 
 In animals, PEPCK is the rate-limiting enzyme catalyzing the first step of hepatic 
gluconeogenesis, the process whereby glucose is synthesized from metabolic precursors 
and responsible for hepatic glucose output. The enzyme has therefore been considered to 
be critical in glucose homeostasis, as evidenced by laboratory mice which manifest 
symptoms of Type 2 diabetes mellitus as a result of the overexpression of PEPCK 
(Valera, et al., 1994).  
 PEPCK in the liver is controlled by two different hormonal mechanisms that 
modulate the rate of gluconeogenesis. PEPCK activity is enhanced upon the secretion of 
cortisol and glucagon. As a hormone produced from the alpha cells of the islets of 
37 
 
Langerhans in pancreas, glucagon elevates the expression of PEPCK mediated by 
increased cAMP level in the liver which consequently phosphorylates cAMP response 
element binding (CREB) protein. CREB can bind to CRE (CREB regulatory element) 
upstream of the PEPCK gene and induce PEPCK transcription. On the other hand, 
cortisol (a hormone released from the adrenal cortex) can permeate into liver cells (due to 
its hydrophobic nature) and then binds to a glucocorticoid receptor (GR). GR dimerizes 
and the cortisol/GR complex then translocates into the nucleus and binds to the 
Glucocorticoid Response Element (GRE) region in a similar fashion to CREB and has 
similar results (synthesis of more PEPCK). Cortisol and glucagon can have huge 
synergistic results if applying together. On the other hand, insulin strongly represses 
PEPCK transcription via the activation of the PI3-K pathway (Hall, et al., 1999).  
 In normal people, the elevation in postprandial blood glucose stimulates insulin 
secretion from the pancreas. This increase in blood insulin concentration leads to the 
downregulation of PEPCK gene expression and then, the decrease in gluconeogenesis by 
the liver (Hall, et al., 1999). However, insulin-resistant hepatocytes are unable to convey 
the insulin signal effectively to decrease PEPCK mRNA transcription. Thus, the de novo 
glucose synthesis maintains in spite of high blood glucose (Quinn, et al., 2005). 
Development of compounds that are able to repress PEPCK expression and reverse 
insulin resistance is crucial for devising strategies to cure or treat diseases associated with 
defects in insulin-mediated glucose disposal.  
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Figure 1-5. Schematic metabolic pathways of PEPCK and GK involved in hepatic   
         glucose metabolism.  
 
G-6-P, glucose-6-phosphate;  
F-6-P, fructose-6-phosphate;  
F-1-P, fructose-1-phosphate;  
F-1, 6-P2, fructose-1,6-bisphosphate; 
GK, glucokinase;  
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G-6-Pase, glucose-6- phosphatase; 
FBPase, fructose-1,6-bisphosphatase;  
PFK 1, phosphofructokinase-1;  
PEPCK, phosphoenolpyruvate carboxykinase;  
PK, pyruvate kinase.  
2.4.6.   5'-AMP-activated protein kinase (AMPK) and its relationship to insulin resistance 
The AMPK system is emerging as a metabolic master switch and sensor of 
cellular energy status in both insulin-sensitive and other tissues that are conserved in all 
eukaryotic cells including mammals and lower-class organisms. It serves as a key 
metabolic sensor (Hardie, et al., 1998) that is capable of responding to metabolic stresses 
(like depletion of intracellular ATP) by shutting down the synthesis. Alterations in 
AMPK activity have been demonstrated to regulate glucose transport in skeletal muscle 
and glucose production by the liver. The AMPK system is known to be partially 
responsible for the beneficial effect of exercise and is the target for the well-known 
antidiabetic drug metformin (Hundal, et al., 2000). It is also a potential therapeutic target 
for obesity, type 2 diabetes, and metabolic syndrome (Hardie, et al., 1998). 
 To be specific, AMPK acts as a key regulator of one or more transcription factors 
associated with a monogenic form of diabetes mellitus. AMPK regulates PEPCK gene 
expression via direct phosphorylation of a novel transcription factor referred to as 
AICAR responsive element binding protein (AREBP) (Inoue, et al., 2006). The AMPK 
alpha2 catalytic subunit controls whole-body insulin sensitivity (Viollet, et al., 2003). 
The G-6-Pase and PEPCK genes are both downregulated by activation of AMPK 
(Lochhead, et al., 2000). 
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The heterotrimeric protein AMPK is formed by α, β and γ subunits with specific 
roles. The α subunit has catalytic activity and the β subunit contains a glycogen-sensing 
domain, and most importantly, the γ subunit includes cystathionine-beta-synthase (CBS) 
tandem domains (also called Bateman domains) that bind to the regulatory nucleotides 
AMP and ATP in a mutually exclusive manner. Hormones (e.g., insulin, leptin and 
adiponectin) and cytokines can interact with AMPK system. 
Decreased AMPK activity has been reported to mediate the development of 
insulin resistance in high fat diet (HFD)-fed animal model (Lindholm CR, et al., 2012). 
Both isoforms of AMPK acitivities were substantially decreased by HFD in white 
adipose tissue, heart, and liver of SD rats. To summarize, the HFD-induced decrease in 
AMPK activity was correlated with systemic insulin resistance and hyperleptinemia 
(Lindholm CR, et al., 2012). AMPK phosphorylation, a measure of its activity, was 
demonstrated to be significantly decreased in both red muscle and liver after glucose 
infusion in parallel with the appearance of insulin resistance (Kraegen, et al., 2006). 
AMPK activation has been reported to inhibit the malonyl-CoA formation (Woods, et al., 
2000), diacylglycerol (DAG) synthesis (Carling, et al., 1987), NF-κB activation, and 
oxidative stress (Zimmet, et al., 2001), all of which have been linked to insulin resistance. 
Additionally, decreased AMPK activity has been observed in muscle and liver of insulin-
resistant rodents, including the ZDF rats, fa/fa rats, ob/ob mouse and IL-6 knockout mice 
(De Vit, et al., 1997; Woods, et al., 2000). Taken together, it is highly suggested that the 
attenuated AMPK activity contributed to the development of insulin resistance in 
multiple tissues including liver, skeletal muscle, white adipose tissue and heart. 
2.4.7. AMPK activation in glucose uptake 
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 Pharmacologically, AMPK can be activated by AICAR and the antidiabetic drug 
metformin. It is reported that the α2 isoform of AMPK could be activated in muscle by 
leptin injection in vivo in rats, accounting for its ability to stimulate these pathways. 
Lines of evidence support that AMPK is essential in the activation of glucose uptake in 
an insulin-independent fashion in isolated rat muscle but not in adipocytes (Musi N, et al., 
2003; Sakoda H, et al., 2002). AMPK pathway has also been reported to mediate 
adiponectin induced glucose uptake in skeletal muscle (Yamauchi, et al., 2002). 
Application of AICAR in rodents activated AMPK, which results in lower blood glucose, 
partially due to enhanced muscle glucose uptake. Moreover, activation of AMPK in 
skeletal muscle also led to enhanced insulin sensitivity and oxidation of fatty acids (Musi 
N, et al., 2002). Many factors affect this process including glycogen content, exercise 
training and fiber type (Musi N, et al., 2003). The role of AMPK activation in the liver is 
to facilitate fatty acid oxidation and inhibit glucose production. All of these properties 
make AMPK a promising and potential pharmacological target for the treatment of type 2 
diabetes. 
2.5 Definition and classification of diabetes 
Diabetes mellitus (DM) is a spectrum of disorders that is featured by 
hyperglycemia and glucose intolerance, owing to insulin deficiency and/or impaired 
insulin action.  
Two major forms of diabetes, named type 1 and type 2 diabetes, have been 
defined. Type 1 diabetes (T1DM) is characteristic of absolute insulin deficiency mainly 
due to the autoimmune-mediated or unknown factor induced destruction of pancreatic β 
cells. The immune-mediated T1DM, previously named insulin-dependent diabetes, type 
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1 diabetes, or juvenile-onset diabetes, comprises approximately 5% to 10% of cases in 
the diabetes syndrome. Autoimmune destruction of β-cells is associated with multiple 
genetic susceptabilities and environmental factors that are still poorly understood. 
Patients in this category are rarely obese. These patients are often prone to other 
autoimmune disorders such as Graves' disease, Hashimoto's thyroiditis, Addison's disease, 
vitiligo, celiac sprue, autoimmune hepatitis, myasthenia gravis, and pernicious anemia. 
Generally speaking, patients with T1DM depend on external insulin for their survival 
because the hormone is not produced internally any more. (American Diabetes 
Association, 2012).  
The hallmark of type 2 diabetes (T2DM) is insulin resistance of the target tissues, 
and more than 90% of the diabetic patients suffered from it. It is caused by both genetic 
and non-genetic factors that result in insulin resistance and relative insulin deficiency. 
The specific genes are not known but intense investigation is underway. Aging, excessive 
caloric intake, overweight, central obesity, and sedentary lifestyle form the non-genetic 
factors. It occupies around 90% to 95% of cases in the diabetes syndrome. Type 2 
diabetes has reached epidemic proportions not only in North America, but worldwide. 
Patients with T2DM are insulin resistant, due to such resistance, they may suffer from a 
relative insulin deficiency. However, for some patients with T2DM, insulin might be the 
last resort if all other medications failed to control symptoms, though this is relatively 
unusual. The hyperglycemia is resulted from insulin deficiency and/or resistance of cells 
to the action of insulin. Very often it’s accompanied by disturbances of carbohydrate, fat, 
and protein metabolism. The major factors contributing to the hyperglycemia of T2DM 
are secondary to the failure of pancreatic β-cells to compensate for the insulin resistance 
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adequately, characterized by decreased whole body insulin-mediated glucose utilization 
and elevated hepatic glucose output (American Diabetes Association, 2012). 
The classification system also included a heterogeneous etiologic category named 
as other types of diabetes, whose causes are established or partially known such as 
pancreatic diseases, endocrinopathies, genetic syndrome, insulin receptor abnormalities, 
infection, immune-mediated reaction and drugs or chemicals induced pancreatic 
alterations.  
Gestational DM (GDM) comprised a fourth category resulted from insulin 
resistance and relative insulin deficiency associated with pregnancy and led to higher 
possibilities of complications for the fetus and mother. Around 7% of pregnant women 
are complicated by GDM, which is totally more than 200,000 cases annually worldwide 
(American Diabetes Association, 2012). 
3. Involvement of H2S in diabetes and the underlying mechanism. 
 In the recent decade, attention has been focused on the pathological role of 
CSE/H2S system in diabetes. H2S formation in rat pancrease and liver was significantly 
increased after diabetes induction by streptozotocin (STZ) injection. CSE and CBS 
mRNAs were overexpressed in liver of diabetic animals. Meanwhile, the level of 
pancreatic CBS mRNA was also elevated in diabetic rats and insulin treatment can 
restore the changes in H2S metabolism (Yusuf, et al., 2005). Pancreatic H2S level in 
Zucker diabetic fatty rats (a T2DM model) was significantly higher than that in non-
diabetic Zucker fatty rats (Jia, et al., 2004). Furthermore, increased CSE activity and H2S 
production from different tissues (pancreas and liver) in diabetic animals and humans 
have been observed in various laboratories (Veldman, et al., 2005; Wijekoon, et al., 2005; 
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Ratnam, et al., 2002; Hargrove, et al., 1989). DL-propargylglycine (PPG) as a CSE 
inhibitor significantly decreased H2S production and improved plasma insulin level in 
Zucker diabetic fatty rats (Jia, et al., 2004). As the metabolic source of H2S, cysteine was 
also found to be elevated in diabetic patients with diabetic nephropathy and in the STZ-
treated rats (Hargrove, et al., 1989; Herrmann, et al., 2005). Moreover, in vitro study 
showed that H2S and cysteine inhibit insulin secretion from islets and insulin-secreting β 
cell lines (INS-1E cells and MIN6 cells), and overexpression of CSE inhibits insulin 
release in INS-1E cells; in contrast, lowering of endogenous H2S by PPG or CSE-targeted 
short interfering mRNA (CSE-siRNA) has the opposite effect (Yang, et al., 2005; 
Kaneko, et al., 2006). All of these evidences suggest a derangement of H2S biosynthesis 
has occurred in diabetes (Yusuf, et al., 2005). 
3.1 Inhibition of glucose metabolism and insulin release by H2S  
Treatment of pancreatic β cells with H2S or its donor L-cysteine at physiological 
relevant concentrations decreased ATP content from glucose, which results from an 
immediate and more potent inhibition of glucose metabolism assessed by a fluorescence 
dye (Kaneko, et al., 2006). Even though L-cysteine slightly but significantly inhibited 
glucose induced mitochondrial membrane hyperpolarization, H2S exerted this effect in a 
more potent way. Similarly, L-cysteine and NaHS have inhibitory effects on glucose-
induced [Ca2+] oscillations from isolated mouse islets and β cells. It is also reported that 
H2S induces a suspended animation-like state in laboratory mice by decreasing the 
metabolic rate, although the concentration of H2S used here is far beyond physiological 
range (Blackstone, et al., 2005; Blackstone, et al., 2007).  
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Exogenously applied H2S was demonstrated to inhibit insulin secretion by 
opening of KATP channels (Yang, et al., 2005; Ali, et al., 2007). Pancreatic islets isolated 
from CSE knockout mice display a better insulin secretion rate upon stimulation by high 
glucose (Yang, et al., 2011), which is related to the shortage of H2S production. The 
interaction of H2S and glucose metabolism in pancreatic β cells under pathological status 
is still unclear, and whether inhibition of H2S biosynthesis represents a novel approach to 
the treatment of these conditions in diabetes, remains to be seen. 
3.2 Proapoptotic and proinflammatory effect of H2S  
 Exposure to H2S has an inhibitory effect on mitogen-induced T-lymphocytes 
proliferation and induces apoptosis of polymorphonuclear (PMN) cells (Valitutti, et al., 
1990; Mariggio, et al., 1998). Endogenous H2S also plays a potential proinflammatory 
role in inflammatory conditions (Bhatia, et al., 2005; Li, et al., 2006). Previous studies 
from our lab have shown that overproduction of endogenous H2S via up-regulating CSE 
expression leads to the inhibition of HEK-293 cell proliferation  (Yang, et al., 2004a) and 
induction of human aorta smooth muscle cell (HASMC) apoptosis (Yang, et al., 2006). In 
addition, exogenously applied H2S induces apoptosis of pancreatic acinar cells (Cao, et 
al., 2006), SMCs, human lung fibroblast cells, and inhibits proliferations of cardiac 
fibroblast cells (Liu, et al., 2011), rat pancreatic stellate cells (Schwer, et al., 2012) and 
human airway smooth muscle cells (Perry, et al., 2011), etc. 
3.2.1 Apoptosis induced by H2S in pancreatic acinar cells and β cells 
 Diabetes is a collection of clinical conditions due to absolute or relative insulin 
deficiency with a deficit of functional β cell mass (Mathis, et al., 2001). Any change in β 
46 
 
cell mass will be a reflection of an imbalance between cell proliferation and cell death 
(Scaglia, et al., 1997). Excessive loss of β cell mass composes one of the causes of 
diabetes, and apoptosis is regarded to be the main reason for β cell death in both T1DM 
and T2DM (Chandra, et al., 2001; Lipson, et al., 2006). Apoptotic cell death in pancreatic 
β-cells is involved in the pathogenesis of diabetes. Signals from death receptors and DNA 
damage have been widely accepted as being triggers of apoptosis in β-cells. Endoplasmic 
reticulum (ER) can sense and transduce apoptotic signals. ER stress-mediated apoptosis 
in β-cells plays an important role in the development of diabetes (Oyadomari, et al., 2002; 
Ozcan, et al., 2004). A very recent investigation supports the role of ER stress as a trigger 
for β-cell dysfunction and autoimmunity in type 1 diabetes (O'Sullivan-Murphy, et al., 
2012). 
 Recent study from our laboratory demonstrated that exogenously applied H2S or 
endogenously produced H2S derived from overexpressed CSE can induce apoptosis of 
INS-1E cells via the phosphorylation of p38 mitogen-activated protein kinase (MAPK) 
and up-regulated expression of endoplasmic reticulum (ER) stress-related genes, BiP, 
CHOP, and SREBP-1c. Taken together, it is suggested that CSE/H2S system plays a 
novel role in regulating pancreatic functions under both physiological and diabetic 
condition by stimulating β cell apoptosis (Yang, et al., 2007b). 
3.2.2 Proinflammatory effect of H2S  
 Apart from the role of H2S in cell survival or death and its pathophysiological 
relevance in cardiovascular and neuronal disorders, considerable interest exists in the 
significance of H2S in inflammation. By using H2S donors and specific inhibitors such as 
PPG, a number of investigations have provided evidence for both pro- and anti-
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inflammatory role of H2S. Active research is underway to elucidate the mechanisms of 
H2S action in inflammation, including acute pancreatitis, sepsis, burn injuries and arthritis. 
Recent studies support a proinflammatory role of H2S in animal models of hindpaw 
edema (Bhatia, et al., 2005; Li, et al., 2006), acute pancreatitis (Bhatia, et al., 2005), 
haemorrhagic shock, cecal ligation and puncture-induced sepsis (Zhang H, et al., 2006) 
and LPS-induced endotoxemia (Li, et al., 2005; Collin, et al., 2005). In these studies, 
tissue CSE expression is up-regulated, leading to increased H2S biosynthesis, whereas 
inhibition of H2S formation by PPG has been shown to display distinct anti-inflammatory 
activity (Collin, et al., 2005; Li, et al., 2006). In addition, exogenous H2S itself causes 
lung inflammation in normal mice as evidenced by the elevation in lung myeloperoxidase 
(MPO) activity and plasma tumor necrosis factor-α (TNF-α)  (Zhang H, et al., 2007).  
H2S has also been shown to induce the synthesis of proinflammatory cytokines in human 
monocyte cells and potentiate interleukin-1β (IL-1β)-induced nitric oxide production in 
SMCs via enhancement of extracelluar signal-regualted kinase (ERK) activation  (Li, et 
al., 2006; Zhi, et al., 2007).   
 T1DM is characterized as an inflammatory disease of the pancreatic islets in 
which a process of apoptosis is elicited in beta cells by interaction of activated T-cells 
and proinflammatory cytokines in the immune infiltrate (Kim, et al., 2007; Rabinovitch, 
et al., 1992). The causes of immune-mediated beta cell destruction which triggers T1DM 
include environmental factors, virus, diet and T1DM susceptible gene variants (Burkart, 
et al., 1993; Tschöpe, et al., 2005). Growing evidence has also pointed to a correlative 
and causative relationship between inflammation and insulin resistance/T2DM, and 
lifestyle modifications and medical treatments lowering the inflammatory state reduce 
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risk of future development of T2DM, suggesting that inflammation may play a role in the 
pathogenesis of type 2 diabetes  (Otero, et al., 2006; Xu, et al., 2003; Hotamisligil, et al., 
1993). The correlation of abnormal production of H2S in beta cells and inflammation 
during the development of diabetes is not clarified, and whether inhibition of H2S 
biosynthesis represents a novel approach to the treatment of inflammation in diabetes, 
remains to be known. 
3.3 H2S as an opener of ATP-sensitive K
+ channels (KATP channels)  
 KATP channels exist in a variety of tissues. H2S has consistent effect to open KATP 
channels in VSMCs, gastro-intestinal SMCs, cardiomyocytes, neurons and pancreatic β-
cells, thereby modulating vascular tone, gastrointestinal contractility, myocardial 
contractility, neurotransmission and insulin secretion. In addition to that, lines of 
evidence support that the processes of inflammation, nociception, pain and cell death are 
regulated by H2S, and H2S displays a beneficial (anti-inflammatory, anti-nociceptive and 
anti-apoptotic) effects via its stimulating effect on KATP channels (Tang, et al., 2010). 
 Opening of KATP channel by H2S may underlie H2S induced vasorelaxant effects 
in various vascular tissues, including isolated rat aorta (Zhao, et al., 2001), portal veins 
(Ali, et al., 2006), perfused rat mesenteric beds (Cheng, et al., 2004) and hepatic vascular 
beds (Fiorucci, et al., 2005b). This conclusion is largely based on the application of 
pharmacological antagonist of KATP channel, glibenclamide, to block the vasorelaxation 
induced by H2S (Zhao, et al., 2001; Cheng, et al., 2004). Direct evidence was supplied by 
patch clamp recording showing that exogenous H2S increases macroscopic or unitary 
KATP currents, and the effect is blocked by glibenclamide in isolated rat aorta and 
mesenteric SMC. Glibenclamide also abolished the hyperpolarization of cell membrane 
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induced by H2S (Tang, et al., 2005; Zhao, et al., 2001; Cheng, et al., 2004). Moreover, 
other mechanisms cannot be excluded, since the vasorelaxation induced by H2S is only 
partially mediated by KATP channels in rat aorta (Zhao, et al., 2001; Zhao, et al., 2002). 
Vasorelaxation induced by H2S is endothelium-dependent and might be mediated by NO 
release and endothelium-derived hyperpolarizing factor (EDHF) as well (Zhao, et al., 
2001; Cheng, et al., 2004). The endothelium-dependent vasorelaxation induced by H2S 
shares many common traits with those of endothelium-derived hyperpolarizing factors 
(EDHF). It is assumed that H2S might fulfil a role of EDHF and/or EDRF (Wang, 2009).  
 The importance of KATP channels in the regulation of glucose-induced insulin 
secretion from pancreatic β cells has been elaborated before (Chapter 2.1.3.1). H2S is the 
first discovered endogenous gaseous opener of KATP channels in vascular smooth muscle 
cells (VSMCs). The activation of KATP channels by H2S underlies many H2S induced 
effects such as lowering blood pressure, protecting the heart from ischemia and 
reperfusion injury, and exerting anti-inflammatory, anti-nociceptive and anti-apoptotic 
effects. By analogy to the activatory effect of H2S on KATP channels in VSMCs, H2S also 
functions as an endogenous opener of KATP channels in INS-1E cells independent of 
activation of cytosolic second messengers (Zhao, et al., 2001; Zhao, et al., 2002; Yang, et 
al., 2005) to inhibit insulin secretion from pancreatic β cells. Additionally, basal KATP 
channel currents were significantly reduced by lowering endogenous H2S level with 
CSE-siRNA transfection in INS-1E cells (Yang, et al., 2005). Interaction among H2S and 
KATP channels in insulin-secreting cells may form a critical and potential mechanism for 
the fine control of insulin secretion from pancreatic β cells, however, their interaction 
during the development of diabetes remains to be known. 
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3.3.1 Molecular basis of KATP channels in pancreatic β cells 
 KATP channels are a group of hetero-octamer assembling of four pore-forming 
inwardly rectifying potassium subunits (Kir6.x) and four regulatory sulfonylurea 
receptors (SURx). These channels are inhibited by intracellular ATP and extracellular 
sulfonylureas, but stimulated by ADP and KATP channel openers (Nichols, 2006).  
. KATP channels in cardiac myocytes and β-cells are inhibited by sulfonylureas at 
remarkably different concentrations. The reason is that these channels have a tissue 
specific design in SUR subunits with different affinity to sulfonylureas. β-cell/neuronal 
channels are known to be composed of SUR1, which has highest affinity for 
sulfonylureas, and KIR6.2 as the inward rectifier. The cardiac KATP channels, however, are 
assembled from a lower affinity SUR2A, and KIR6.2, explaining the reason for the 
necessity of higher doses of sulfonylureas to inhibit cardiac channels. In contrast, KATP 
channels in smooth muscle cells consist of SUR2B receptors and KIR6.1 belonging to the 
lower conductance nucleotide diphosphate (NDP)-activated K+ channels (Akrouh, et al., 
2009). 
 The early discoveries pursued in β-cells discovered that glucose induced closure 
of KATP channels underlies the ionic mechanism of first-phase GSIS (Bennett, et al., 
2010).  
3.3.2 Mechanism of H2S induced direct KATP activation 
 Pancreatic KATP channels play a major role in the regulation of insulin secretion in 
β cells. Electrophysiological study provides direct evidence that exogenous H2S increases 
macroscopic or unitary KATP currents, which are blocked by glibenclamide in isolated rat 
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aortic and mesenteric arterial SMCs (Zhao, et al., 2001; Cheng, et al., 2004; Tang, et al., 
2005). In HEK-293 cells transfected with rvKir6.1 and/or rvSUR1 genes, the stimulatory 
effect of H2S on recombinant KATP channels was observed only when rvSUR1 subunit 
was co-expressed with rvKIR6.1 gene, but not on expressed KATP channel with rvKIR6.1 
gene alone, indicating that rvSUR1 subunit of KATP channel complex is the target of H2S 
(Jiang, et al., 2010). Among the replaced cysteine residues of rvSUR1 subunit by 
mutagenesis approach, only the replacement of extracellular C6S or C26S renders the 
loss of channel sensitivity to H2S (Jiang, et al., 2010), demonstrating that these two 
extracellular cysteine residues of rvSUR1 subunit are the target amino acids of H2S 
action. H2S, as a simplest donor of –SH group, might induce sulfhydration of cysteine 
residues on target proteins and then enhance protein activity (Mustafa, et al., 2009).  
 However, it remains unclear whether H2S induced activation of KATP channels 
resulted from S-sulfhydration of KATP channels via the formation of persulfides between 
H2S and exposed free-SH groups of channel protein cysteine residues  (Jiang, et al., 
2010).   
3.4 H2S, a novel regulator of insulin resistance  
 The involvement of imbalance of endogenous H2S production to the pathogenesis 
of diabetes has been discussed previously. As an insulin-sensitive organ, adipose tissue is 
critical for glucose homeostasis in the whole body by mediating glucose uptake and 
metabolism. White adipose tissue as an energy metabolism-active organ involves in 
glucose uptakes and takes up amino acids, including methionine, to convert into fatty 
acid (Feller, et al., 1963). It is reported that CSE expressed in rat adipose tissue is 
responsible for generating H2S endogenously. Both rat adipocytes and pre-adipocytes 
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possess CSE/H2S system, which was up-regulated with aging (Feng, et al., 2009). 
However, higher level of glucose was found to down-regulate the system in a dose- and 
time-dependent fashion. Both basal and insulin-stimulated glucose uptake of mature 
adipocytes was inhibited by H2S, whereas application of CSE inhibitors improved the 
glucose uptake from adipocytes. It is suggested that the PI3-K but not KATP channel 
pathway underlies the mechanism of the inhibitory effect of H2S on glucose uptake. 
Additionally, in fructose-induced diabetic rat model, up-regulated CSE/H2S system was 
observed in adipose tissue, which was negatively correlated with glucose uptake (Feng, et 
al., 2009). A very recent study reported that H2S enhanced renal gluconeogenesis by 
upregulating the gene expression level and gene transcriptional activity of peroxisome 
proliferator-activated receptor-γ (PGC)-1 α, a major regulator of gluconeogenesis by 
activating fructose-1,6-bisphosphatase (FBPase) and PEPCK (Untereiner, et al., 2011). 
Previous study from our lab also revealed that NaHS deteriorated glucose tolerance in 
mice and increased blood glucose level in nonfasting mice (Yang, et al., 2011). All of the 
findings above suggest that H2S might fulfil the role of a novel insulin resistance 
regulator. 
 The involvement of H2S in the pathogenesis of insulin resistance and metabolic 
syndrome has been reviewed in detail lately (Desai, et al., 2011). Since research on H2S 
and the metabolic syndrome is still preliminary, it is difficult to get a conclusive 
mechanism of how H2S is associated with the pathogenesis of, and/or protective 
mechanism against, the metabolic syndrome from varied reports.  
 Elevated blood glucose level (hyperglycemia) is one of the criteria to define 
metabolic syndrome (Alberti, et al., 2005). It will lead to hyperinsulinemia at the early 
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stage, then reduced insulin levels at the late stage if β cells fail to compensate eventually. 
The leptin receptor-mutated (fa/fa) Zucker diabetic fatty (ZDF) rats represent a typical 
genetic animal model of Type2 Diabetes (T2DM), featured by both hyperglycemia and 
insulin resistance. Plasma insulin level in ZDF rats is initially high but drops a lot after 7–
10 weeks associated with disruption of islet morphology, β-cell degranulation, and 
increased β-cell death (Clark, et al., 1983). Overproduction of H2S in the pancreatic islets 
of ZDF rats suggested a probable role of CSE/H2S system in the development of T2DM 
and in insulin synthesis/release (Wu L, et al., 2009). The downstream of H2S effect is the 
opening of KATP channel (Yang, et al., 2005), which plays a primary role in insulin 
secretion.  
 16-week ZDF rats display noticeably greater pancreatic CSE level and H2S 
production but lower serum insulin level compared to the nondiabetic Zucker fatty (ZF) 
or Zucker lean (ZL) rats (Wu, et al., 2009). 8-week ZDF rats in the prediabetic stage had 
a higher serum insulin level than that of age-matched ZL and ZF rats. However, increased 
CSE expression in pancreatic islets from ZDF rats is already observable at this early stage. 
Administration of PPG to inhibit CSE activity improved glucose tolerance of ZDF rats, 
which should be due to improved insulin release associated with reduced pancreatic H2S 
formation. Other parameters like blood glucose and HbA1c level were also improved by 
PPG allocation in ZDF rats. The suppression of the impaired effect of H2S by PPG may 
underlie the antidiabetic effect of PPG on pancreatic insulin release. Of note, non-specific 
effect of PPG independent of CSE inhibition cannot be excluded, since PPG was 
conducted only at one concentration owing to the high expense of animal models. Taken 
together, the relationship between plasma insulin, plasma glucose concentration, 
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pancreatic H2S production and the stage (prediabetic or diabetic) of insulin resistance still 
needs to be elucidated using different rodent models of diabetes, even in diabetic patients 
(Wu, et al., 2009; Wang, 2012).  
 Hypothetically, structure of insulin molecule or insulin receptors on pancreatic β 
cells may be modified by H2S via sulfhydration, leading to impaired insulin release and 
insulin resistance (Wang, 2012). Indeed, injection of the mice with NaHS has lead to an 
instant elevation in blood glucose, decreased plasma insulin, and deteriorated glucose 
tolerance in mice (Yang, et al., 2011).  
 All these data would suggest a potential pharmacological therapeutic approach to 
insulin resistance by inhibiting CSE/H2S system in adipose and liver tissues. 
4. Glucose regulation of gene expression 
 Nutrient regulated gene expression is an important adaption mechanism allowing 
species from yeast to mammals to survive on their intermittent food supplies. Glucose, as 
the most abundant nutrient and primary source of energy in most organisms, is an 
example of such. Regulatory mechanism has been developed by organisms including 
most prokaryotic and eukaryotic species to cope with a fluctuating level of glucose 
supply. Specifically in mammals, the response to glucose is more complicated 
considering the combined effects related to glucose metabolism itself and effects 
secondary to glucose-stimulated hormonal regulations, mainly glucose stimulated insulin 
secretion from pancreatic β cells and inhibition of glucagon secretion from pancreatic α 
cells (Girard, et al., 1997). Apart from the well-known role of insulin and glucagon in the 
regulation of gene expression, glucose has also been shown to be of importance in the 
transcriptional regulation of genes. 
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 Multiple gene expressions are modulated by glucose on the transcriptional level, 
but mostly reported in liver cells such as L-type pyruvate kinase (L-PK), spot 14 (S14), 
aldolase B and fatty acid synthase (Liu, et al., 1993; Bergot, et al., 1992; Thompson, et al., 
1991; Diaz Guerra, et al., 1993; Vaulont, et al., 1994; Decaux, et al., 1991; Giffhorn-Katz, 
et al., 1986). In most cases, glucose and insulin are both required to activate glycolytic 
and lipogenic genes in hepatocytes and the promoters of these genes contained a glucose 
responsive element (GRE). 
 A comprehensive study analyzed large-scale gene expression using Affymetrix 
microarrays and qRT-PCR from islets of normal rats (Wistar rats) and spontaneously 
diabetic Goto-Kakizaki (GK) rats after 48 h of culture at 3 or 20 mM glucose (Ghanaat-
Pour, et al., 2007). Among the 2020 transcripts being investigated, 1033 were up-
regulated and 987 were down-regulated in diabetic islets compared to control. A big 
proportion of these glucose responsive genes are involved in metabolism, signalling, 
transport, apoptosis, transcription, proliferation, and immune response (Ghanaat-Pour, et 
al., 2007). To be specific, several genes encoding glycolytic enzymes were up-regulated 
by high glucose in normal islets, such as glucose phosphate isomerase (Gpi), hexokinase 
2 (Hk2) and Aldolase C, indicating an adaptive response of islets to hyperglycemia. In 
contrast, these glycolytic genes were down-regulated by high glucose in diabetic islets, 
suggesting impaired glycolytic signalling that may account for β-cell dysfunction in GK 
rats, which also confirmed the similar results obtained in islets from patients with type 2 
diabetes (Gunton, et al. 2005). Numerous critical effectors of protein phosphorylation and 
exocytosis were also imbalanced in GK islets (Ghanaat-Pour, et al., 2007). AMPK, 
proposed as a novel β-cell glucose sensor (Leclerc & Rutter 2004), was shown to be 
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down-regulated in diabetic islets (Ghanaat-Pour, et al., 2007), which  is  consistent with 
reports of reduced AMPK activity in human islets from type 2 diabetic subjects (Del 
Guerra et al. 2005).  
 To explore the alterations of glucose regulated gene expression may provide 
evidence to the pathogenesis of human type 2 diabetes and should be of predictive and 
therapeutical value to confer β-cell protection against apoptosis, impaired regenerative 
capacity, and functional suppression occurring in diabetes. 
4.1 Kinase cascade and role of MAPK 
 At least five different mammalian MAPK signalling modules including ERK 1/2, 
p38 MAPK, Jun N-terminal kinase (JNK), ERK3, and ERK5 participate in signal 
transduction pathways (Pearson, et al., 2001). They are activated by several extracellular 
factors and are involved in numerous cellular regulatory processes, such as gene 
expression, protein translation, protein stability, protein localization and enzyme activity, 
thus affecting various cellular endpoints including cell proliferation, differentiation, cell 
survival and cell death (Wada, et al., 2004; Turjanski, et al., 2007). Therefore, it is not 
surprising to see that MAPKs play a variety of roles in physiological processes, including 
embryogenesis, innate and adaptive immunity, metabolic homeostasis, cardiac function 
and neuronal plasticity, and the abnormalities in MAPK signalling are correlated with 
various pathological statuses, ranging from obesity⁄diabetes, rheumatoid arthritis, neuro-
degenerative disorders to cancers (Kyriakis, et al., 2012; Rincon, et al., 2009; Dhillon, et 
al., 2007; Lawrence, et al., 2008). 
 Conventionally, the activation of ERKs is associated with survival responses, 
whereas p38 MAPK and JNK, belonging to the category of stress activated protein kinase 
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(SAPK), are reported to correlate with cell death. However, it is suggested that the 
actions of p38 MAPK are more than generalized stress-response. A more broad 
biological and physiological role of p38 MAPK has been realized (Schindler, et al., 2007). 
p38 MAPK is reported to mediate physiological factor(cytokines, hormones, and osmotic 
and heat shock)-regulated cellular inflammation, development, differentiation, 
proliferation, and survival (Nebreda, et al., 2000; Ono, et al., 2000; Brancho, et al., 2003). 
Extracellular signal-regulated protein kinases 1 and 2 (ERK1 and ERK2) has been well 
known as the terminal enzymes in a ubiquitous three-kinase cascade (Raf——MEK1, 
MEK2——ERK1, ERK2). ERK1 and ERK2 have been implicated not only cell growth 
and proliferation, but also in several inflammatory processes (Kracht, et al., 2002). In 
insulin secreting β cells, ERKs were demonstrated to be stimulated by secretory agonists 
(Frödin, et al., 1995). It has been previously identified that glucose can activate ERK1/2 
and p38 MAPK pathway in insulin-secretion cell lines, whereas JNK were insensitive to 
glucose (Khoo, et al., 1997). The activation of ERK1/2 in pancreatic β cells has been 
supported by other studies (Briaud et al., 2003; Longuet et al., 2005) and it is shown that 
this activation remains in the cytoplasm and participates in the regulation of insulin 
secretion (Longuet et al., 2005). 
4.2 Glucose regulates gene transcription in pancreatic β cells  
 Physiologically speaking, the most important property of pancreatic β cells is to 
store, synthesize and release insulin corresponding to the surrounding glucose level in 
order to maintain glucose homeostasis. Logically and indeed, glucose is a regulator of β 
cell. The β cells have been evolved to be delicately sensitive to glucose and respond to 
even small changes in glucose level in widely varying species. Multiple genes in 
58 
 
pancreatic β cells are demonstrated to be regulated by glucose in an acute or chronic way. 
Generally speaking, the acute effects of glucose within minutes usually rely on the 
allosteric or covalent modification of certain proteins, such as KATP channels modulated 
by the ratio of [ATP/ADP] (Detimary, et al., 1998) and small G-protein Rab-3a activated 
by GTP (Lang, et al., 1999). The consequence will be the closure of KATP channels 
leading to insulin release and GTP induced insulin vesicle budding and exocytosis 
respectively. In addition, glucose induced alteration of the gene expression encoding the 
effector or regulator proteins involved in the acute effect is the foundation for subacute 
(hours) and chronic (days) effect of glucose.  
 Several investigations have explored the identity of genes undergoing glucose 
regulation in pancreatic β cells (Flamez, et al., 2002; Webb, et al., 2000; Minami, et al., 
2000; Ghanaat-Pour, et al., 2007). Glucose level has been shown to be of importance for 
the maintenance of β cell function (energy metabolism, transport, signalling pathway, 
insulin synthesis and secretion and protein synthesis/degradation), whereas prolonged 
exposure to high glucose environment results in insensitivity and eventual toxicity to β 
cells (Schuit, et al., 2002).  
 In pancreatic β cells, glucose is well known to be a key stimulator of insulin gene 
transcription. Glucose can induce two to five folds increase in insulin gene transcription 
in order to restore depleted insulin stores within the first hour after glucose stimulation. 
DNA sequence located around 4 kb upstream of transcription start site is responsible for 
glucose regulated insulin gene transcription (Steiner, et al., 1985). However, a 340 bp 
region proximal to the transcriptional start site is most critical and sufficient for glucose 
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regulated β cell-specific transcription (Fromont-Racine, et al., 1990; German, et al., 
1994).  
 Glucose has to be metabolized to exert the regulatory function for gene 
transcription, which means not glucose itself, but glucose metabolite generated an 
intracellular signal after glucose enters insulin-sensitive tissues, including liver, adipose 
tissues, and pancreatic β cells. G-6-P, as the metabolite in the first step of glycolysis, is 
shown to be necessary for glucose-dependent gene regulation (either upregulated or 
downregulated). Indeed, lines of evidence suggested that G-6-P itself functions as a 
glucose sensitive signalling molecule not only in β cells, also in liver cells (Girard, et al., 
1997; Goya, et al., 1999; Li, et al., 2010; Dentin, et al., 2012). It is demonstrated that G-
6-P concentration is correlated closely with the glucose induced transcription of genes 
(Mourrieras, et al., 1997). However, the role of other glucose metabolites in mediating 
glucose signalling cannot be excluded (Girard, et al., 1997; Scott, et al., 1998; Jitrapakdee, 
et al., 2010; Wiederkehr, et al., 2012). Alternatively, the hexosamine biosynthetic 
pathway as a cellular “sensor” of energy availability mediated the transcriptional effects 
of glucose on gene expression (Sayeski, et al., 1996; Wang, et al., 1998). 
4.3 Transcriptional factors of the Sp1 family are involved in glucose responsiveness  
 Mounting evidences demonstrate that Sp1 as a ubiquitously existed transcription 
factor may underlie a mechanism of glucose responsiveness (Daniel, et al., 1996a; Daniel, 
et al., 1996b; Chen, et al., 1998; Moreno-Aliaga, et al., 2007; Li, et al., 2008). Gene 
transcriptions of leptin, fatty acid synthase, ATP citrase-lyase and mouse vesicular 
glutamate transporter 2 were reported to be regulated by glucose via the Sp1 family 
members (Fukuda, et al., 1999a; Fukuda, et al., 1999b; Li, et al., 2008). Acetyl-CoA 
60 
 
carboxylase (ACC), as the critical enzyme for the biosynthesis of fatty acids, was the first 
gene found in adipocytes to be induced by glucose via the Sp1 binding activity (Daniel, et 
al., 1996a). Dephoshorylation but not the alteration of amount of Sp1 in the nucleus was 
responsible for this induction. The dephosphorylation of Sp1 was mediated by type 1 
protein phosphatise, which was activated by glucose treatment (Daniel, et al., 1996b). 
The glucose-dependent dephosphorylation of Sp1 led to an enhanced binding activity to 
ACC promoter. Similar phenomenon was observed in the promoter activities of aldolase 
A and pyruvate kinase M2, which were increased by glucose via the dephosphorylation 
of Sp1 (Schäfer, et al., 1997). A key role of Sp1 in the transcriptional activation of the 
leptin gene promoter by glucose metabolism has also been explored (Moreno-Aliaga, et 
al., 2007). 
5. Sp1 phosphorylation in gene regulation 
 Sp1 is the prototype of a family of zinc finger transcription factors, including at 
least four Sp1 transcription factors (Black, et al., 2001; Cook, et al., 1999). The activities 
of these transcription factors can be regulated at different levels, such as post-
translational modification (e.g,phosphorylation and glycosylation) and intracellular 
translocation. Specifically for Sp1, the phosphorylation has led to altered DNA binding or 
promoter activation, involving in a variety of physiological processes including cell 
growth, differentiation, apoptosis, angiogenesis, and immune response (Tan, et al., 2009), 
suggesting an important role of the phosphorylation state of Sp1 in the regulation of cell 
physiology. Meanwhile, a recent investigation found that Sp1 phosphorylation by cyclin-
dependent kinase 1 (CDK 1) /cyclin B1 represses its DNA-binding activity during mitosis 
in cancer cells, which promoted cancer-cell proliferation (Chuang, et al., 2012) and 
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implicated Sp1 in the pathological condition. Accumulated evidence has shown that Sp1 
can be phosphorylated by many kinases and the phosphorylation can be affected by 
protein phosphatases.  
5.1 Gene regulation by Sp1 
 GC (GGGGCGGGG) boxes as important cis-acting elements are known to be 
necessary for the transcriptional regulation of many genes ranging from housekeeping 
genes to tissue specific genes, viral and inducible genes (Philipsen, et al., 1999; Suske, et 
al., 1999; Bouwman, et al., 2002). Transcription factor Sp1 is a zinc finger protein that 
binds to GC-rich DNA sequence in both constitutively activated genes and inducible 
genes to regulate their expressions. Sp1 can also interact with cellular factors  (Merika, et 
al., 1995; Datta, et al., 1995; Karlseder, et al., 1996;  Perkins, et al., 1994; Lee, et al., 
1993) and viral gene products  (Trejo, et al., 1997; Krady, et al., 1995; Li, et al., 1991), 
suggesting protein protein interactions are underlying Sp1 mediated signal transduction in 
a cell and gene specific manner despite its ubiquitous existence. Additionally, 
posttranlational modification such as phosphorylation, glycosylation, acetylation, 
sumoylation, and ubiquitination as well as changes in the level of Sp1 can potently 
modulate activity of Sp1 (Saffer, et al., 1991). Until very recently, potential interplay 
between various modification forms of Sp1 has been demonstrated to exert an important 
role in cell cycle entry and mitosis (Wang, et al., 2011). 
5.2 Pathways of Sp1 phosphorylation 
 Investigations have identified more and more kinases that phosphorylate Sp1 in a 
direct or indirect way, including DNA-dependent protein kinase (DNA-PK), PKA, PKC-ζ, 
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casein kinase II (CK-II), ERK, cyclin-dependent kinases (CDK), PP2A, GSK3β and some 
unknown kinases (Armstrong, et al., 1997; Chun, et al., 1998; Fojas de Borja, et al., 2001; 
Milanini-Mongiat, et al., 2002; Chen, et al., 2011; Chu, et al., 2012). Viral infection, 
growth factors, hormones, some drugs and mechanical stress are the triggers known to 
induce Sp1 phosphorylation (Chu, et al., 2012). 
 Putative phosphorylation sites were found in human Sp1 (NCBI accession number 
P08047). The residues include Ser, Thr, and Tyr (from NetPhos 2.0; data not shown) 
(Tan, et al., 2009), which have been confirmed by numerous studies (Chu, et al., 2012). 
5.3 Phosphorylation sites of Sp1 correlating to functional changes  
  Ser59, Ser131, Thr453, Thr579, and Thr739 are the confirmed phosphorylation 
sites on Sp1. They are phosphorylated by ERK, CDK, DNA-PK and CK-II respectively 
(Armstrong, et al., 1997; Chun, et al., 1998; Fojas de Borja, et al., 2001; Milanini-
Mongiat, et al., 2002; Zheng, et al., 2001). Considering the wide range of pathways, 
kinases or phosphatases that regulate Sp1 phosphorylation, one can expect complicated 
results to occur after Sp1 phosphorylation (Chu, et al., 2005). Indeed, it has long been 
noted that the phosphorylation of Sp1 may have positive or negative effects on Sp1 
dependent DNA binding and promoter activation. Take glucose-responsive genes as an 
example, it has been reported that glucose activated adolase A gene in a rat hepatoma cell 
line via Sp1 dephosphorylation (Schäfer, et al., 1997), whereas glucose induced 
phosphorylation of Sp1 through MAPK enhanced Sp1 binding activity to the mVGLUT2 
promoter in a mouse pancreatic β cell line, and dephosphorylation by protein phosphatase 
1 dramatically decreased its binding activity to the same promoter (Li, et al., 2008). The 
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varied effect can be explained because of the cell-type and gene dependent role of Sp1 on 
gene transcription.  
6. Rationale and hypotheses 
 The association of CSE/H2S system with hyperglycemic and insulin resistant 
condition such as Type 1 and Type 2 diabetes mellitus has been intensively studied. CSE 
appears to be the predominant H2S producing enzyme in the pancreas and liver (Wu, et 
al., 2009; Mani, et al., 2011). Increased CSE protein level in pancreas and liver tissues of 
diabetic animals, which in turn gives rise to enhanced H2S production, has been linked to 
the development of diabetic symptoms such as decreased insulin secretion and impaired 
glucose uptake (Yusuf, et al., 2005; Yang, et al., 2005; Yang, et al., 2011; Wu, et al., 
2009). Previous study from our lab showed that H2S inhibited insulin secretion from INS-
1E cell line and high glucose appears to decrease H2S production in these pancreatic β 
cells (Yang, et al., 2005). Specifically for pancreatic β cells, glucose is the major 
physiological stimulus for the regulation of insulin secretion. Glucose has also been 
demonstrated to be critical in regulation of genes at both the transcriptional and 
translational level (Girard, et al., 1997; Towle, et al., 1997; Scott, et al., 1998).  
 Considering both the critical role of glucose on gene expression related to insulin 
secretion and effects of CSE/H2S system on insulin secretion, we hypothesize that 
glucose may regulate CSE gene expression in pancreatic β cells and we want to explore 
the underlying mechanisms as well. 
 In terms of the relationship between glucose metabolism and H2S, there has been 
evidence that both exogenous and endogenous H2S can enhance renal gluconeogenesis by 
upregulating PGC-1α, a critical regulator of energy metabolism (Untereiner, et al., 2011).  
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Given that liver is a major part for gluconeogenesis, we hypothesize that H2S may 
regulate hepatic glucose metabolism by influencing important enzyme activities of 
glucose metabolism, such as PEPCK and GK. Since reports from our lab showed the 
elevated serum H2S level existed in ZDF rats which developed insulin resistance (Wu, et 
al., 2009), and PPG treatment improved serum insulin level of ZDF rats to that of their 
control littlemates, we therefore hypothesize CSE/H2S system may also influence hepatic 
insulin resistance and insulin signalling pathway in liver cells. 
 In summary, the above observations lead us to hypothesize that the lack of H2S 
from the β cells and liver cells of CSE knockout mice has protective effects against the 
development of diabetes. Administration of PPG by inhibiting endogenous CSE activity 
may have similar effects in those cells, including improved insulin secretion in β cells 
and improved glucose utilization in hepatocytes. Furthermore, glucose may modulate 
CSE gene expression in pancreatic β cells. Interplay between glucose and H2S may be 
involved in the physiological and pathological regulation of glucose and insulin level. 
7. Objectives and experimental approaches 
 I. To investigate the relationships of high glucose, CSE gene expression and H2S 
production in rat pancreatic β cells (INS-1E cells) and freshly isolated islets.  
 We investigated whether high glucose had effects on CSE protein level and 
mRNA level in INS-1E cells. Glucose effect on CSE promoter activity was also 
examined by constructing a proximal Cse promoter vector containing specificity protein 
1 (Sp1) consensus sequence. H2S levels were measured in INS-1E cells cultured in the 
presence of high (20 mM) or low glucose (5 mM) for 24 h. As a functional parameter, 
65 
 
insulin release was detected at INS-1E cells after exposure to high or low glucose with or 
without PPG (5 mM). 
 II. To test the effect of exogenous and endogenous H2S on glucose uptake, 
glycogen storage, and glucose production (including the rate of gluconeogenesis and 
glycegenolysis) in liver cells and explore the underlying molecular mechanism. 
 The role of H2S on glucose utilization, glycogen synthesis, as well as 
gluconeogenesis and glycogenolysis in human hepatoma HepG2 cells and primary mouse 
hepatocytes were investigated by a colorimetric method. Activities of glucose metabolic 
enzymes including GK and PEPCK were examined in HepG2 cells in the presence of 
various doses of H2S and PPG. Adenovirus-mediated CSE overexpression was used to 
increase endogenous H2S production. Then the glycogen content was measured in these 
CSE overexpressed HepG2 cells. Glycogen content was also compared between wild type 
mice and CSE knockout mice in both fasting and fed conditions. HepG2 cell viabilities 
were determined after exposure to H2S and PPG at different time points or after 
infections of adenovirus vectors using MTT and trypan blue methods, respectively. 
 III. To determine the role of H2S on hepatic insulin resistance and the alteration 
of the molecular markers in the insulin signalling pathway. 
 Protein levels of phospho-AMPK and total AMPK were checked after incubation 
with physiological concentrations of H2S and PPG by Western blots. AICAR was used as 
a stimulator of AMPK activity to see the reversibility of glucose uptake by H2S. Insulin 
stimulated protein level of phospho-AKT was explored under treatment of H2S, which 
reflects the strength of insulin signalling transduction. 
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CELL CULTURE  
 Rat insulinoma INS-1E cells were kindly provided by Dr. C. B. Wollheim, 
Geneva, Switzerland. INS-1E cells contain numerous insulin granules and exhibit glucose 
stimulated insulin secretion (GSIS). 
 For experiments, passages between No. 50 and 80 were taken. The cells were 
routinely cultivated in RPMI 1640 medium without glucose (Sigma) supplemented with 
glucose (5 or 20 mM), 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonate (HEPES), 
10% fetal bovine serum, 1 mM sodium pyruvate, 50 μM 2-mercaptoethanol, 100 units/ml 
penicillin, and 100 μg/ml streptomycin. The experiments were performed when the cells 
reached 70–80% confluence as previously described (Yang W, et al., 2005). Before 
treatment with different concentrations of glucose, INS-1E cells were preincubated 
overnight in RPMI 1640 medium containing 1% FBS and 5 mM glucose at 37°C in a 
humidified mixture of 5% CO2 and 95% O2 and then subjected to different concentrations 
of glucose or other compounds together with 10% FBS. Glucose stock solution was 
filtered and added directly to culture medium to reach the desired final concentration.  
 HepG2 human hepatoma cell line was obtained from American Type Culture 
Collection (Manassas,VA) and maintained in basal glucose (5.5 mM) Dulbecco's 
modified Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 
units/mL penicillin, 100 μg/ml streptomycin and kept at 37 °C in a humidified 
atmosphere of 5% CO2. Cells were grown upon reaching 70-80% confluence, and then 
preincubated in serum-free medium for 24 h before treatments.  
ANIMAL PREPARATION 
68 
 
 CSE KO mice were generated as previously described (Yang, et al., 2008).  
Twelve week old male CSE KO mice and age-matched male wild-type (WT) littermates 
on C57BL/6J × 129SvEv background were used.  PCR-genotyping of CSE KO mice was 
performed using a three-primer assay in two reactions.  All animal experiments were 
conducted in compliance with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 
1996) and approved by the Animal Care Committee of Lakehead University, Canada.  
All animals were maintained on standard rodent chow and had free access to food and 
water. 
MEASUREMENT OF ENDOGENOUS H2S PRODUCTION IN THE MEDIUM 
AND H2S PRODUCTION RATE  
 H2S production rate was measured as previously described (Stipanuk & Beck, 
1982) with modifications, which has been routinely used in our laboratory (Zhao, et al., 
2001, 2003; Cheng, et al., 2004; Yang, et al., 2008). Briefly, cultured cells reaching 80% 
confluent were collected and homogenized in 50 mM ice-cold potassium phosphate 
buffer pH 6.8. The reaction mixture contained (mM): 100 potassium phosphate buffer pH 
7.4, 10 L-cysteine, 2 pyridoxal 5′-phosphate, and 10% (w/v) homogenate. Cryovial test 
tubes (2 ml) were used as the centre wells, each containing 0.5 ml 1% zinc acetate as 
trapping solution and a filter paper 2 cm×2.5 cm to increase air: liquid contacting surface. 
Reaction was performed in a 25 ml Erlenmeyer flask (Pyrex, USA). The flasks 
containing the reaction mixture and centre wells were flushed with N2 before being 
sealed with a double layer of Parafilm. Reaction was initiated by transferring the flasks 
from ice to a 37°C shaking water bath. After incubating at 37°C for 90 min, 0.5 ml of 
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50% trichloroacetic acid was added to stop the reaction. The flasks were sealed again and 
incubated at 37°C for another 60 min to ensure a complete trapping of H2S released from 
the mixture. Contents of the centre wells were then transferred to test tubes, each 
containing 3.5 ml of water. Subsequently, 0.5 ml of 20 mM N, N-dimethyl-p-
phenylenediamine sulphate (DPD) in 7.2 M HCl was added immediately followed by 
addition of 0.5 ml 30 mM FeCl3 in 1.2 M HCl. Absorbance of the resulting solution at 
670 nm was measured 20 min later with a spectrophotometer. H2S content was calculated 
against the calibration curve of standard H2S solutions. 
 To measure H2S concentration in the medium, 200 μl of culture media from each 
treatment were collected and added to microcentrifuge tubes containing zinc acetate (1% 
w/v, 600 μl) to trap H2S. After 5 min, the reaction was terminated by adding 400 μl of 
DPD (20 μM in 7.2 M HCl) and 400 μl of FeCl3 (30 mM in 1.2 M HCl). After the 
mixture was kept in the dark for 20 min, 300 μl of trichloroacetic acid (10% w/v) was 
added to precipitate any protein that might be present in the culture media. Subsequently, 
the mixture was centrifuged at 10,000×g for 10 min. H2S in the sampled culture media 
interacts with N,N-dimethyl-p-phenylenediamine sulfate to form methylene blue, and the 
absorbance of the resulting solution was determined at 670 nm (Yang, et al., 2007). H2S 
concentration in the culture media was calculated against the calibration curve of 
standard H2S solutions. 
WESTERN BLOTS  
 Whole cell extracts were prepared as described previously (Yang W, et al., 2005). 
Briefly, cultured cells were harvested and lysed in a lysis buffer (EDTA 0.5 M; Tris-Cl 1 
M, pH 7.4; sucrose 0.3 M; antipain hydrochloride 1 μg/ml; benzamidine hydrochloride 
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hydrate 1 M; leupeptin hemisulphate 1 μg/ml; 1,10-phenanthroline monohydrate 1 M; 
pepstatin A 1 μM; plenylmethylsulphonyl fluoride 0.1 mM, and iodoacetamide 1 mM). 
Extracts were separated by centrifugation at 14 000 g for 15 min at 4°C. SDS-PAGE and 
Western blot analysis were performed as previously described (Yang, et al.,2004a). 
Briefly, equal amount of proteins were boiled in 1 × SDS sample buffer (62.5 mM Tris-
Cl, pH 6.8, 2% SDS, 10% glycerol, 50 mM DTT, and 0.01% bromophenol blue) and 
resolved on a 10% SDS-PAGE gel, and transferred onto nitrocellulose membranes (Pall 
corporation, Pensacola, US). Dilutions for the primary antibodies were 1: 1000 for CSE, 
and 1: 5000 for β-actin. HRP-conjugated secondary antibody was used at 1: 5000. 
Immunoreactions were visualized by enhanced chemiluminescence (ECL) and exposed to 
X-ray film (Kodak Scientific Imaging film). Membranes were stripped by incubating in a 
buffer containing 100 mM β-mercaptoethanol, 2% SDS and 62.5 mM Tris-HCl (pH 6.8).  
CELL VIABILITY ASSAY 
 MTT method and Trypan blue assay were used to determine cell viability in INS-
1E cells and HepG2 cells respectively. MTT assay was employed to determine whether 
high glucose had cytotoxic effect on INS-1E cells or HepG2 cells. In brief, cells were 
seeded into 96-well plates at a density of 104 cells per well for 24 h. Detailed 
experimental stages were as follows: 0.5% (5 mg/ml) stock MTT solution was prepared 
by dissolving 100 mg MTT (Sigma) in 20 ml PBS under a sterile and dark atmosphere. 
Solution was then filtered with a 0.22-μm filter and debris was removed. This solution 
could be kept for a month in the dark at 4°C. Culture mediums containing no treatment 
agents were used as control. After incubation with high or basal glucose RPMI-1640 
medium or different doses of H2S or PPG, 20 μl (5mg/ml) MTT was added to each well 
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to a final volume of 200 μL. The plates were wrapped by aluminium foil and incubated 
for 4 h at 37°C incubator. The absorbance of formazan products at 570nm was measured 
in a FLUOstar OPTIMA microplate spectrophotometer (BMG LABTECH, Offenburg, 
Germany). The cells incubated with control medium were considered 100% viable.
 Trypan blue method was used to detect cell viability of HepG2 cells after infection 
of adenovirus vectors. Briefly, cells were resuspended in 1 ml PBS (105cells/ml). 0.4% 
trypan blue and cell suspension (dilution of cells) were mixed in 1:1 ratio and incubated 
for 3 min at room temperature. Around 20 μl of the trypan blue/cell mixture was applied 
to a hemacytometer to do cell counting. The unstained (viable) and stained (nonviable) 
cells were counted separately in the hemacytometer to obtain the total number of viable 
cells. Cell viability was expressed as a percentage of cells excluding trypan blue out of 
the total cells.   
PREPARATION OF INTACT RODENT PANCREATIC ISLETS  
Both rat and mice pancreatic islets were isolated in different studies. Male SD rats 
(8-12w) were received from Charles River Laboratories Canada. (Senneville, QC). These 
animals were housed at 21 °C with 12-h light/dark cycles.  SD rats were anaesthetized by 
intraperitoneal injection of ketamine (90 mg/kg body weight) and xylazine (50 mg/kg 
body weight). For mouse studies, 2-3 month-old mice (CSE-WT and KO) were 
anesthetized with CO2. The abdominal wall was then opened. The pancreas was 
distended by injection of 1 ml of Krebs-Ringer Bicarbonate (KRB) solution (PH=7.4) 
(mM) (129 NaCl, 4.8 KCl, 1.2 KH2PO4, 5 NaHCO3, 1.2 MgCl2, 10 HEPES, 2.5 CaCl2) 
containing 0.5~1 mg/ml Collagenase type V (Sigma, Oakville, Ontario) and 0.5~1 ul/ml 
DNase I (Sigma, Oakville, Ontario), and BSA (0.5 mg/ml) through a cannula inserted in 
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the common bile duct. The pancreas was then removed carefully and transferred to a 50 
mL Falcon tube with above enzyme solution, and incubated for 5~10 minutes in a water 
bath at 37°C. Following this digestion procedure, clean islets of Langerhans were hand-
picked under a dissect microscope after 3 time centrifuge washout (at 1500 rpm for 3 min 
at 4°C) with Ca2+/Mg2+-free KRB solution. Isolated islets were cultured in RPMI 1640 
media supplemented with 10% FBS and 5 mM glucose at a 37°C humidified mixture of 
5% CO2 and 95% O2.     
 
 
 
Figure 2-1. Flow chart of the islet isolation experiments 
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HEPATOCYTE PREPARATION 
 Hepatocytes were isolated from both CSE KO and WT mice as described before 
(Klaunig, et al., 1981) with slight modification.  In brief, livers of 8-12 week old mice 
were perfused through the inferior vena cava with a buffer consisting of (in mM) 140 
NaCl, 2.6 KCl, 0.28 Na2HPO4, 5 glucose, and 10 HEPES (pH 7.4).  The perfusion was 
first for 5 min with the buffer supplemented with 0.5 mM EGTA and then for 10 min 
with the buffer containing 5 mM CaCl2 and 100 U/ml collagenase type IV (Worthington, 
Lakewood, NJ).  All the solutions were prewarmed at 37°C incubator.  The isolated 
hepatocytes were filtered on nylon mesh (100 μm pore size), and selected by 
centrifugation in a 36% Percoll isodensity gradient and then seeded at 7.5×104 cells/per 
well in collagen coated 24 well plates in DMEM (5.5 mM glucose) containing 10% fetal 
bovine serum.  The viability of hepatocytes was measured by Trypan blue staining.  The 
viability of all preparations were above 95%. 
DETERMINATION OF mRNA LEVEL BY REAL-TIME PCR  
 INS-1E cells were harvested and the total RNA was isolated using TriReagent. 
First-strand cDNA was prepared by reverse transcription using M-MuLV reverse 
transcriptase and random hexamer primers from a ProtoScript II RT-PCR Kit (New 
England Biolabs, Pickering, ON, Canada) according to the manufacturer’s protocol. 
Control samples containing no reverse transcriptase were used to safeguard for genomic 
DNA contamination. The primers of rat Cse (GenBank accession number AY032875) 
were 5'-AGCGATCACACCACA-GACCAAG-3'ı (sense, position 432–453) and 5'-
ATCAGCACCCAGAGCCAAAGG-3' (antisense, position 589–609). These primers 
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produced a product of 178 bp. Quantum RNA β-actin internal standards were purchased 
from Ambion (Foster City, CA, USA), which produce a product of 295 bp. Real-time 
PCR was performed in an iCycler IQ 5 apparatus (Bio-Rad, Mississauga, ON, Canada) 
associated with the iCycler optical system software (version 3.1) using SYBR Green PCR 
Relative mRNA quantification was calculated by using the arithmetic formula “2-ΔΔCT” 
(Yang, et al., 2005; Yang, et al., 2007b), where ΔCT is the difference between the 
threshold cycle of a given target cDNA and an endogenous reference β-actin cDNA. 
Based on the calculated ΔCT value, the target mRNA level in the treated group was 
subsequently expressed as the percentage of that in the control group. 
SHORT INTERFERING RNA (siRNA) TRANSFECTION  
 Pre-designed Sp1-targeted siRNA (Sp1-siRNA) and control siRNA were 
purchased from Santa Cruz. INS-1E cells were seeded in six-well plates at a density of 
1×105 cells per well in the presence of 5 mM glucose. Transfection of siRNA into INS-
1E cells was achieved using Lipofectamine 2000 Transfection Reagent (Invitrogen, 
Burlington, ON, USA). Briefly, the cells were transfected with 20 nM Sp1-siRNA or 
control-siRNA (non-targeting siRNA) in Opti-MEM I culture medium (Invitrogen) 
without antibiotics for 4 h. Fresh normal growth medium including antibiotics was then 
added, and the cells were incubated for another 44 h.  
MEASUREMENT OF INSULIN SECRETION FROM ISOLATED PANCREATIC 
ISLETS 
For insulin release determination, freshly isolated islets (10 for each batch) were 
washed and pre-incubated with glucose-free Krebs–Ringer-bicarbonate medium (pH 7.4) 
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containing (mM): 135 NaCl, 3.6 KCl, 5 NaHCO3, 0.5 NaH2PO4, 0.5 MgCl2, 1.5 CaCl2, 
10 Hepes, plus 0.1% BSA in 24-well plates (Yang W, et al., 2005). After 30 min pre-
incubation, cells were incubated for 30 min at 37 °C in the presence of different 
concentrations of tested chemicals (glucose, NaHS, STZ, PPG, sodium pyruvate or 2-
deoxy-D-glucose). Where sodium salts of pyruvate were added, the Na+ content of the 
KRB was correspondingly decreased. At the end of each incubation period, the medium 
was collected and centrifuged for 10 min at 1500 rpm to remove islet debris. The 
supernatant was immediately stored at −20 °C until insulin determination using the 
mouse insulin ELISA kit (Mercodia AB, Sylveniusgatan, Uppsala, Sweden). After insulin 
measurement, the islets were scraped from 24 well plates on the ice into the centrifuge 
tube and then measure protein concentration using Bradford Reagent (Sigma).  
ADENOVIRUS-MEDIATED CSE OVEREXPRESSION IN HEPG2 CELLS  
 Recombinant CSE adenovirus vector (Ad-CSE) was previously constructed in our 
lab (Yang W, et al., 2005). The recombinant adenovirus encoding bacterial β-
galactosidase (Ad-LacZ) derived from the same vector was used as a control.  For 
adenoviral infection, subconfluent HepG2 cells were incubated with Ad-CSE or Ad-LacZ 
in serum-free media. After 4 h of incubation, medium was removed, and cells were 
incubated in appropriate media for 48 h. The transfection efficiency of adenoviral vector 
in HepG2 cells was determined by Western blotting of CSE protein. At MOI (multiplicity 
of infection) = 100, a great increase of CSE expression was seen in Western blotting 
without significant loss in cell viability.  Subsequent experiments were performed at MOI 
of 100. To determine the cell viability after CSE overexpression, all cells were collected 

77 
 
GK activity assay 
 Enzyme activity of glucokinase (GK) was measured following a protocol  on 
Sigma’s website. 
http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Enzyme_Assay/glucokinase.Par.0
001.File.dat/glucokinase.pdf.   
 For each assay, enzymatic activity was determined by the conversion of NADH to 
NAD+ measured by the change in absorbance at 340 nm over time. Enzyme activity was 
measured in a multicell spectrophotometer (Fisher Scientific, Ottawa, Ontario) and was 
expressed as per mili- international unit per minute per milligram (mIU/min/mg) of 
protein. Results were normalized by protein concentration determined by Bradford 
method (Sigma).  
MATERIALS AND DATA ANALYSIS 
   Chemicals were all obtained from Sigma (Oakville, ON, Canada) unless 
otherwise mentioned. Unless otherwise specified, “glucose” refers to D-glucose in this 
communication. The data are expressed as mean ± SEM from at least three or four 
independent experiments. Statistical analyses were performed using Student’s t test on 
paired data or one-way ANOVA. Statistical significance was considered at p<0.05. 
 
 
. 
 
78 
 
 
 
 
 
CHAPTER 3  
 
 
RAT PANCREATIC LEVEL OF CYSTATHIONINE 
GAMMA-LYASE IS REGULATED BY  
GLUCOSE LEVEL VIA SP1 PHOSPHORYLATION 
 
 
Ling Zhang1, Guangdong Yang2, Guanghua Tang3, Lingyun Wu3, Rui Wang1* 
 
1Department of Biology, Lakehead University, Thunder Bay, Ontario, Canada 
2 The School of Kinesiology, Lakehead University, Thunder Bay, Ontario, Canada 
3Department of Pharmacology, University of Saskatchewan, Saskatoon, Saskatchewan, 
Canada 
 
 
 
 
 (This chapter has been published in Diabetologia, 2011; 54(10):2615-2625) 
79 
 
ABSTRACT 
Aims/hypothesis Cystathionine γ-lyase (CSE) catalyses the endogenous production of 
hydrogen sulfide (H2S) in pancreatic β cells, and H2S has been shown to inhibit insulin 
release from these cells. As altered pancreatic H2S production modulated by glucose has 
been previously shown, we hypothesised that the Cse gene could be regulated by glucose 
level in insulin-secreting cells. 
Methods The effects of glucose on CSE protein level and mRNA level were analysed in 
INS-1E cells. Glucose effect on Cse promoter activity was tested by constructing a 
proximal Cse promoter vector including specificity protein 1 (Sp1) consensus sequence. 
Results High glucose (20 mM) inhibited H2S production in INS-1E cells and freshly 
isolated rat pancreatic islets. Cse mRNA expression, CSE activity and protein abundance 
were also profoundly reduced by high glucose. The involvement of SP1 in basal and 
high-glucose-regulated CSE production was demonstrated. Sp1-knockdown abolished a 
large portion of CSE production at basal glucose. Phosphorylation of SP1 stimulated by 
high glucose was inhibited by p38 mitogen-activated protein kinase (MAPK) inhibitors 
SB203580 and SB202190. After blocking p38 MAPK phosphorylation, the inhibitive 
effects of high glucose on CSE protein production and promoter activity in INS-1E cells 
were also virtually abolished.  
Conclusions/interpretation Glucose stimulates the phosphorylation of SP1 via p38 
MAPK activation, which leads to decreased Cse promoter activity and subsequent 
downregulation of Cse gene expression. Inhibited H2S production through glucose-
mediated CSE activity and production alterations may be involved in the fine control of 
glucose-induced insulin secretion.  
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INTRODUCTION 
 Study of H2S has gained momentum in recent years as its role as an important 
gasotransmitter with multifaceted biological significance has become recognised. 
Gasotransmitters are a family of endogenous gaseous signalling molecules involved in 
multi-level regulation of physiological and pathological functions (Wang, 2002). 
Following the identification of nitric oxide (NO) and carbon monoxide (CO) as the first 
two gasotransmitters, mounting evidence has demonstrated that H2S is the third one.  
 H2S is produced in various types of cells via the enzymatic function of two 
enzymes: cystathionine -synthase (CBS) and cystathionine γ-lyase (CSE) (Wang, 2002). 
CSE has been shown to be the predominant H2S-generating enzyme in pancreatic β cells 
(Yang, et al., 2005) and freshly isolated rat islets (Wu, et al., 2009). 
   Activation of ATP-sensitive K+ (KATP) channels is demonstrated to be responsible 
for the inhibitory effect of H2S on glucose-induced insulin release from INS-1E (Yang, et 
al., 2005) and HIT-T15 cell lines (Ali, et al.,2007). As opening of KATP channels leads to 
β cell membrane hyperpolarisation, insulin release from pancreatic islets would be 
inhibited because of reduced Ca2+ influx. Exogenously applied H2S or overproduction of 
CSE has been reported to induce apoptosis of INS-1E cells, suggesting an inhibitory 
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effect of H2S on insulin production by reduction of β cell mass (Yang, et al., 2005). 
Glucose level has been seen to regulate various gene expressions in β cells such as Glut2 
(also known as Slc2a2) (Waeber, et al., 1996), acetyl-CoA carboxylase (Acc [also known 
as Acaca]) (Brun, et al., 1993), and connexin 36 (Allagnat, et al., 2005). Previous 
research suggested a suppressive role of glucose on endogenous H2S production in INS-
1E cells (Yang, et al., 2005). Considering the critical role of glucose level on gene 
regulation in pancreatic β cells and the effect of H2S on insulin secretion, we planned to 
investigate if the production of CSE is regulated by glucose level in insulin-secreting 
cells and the underlying mechanism. Our results indicated that CSE production is 
inhibited by glucose at high concentrations. We further demonstrated that glucose-
induced downregulation of CSE production requires SP1 and p38 mitogen-activated 
protein kinase (MAPK) phosphorylation. The effect of high glucose on CSE production 
may constitute a novel regulatory mechanism for the fine control of insulin secretion 
from pancreatic β cells.  
 
METHODS 
Cell culture  
 INS-1E cells were cultured as previously described by Yang et al. and used 
between passages 50 and 80 (Yang, et al., 2005). The experiments were performed when 
cultured cells reached 70-80% confluence. Before treatment with different concentrations 
of glucose, INS-1E cells were pre-incubated overnight in RPMI 1640 medium containing 
1% FBS and 5 mM glucose at 37°C in a humidified mixture of 5% CO2 and 95% O2 
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(vol./vol.) and then subjected to different concentrations of glucose or other compounds 
together with 10% FBS.  
Preparation of intact islets 
  Pancreatic islets were isolated from male Sprague Dawley rats (8-12 weeks) by 
the collagenase digestion method. The solution used for the isolation was KRB 
supplemented with 0.5–1 mg/ml collagenase type V, 0.5–1 µl/ml DNase I and 0.5 mg/ml 
bovine serum albumin. Animal experiments were conducted in compliance with the 
Guide for the Care and Use of Laboratory Animals published by the US National 
Institutes of Health (NIH Publication No. 85-23, revised 1996) and approved by the 
Animal Use Committee of Lakehead University, ON, Canada.  
Measurement of endogenous H2S production  
 H2S production rate was measured as previously described (Zhao, et al., 2001; 
Cheng, et al., 2004; Yang, et al., 2008). Briefly, INS-1E cells were incubated with either 
5 or 20 mM glucose for 24 h, then collected and lysed in 50 mM ice-cold potassium 
phosphate buffer (pH 6.8). The cell lysates were first incubated with L-cysteine (10 mM) 
for 90 min at 37°C, and then trichloroacetic acid was added to stop the reaction. The level 
of Methylene Blue generated by the interaction of H2S with N,N-dimethyl-p-
phenylenediamine sulfate was determined at 670 nm with a FLUOstar OPTIMA 
microplate spectrophotometer (BMG LABTECH, Offenburg, Germany). H2S content in 
the culture medium was measured as previously described by Yang et al. (Yang, et al., 
2007).  
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Western blots  
 Cultured cells were harvested and lysed in a Tris-EDTA sucrose lysis buffer plus 
protease inhibitors as previously described by Yang et al. (Yang, et al., 2005). Protein 
extracts were separated by SDS-PAGE and blotted onto nitrocellulose membranes (Pall 
Corporation, Pensacola, FL, USA) (Yang, et al., 2004b). The primary antibodies used 
were: anti-CSE antibody (Abnova, Taiwan, Republic of China), anti-SP1 antibody (Santa 
Cruz Biotechnology, Santa Cruz, CA, USA), anti-phospho SP1 (threonine 453) (Abcam, 
Cambridge, MA, USA), anti-phospho-p38 MAPK, anti-p38 MAPK (Cell Signalling 
Technology, Beverly, MA, USA) and β-actin (Sigma). Immunoreactions were visualised 
by ECL Western Blotting System (GE Healthcare, Amersham, UK). Densitometric 
quantification was performed using Alpha Digi Doctor software (Richardson, TX, USA) 
and normalised against the quantity of -actin.  
Short interfering RNA (siRNA) transfection 
  Pre-designed Sp1-targeted siRNA (Sp1-siRNA) and control siRNA were 
purchased from Santa Cruz. INS-1E cells were seeded in six-well plates at a density of 
1×105 cells per well in the presence of 5 mM glucose. Transfection of siRNA into INS-
1E cells was achieved using Lipofectamine 2000 Transfection Reagent (Invitrogen, 
Burlington, ON, USA). Briefly, the cells were transfected with 20 nM Sp1-siRNA or 
control-siRNA in Opti-MEM I culture medium (Invitrogen) without antibiotics for 4 h. 
Fresh normal growth medium was then added, and the cells were incubated for another 
44 h.  
Determination of mRNA level by real-time PCR  
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 INS-1E cells were harvested and the total RNA was isolated using TriReagent. 
First-strand cDNA was prepared by reverse transcription using M-MuLV reverse 
transcriptase and random hexamer primers from a ProtoScript II RT-PCR Kit (New 
England Biolabs, Pickering, ON, Canada) according to the manufacturer’s protocol. The 
primers of rat Cse (GenBank accession number AY032875) were 5'-
AGCGATCACACCACA-GACCAAG-3' and 5'-ATCAGCACCCAGAGCCAAAGG-3'. 
Quantum RNA β-actin internal standards were purchased from Ambion (Foster City, CA, 
USA). Real-time PCR was performed in an iCycler IQ 5 apparatus (Bio-Rad, 
Mississauga, ON, Canada) associated with the iCycler optical system software (version 
3.1) using SYBR Green PCR Master Mix and relative mRNA quantification was 
calculated as described previously (Yang, et al., 2005; Yang, et al., 2007b).  
Cloning of mouse Cse promoter region and construction of reporter plasmids  
  The 172 bp genomic DNA fragment upstream from the transcriptional start site (-
149 to +23) of the Cse gene, containing canonical TATA and CAAT boxes and the SP1 
site, was isolated by PCR from mouse-tail genomic DNA (Ishii, et al., 2004). Briefly, the 
small fragment was amplified using 1.5 μg mouse genomic DNA as template in a 20 μl 
volume reaction with 5 pmol/μl of each primer. The sequences of the primers used were 
as follows: F-Cse-Sp1 (KpnI) (-149/-134), 5'-CGGTACCTCTGTGCCACTGGGAG-3'; 
R-Cse-Sp1 (HindIII) (+7/+23), 5'-GAAGCTTGAGTGCGAGGTGTTGCT-3'. The 
underlined sequence is the restriction site for KpnI or HindIII. The cloned fragments were 
subcloned into the promoterless expression vector pGL3 basic (Promega, Madison, WI, 
USA) to obtain the reporter plasmid pGL3 (-149/+23)-Cse-Prom-Luc. Another plasmid 
was constructed, which was derived from the pGL3 (-149/+23)-Cse-Prom-Luc, and 
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contained a mutated SP1 site. The SP1 response element (5'-GAGGCGGGGC-3') was 
mutated into (5'-GATTCGGGGC-3') by using QuikChange Site-Directed Mutagenesis 
Kit (Stratagene, Mississauga, ON), with oligonucleotide (-144 to -117) 5'-
GCCACTGGGATTCGGGGCAGGAACGATC-3' and its complementary 
oligonucleotide according to the manufacturer’s recommendations. The mutations were 
underlined and in italic letters. All plasmid constructs were verified by DNA sequencing. 
Transient transfection and luciferase assay 
   INS-1E cells were transfected with 900 ng of the reporter plasmid pGL3 (-
149/+23)-Cse-Prom-Luc DNA (CSE-Sp1 vector), mutated-Sp1 promoter or pGL3-basic 
vector, mixed with 100 ng pRL-TK vector (Promega) as an internal control using 
Lipofectamine 2000. Six hours after the transfection, the OptiMEM medium was 
replaced by RPMI 1640 medium with 5 mM or 20 mM glucose in the presence or 
absence of 10 μM p38 MAPK inhibitors SB203580, SB202190 or their non-active 
analogue SB202474 and incubated for another 24 h before harvesting with passive lysis 
buffer (Promega). Samples of the lysates were assayed for luciferase activities in a 
Fluostar Luminometer (BMG LABTECH, Germany) using the Dual-Luciferase Reporter 
Assay System (Promega). Both firefly and Renilla luciferase activities were measured as 
luminescence intensities and the promoter activity was expressed as ratios between firefly 
and Renilla luciferase activities. 
Measurement of insulin secretion from INS-1E cells  
  INS-1E cells were washed and pre-incubated with glucose-free KRB (pH 7.4) 
plus 0.1% BSA in 24 well plates. After 30 min pre-incubation, cells were incubated for 
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another 30 min at 37 °C in the presence of different glucose concentrations with or 
without 5 mM DL-propargylglycine (PPG), 20 mM sodium pyruvate or 20 mM 2-deoxy-
D-glucose (2-DG). Where sodium salts of pyruvate were added, the Na+ content of the 
KRB was correspondingly decreased. At the end of each incubation period, the medium 
was collected and immediately stored at −20°C until insulin determination was completed 
by using the rat insulin ELISA kit (Mercodia AB, Sylveniusgatan, Uppsala, Sweden). 
Materials and data analysis 
   Chemicals were all obtained from Sigma (Oakville, ON, Canada) unless 
otherwise mentioned. Unless otherwise specified, ‘glucose’ refers to D-glucose in this 
communication. The data are expressed as mean ± SEM from at least three independent 
experiments. Statistical analyses were performed using Student’s t test on paired data or 
one-way ANOVA. Statistical significance was considered at p<0.05. 
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RESULTS 
 
High glucose suppressed H2S release from INS-1E cells and pancreatic islets 
 High glucose (20 mM) lowered H2S content of the culture media by 42.1 ± 2.8 % 
(n=6, p<0.05) for INS-1E cells (Figure 3-1A) and 76.4 ± 1.8 % (n=3, p<0.05) for freshly 
isolated rat pancreatic islets (Figure 3-1B) compared with that treated with 5 mM glucose. 
High glucose also decreased H2S production rate in INS-1E cells (n=4; p<0.05) (Figure 
3-1C).  
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Figure 3-1. High glucose inhibited H2S production from INS-1E cells and freshly 
isolated rat islets. INS-1E cells and freshly isolated rat islets were cultured overnight in 
5 mM glucose medium with 1% FBS, and then changed to 5 or 20 mM glucose medium 
with 10% FBS for another 24 h. High glucose significantly inhibited H2S production in 
the culture medium for INS-1E cells (A) and pancreatic rat islets (B). H2S production rate 
in INS-1E cells (C) was also significantly decreased by high glucose. Data in (A) and (B) 
were from at least three independent experiments; data in (C) were from four 
independent experiments. *p<0.05 
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High glucose decreased Cse mRNA expression and CSE protein production in INS-
1E cells  
 After incubation with high glucose for 24 h, CSE protein production was 
significantly decreased (Figure 3-2A). Cse mRNA level in INS-1E cells treated with 20 
mM glucose was 36.5 ± 9.9% of that with 5 mM glucose (Figure 3-2B). To test if the 
decreased Cse gene expression occurred at the transcriptional level, INS-1E cells pre-
incubated for 24 h in 5 or 20 mM glucose medium were then exposed to actinomycin D 
(5 μM) for 0.5 or 2 h (Figure 3-2C). Inhibition of RNA synthesis with actinomycin D in 
the presence of 20 mM glucose did not lead to further reduction in the Cse mRNA level 
compared with 5 mM glucose incubation, suggesting that glucose may not affect Cse 
mRNA stability. Therefore, it repressed the expression of Cse mRNA at the level of 
transcription. 
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Figure 3-2. High glucose downregulated Cse mRNA and CSE protein expression 
in INS-1E cells. After INS-1E cells were incubated with the indicated concentration of 
glucose for 24 h, the cells were collected and subjected to western blots (A) and real-time 
PCR (B) analyses. (C) Glucose had no effect on the stability of the Cse transcript. INS-
1E cells were pre-incubated with 5 or 20 mM glucose for 24 h, and then treated in the 
absence (white bars) or presence of 5 μM actinomycin D (shaded bars) for 0.5 or 2 h. The 
data were normalised to β-actin production and are presented relative to production at 5 
mM glucose. In (A) and (B) the data are from four independent experiments; in (C) the 
data are from three independent experiments. *p<0.05 
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Effects of pharmacological treatments on the expression of CSE  
 Western blots results showed that 20 mM 2-DG mimicked the inhibitive effect of 
20 mM glucose on CSE production in INS-1E cells (Figure 3-3A) and rat islets (Figure 3-
3B). Pyruvate at 20 mM significantly decreased CSE production in both INS-1E cells 
(Figure 3-3A) and isolated rat islets (Figure 3-3B), whereas 20 mM L-glucose and 
mannitol were ineffective. To explore whether β cell depolarisation affects glucose-
induced downregulation of CSE production, INS-1E cells were incubated with 5 mM 
glucose in the presence of KCl (20 mM). KCl treatment did not alter CSE production 
(Figure 3-3A). 
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Figure 3-3. Effect of pharmacological treatments on the expression of CSE. INS-1E 
cells (A) and pancreatic rat islets (B) were incubated with 5 or 20 mM D-glucose, 20 mM 
pyruvate, 20 mM 2-DG, 20 mM KCl in the presence of 5 mM D-glucose, 20 mM 
mannitol or 20 mM L-glucose for 24 h, respectively. After that, the cells or islets were 
collected and subjected to western blot analysis. The data are from three independent 
experiments. *p<0.05 vs 5 mM D-glucose. Glu, glucose; Pyr, pyruvate 
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High-glucose-modulated CSE expression requires the phosphorylation of p38 
MAPK and SP1  
 The phosphorylation of p38 MAPK in INS-1E cells was evident within 15 min of 
high glucose treatment and peaked at 1 h (Figure 3-4A). High-glucose-induced 
phosphorylation of SP1 protein without changing the amount of total SP1 protein (Figure 
3-4B). SB203580 and SB202190 (p38 MAPK inhibitor) but not SB202474 at 10 μM 
abolished the inhibitive effect of high glucose on CSE production. Moreover, inhibition 
of the SP1 binding to the GC boxes of promoter by 100 nM mithromycin A (MA) 
induced a greater decrease of CSE production (Figure 3-4C). 
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Figure 3-4. Glucose-stimulated phosphorylation of p38 MAPK and SP1. (A) 
Glucose induced phosphorylation of p38 MAPK. INS-1E cells were incubated with 
glucose at 5 mM or 20 mM for the indicated time. After that, the cells were collected and 
subjected to western blots analysis. *p<0.05 vs 5 mM glucose treatment group at the same 
time point. (B) Glucose stimulated SP1 phosphorylation. INS-1E cells were pretreated 
with 5 mM glucose RPMI-1640 medium containing 1% FBS overnight and then 
incubated with 5 mM or 20 mM glucose for 24 h. After that, the cells were collected and 
subjected to western blot analysis. *p<0.05. (C) The p38 MAPK-SP1 pathway mediated 
the effect of glucose on CSE production. INS-1E cells were pretreated with or without 
SB203580, SB202190 or SB202474 (control reagent) for 1 h, and then incubated with 
glucose at 5 mM or 20 mM for 24 h in the presence or absence of 100 nM MA. *p<0.01 
vs 5 mM glucose alone group; #p<0.01 vs 5 mM glucose with SB202474 group. The data 
are from three independent experiments 
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Role of p38 MAPK in glucose-induced phosphorylation of SP1  
 To confirm the observation that p38 MAPK is involved in SP1-mediated glucose 
deactivation of CSE, we examined the effects of p38 MAPK inhibitors on glucose-
induced change in production of phospho and total SP1. Pretreatment with two specific 
p38 MAPK inhibitors, SB203580 and SB202190 (both 10 μM), drastically decreased 
glucose-induced phosphorylation of SP1 without changing the amount of total SP1 
compared with the control reagent SB202474, DMSO (1%) or high glucose alone (Figure 
3-5A). Furthermore, the effects of Sp1-specific siRNA on Cse expression were 
determined at protein levels (Figure 3-5B). Transfection of Sp1-specific siRNA 
significantly reduced CSE production. These results indicated an important role of SP1 in 
CSE production. 
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Figure 3-5. Role of SP1 in glucose-induced regulation of CSE. INS-1E cells were 
cultured in 5 mM glucose RPMI-1640 medium containing 1% FBS overnight, and were 
changed on the next day to fresh medium (5 mM glucose), pretreated with or without 
0.1% DMSO (vehicle), 10 μM SB202474, SB203580 or SB202190 for 1 h, respectively, 
and then incubated with 20 mM glucose for an additional 24 h. Production of SP1 and 
phosphorylated SP1 was detected by western blot using specific antibodies. (A) p38 
MAPK inhibitors SB203580 and SB202190 but not non-active analogue SB202474 
decreases high-glucose-induced SP1 phosphorylation in INS-1E cells without changing 
total SP1 production. *p<0.05 vs control at 20 mM glucose alone. (B) INS-1E cells were 
transfected with either control siRNA (black bars) or Sp1-siRNA (white bars) for 48 h at 
5 mM glucose RPMI-1640 medium. Western blot analysis showed successful Sp1 
knockdown and reduced CSE production in INS-1E cell lines. The data were normalised 
and are presented as ratio to β-actin production. The data are from three independent 
experiments. *p<0.05 
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p38 MAPK-SP1 signalling pathway mediated high-glucose-induced decrease of Cse 
promoter activity  
 Transfection of INS-1E cells with Cse core promoter (Cse-Sp1 promoter) resulted 
in a 39-fold increase in luciferase activation in the presence of 5 mM glucose (n=5; 
*p<0.01 vs cells transfected with the promoterless pGL3 basic vector). However, Cse-
Sp1 promoter activity was inhibited significantly by high glucose (20 mM).  
 Mutating the consensus SP1 binding site completely abolished Cse core promoter 
(Cse-Sp1 promoter) activity (Figure 3-6A). By inhibiting p38 MAPK, SB202190 and 
SB203580 completely abolished the inhibitory effect of 20 mM glucose on Cse promoter 
activity in the presence or absence of 10 μM SB202474 (Figure3-6B). 
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Figure 3-6. Effect of glucose on mouse CSE promoter activity. (A) High glucose 
attenuated CSE promoter activity. INS-1E cells were co-transfected with reporter 
plasmids Cse-Sp1 vector (black bars), pGL3-basic vector (shaded bars) or mutated-Sp1 
construct (white bars) together with pRL-TK vector for 6 h, then incubated at 5 or 20 mM 
glucose RPMI-1640 medium for an  additional 24 h. Relative luciferase activity was 
normalised with Renilla luciferase from pRL-TK vector. The data were from five 
independent experiments. *p<0.01 vs 5 mM glucose alone group. (B) SB203580 and 
SB202190 but not SB202474 reversed glucose-reduced CSE promoter activity. INS-1E 
cells were transfected with Cse-Sp1 vector in the presence or absence of the indicated 
concentration of glucose or inhibitors for 24 h. Relative luciferase activity was 
normalised with Renilla luciferase from pRL-TK vector. The data were from four 
independent experiments. *p<0.01 vs 5 mM glucose alone group; #p<0.01 vs 5 mM 
glucose plus SB202474 group 
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PPG, but not pyruvate or 2-DG, enhances high glucose-induced insulin secretion  
 High glucose (20 mM) stimulated insulin secretion from INS-1E cells by 
approximately threefold compared with the basal glucose (5 mM). After treatment with 5 
mM PPG to inhibit CSE activity, insulin secretion at basal glucose was not altered. 
However, high-glucose-stimulated insulin secretion was slightly but significantly 
increased (Figure 3-7A). Conditions of 20 mM 2-DG alone or in the presence of 5 mM 
glucose did not stimulate insulin secretion. However, in the presence of 20 mM glucose, 
2-DG significantly inhibited glucose-induced insulin secretion. Pyruvate (20 mM) had no 
effect on insulin release in the presence or absence of glucose within 30 min of 
application (Figure 3-7B).  
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Figure 3-7. Inhibition of CSE activation enhanced glucose-induced insulin 
secretion. After 30 min pre-incubation with glucose-free KRB, INS-1E cells were 
incubated for another 30 min at 37°C in the presence of different glucose concentrations 
with or without 5 mM PPG (A), 20 mM pyruvate or 2-DG (B). Insulin level in the culture 
media was measured by ELISA. The data were from four independent experiments. 
*p<0.05 vs 5 mM glucose alone group. #p<0.05 vs 20 mM glucose alone group 
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DISCUSSION 
 Endogenous H2S level in pancreatic beta cells plays a critical role in regulating 
insulin release. H2S has been shown to inhibit insulin secretion from insulin-secreting cell 
lines (INS-1E, MIN6 and HIT-T15) and isolated islets (Yang, et al., 2005; Ali, et al., 
2007; Kaneko, et al., 2006; Yusuf, et al., 2005). H2S has also been linked to glucose 
metabolism and insulin resistance by interaction with methylglyoxal, an intermediate of 
glucose metabolism (Chang, et al., 2010) and by inhibiting basal and insulin-stimulated 
glucose uptake in adipocytes (Feng, et al., 2009).  
 Pancreatic production of H2S is regulated by CSE and/or CBS (Yang, et al., 2005; 
Ali, et al., 2007; Kaneko, et al., 2006; Yusuf, et al., 2005). Cse gene knockdown by Cse-
siRNA largely eliminated H2S production from INS-1E cells (Yang, et al., 2005). We 
reported significant production levels of CSE in rat pancreatic islets, but Cbs mRNA 
expression was extremely low (Wu, et al., 2009). PPG, as a specific CSE inhibitor, 
drastically reduced H2S production rate to near zero in pancreatic islets from both Zucker 
diabetic fatty and Zucker fatty  rats. Taken these together, it is believed that CSE is the 
main enzyme for H2S production in rat pancreatic beta cells and the INS-1E cell line.  
 High glucose is capable of regulating the expression of many genes in pancreatic 
beta cells (Schuit, et al., 2002). For example, Glut2 (Waeber, et al., 1996) and Acc (Brun, 
et al., 1993) were upregulated by glucose, whereas Cx36 (also known as Gjd2) (Allagnat, 
et al., 2005), Pparα (also known as Ppara) (Roduit, et al., 2000) and those encoding the 
sulfonylurea receptor 1/inwardly rectifying K+ channel 6.2 (Sur/Kir6.2 [also known as 
Abcc8/Kcnj11]) (Moritz, et al., 2001) were downregulated by high glucose. We have 
previously demonstrated that endogenous H2S production rate in INS-1E cells was 
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modulated by different glucose levels (Yang, et al., 2005). The underlying molecular 
mechanism for the interaction of high glucose and H2S production, however, had been 
unclear. In this study, we found that high glucose inhibited CSE activity represented by 
decreased H2S production rate within 2 h (data not shown). Also for the first time, we 
demonstrated CSE production was repressed by high glucose. Therefore, high glucose 
would both downregulate CSE production and inhibit CSE activity. The latter may be a 
relatively rapid mechanism for mediating glucose-induced insulin secretion.  
  We further investigated whether this inhibitory effect of glucose on CSE 
production is specifically related to cellular metabolism and use of glucose. L-glucose, an 
analogue of glucose that cannot enter beta cell (Vanderford, et al., 2007), had no effect on 
CSE protein abundance. The inhibitory effect of 20 mM glucose on CSE production is 
also unlikely to be due to osmolality change as 20 mM mannitol did not alter CSE 
production. Another analogue of glucose, 2-DG, can be taken up by beta cells through 
GLUT2 transporters and phosphorylated by glucokinase but cannot be metabolised 
beyond the level of glucose 6-phosphate in the glycolytic or pentose-phosphate pathway 
(Girad, et al., 1997). Interestingly, 2-DG inhibited CSE production (Figure 3). This 
phenomenon suggests that glucose 6-phosphate may be key to the glucose-induced 
downregulation of CSE production. Brun et al. (Brun, et al., 1993) reported previously 
that a wide variety of metabolisable nutrients were incapable of inducing Acc mRNA in 
the INS-1 cell line. However, 2-DG was capable of inducing Acc mRNA, suggesting that 
glucose does not have to be metabolised beyond glucose 6-phosphate in the glycolytic 
pathway to induce production of this gene product. Further studies are merited to 
determine the direct effect of glucose 6-phosphate on CSE production to confirm this 
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hypothesis. Pyruvate also significantly decreased CSE protein production even more than 
high glucose did in rat islets (Figure 3-3B). This result indicates that pyruvate, a product 
of a CSE-catalysed reaction, may inhibit CSE production as a product-based feedback 
control mechanism. 
 As 2-DG and pyruvate decreased the production of CSE, it would be expected 
that the consequently lowered endogenous H2S level might promote insulin release, the 
same effect as offered by PPG (Figure 3-7A). However, as the application of 2-DG and 
pyruvate in the insulin release experiments was limited to 30 min, CSE protein level 
would not be changed within this short period of time. We also found that 2-DG and 
pyruvate alone had no effect on H2S  production rate in INS-1E cells, which reflects CSE 
activity (data not shown). Taken together, the effects of 2-DG and pyruvate on insulin 
release (Figure 3-7B), if any, could not be ascribed to changed CSE production or activity. 
Indeed, 20 mM 2-DG significantly inhibited the insulin release stimulated by 20 mM 
glucose. Similar results had been reported previously that 2-DG at 17 mM decreased 
insulin release from rat pancreas (Gagliardino, et al., 1966). The underlying mechanism 
for this interaction of 2-DG and glucose may be related to the competition of 2-DG with 
glucose for transportation into the cells (Kipnis, et al., 1959) and for reaction with 
glucokinase or hexokinase within the cell (Nakada, et al., 1956; Landau, et al., 1958; 
Wick, et al., 1957).  
 Glucose metabolism stimulates insulin secretion by closing KATP channels and 
subsequent calcium influx, eventually leading to exocytosis of insulin granules. To 
examine if glucose-induced depolarisation of beta cells is responsible for CSE 
downregulation, INS-1E cells were treated with 20 mM KCl in the presence of basal 
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glucose. This treatment did not alter CSE production (Figure 3-3A). Similar results were 
obtained from freshly isolated islets under the same treatments (Figure 3-3B). These 
results suggested that Ca2+ influx caused insulin secretion was not implicated in glucose-
repressed CSE production. 
 The human CSE and rodent Cse genes have been cloned before (Ishii, et al., 2004; 
Lu, et al., 1992). The core promoter of mouse Cse contains several putative 
transcriptional factor-binding sites, including myeloid zinc finger protein 1 (MZF-1) and 
SP1 (Ishii, et al., 2004). Deletion of Mzf-1 (in Cos-7 and HEK-293 cells) or Sp1 
consensus sequence (in HEK-293 cells) from Cse promoter significantly decreased the 
promoter activity, suggesting the involvement of these factors in the basal transcriptional 
activity of Cse. Bioinformatics analysis of the promoter region of the mouse and rat Cse 
also revealed the presence of a potential Sp1 consensus sequence (5'-GAGGCGGGGC-3') 
located within the -149/+23 region of the mouse Cse promoter and at -182/-173 region in 
the rat Cse promoter. Previous investigation found (-137 to +18) sequence conferred the 
highest promoter activity in HEK-293 cells using the promoter deletion and mutation 
method (Ishii, et al., 2004). Given that the use of mouse Cse promoter has been examined 
thoroughly, and SP1 is a ubiquitous transcription factor abundantly expressed in different 
species with a highly conservative consensus sequence of ‘GAGGCGGGGC’, we 
generated a pGL3 (-149/+23)-Cse-promoter expression vector (Cse-Sp1 vector) cloned 
upstream to luciferase and used it to transfect INS-1E cells. We demonstrated that SP1 is 
a crucial transactivator for Cse gene expression because transfection of INS-1E cells with 
this Cse core promoter containing the Sp1 consensus sequence (Cse-Sp1 vector) resulted 
in a 39-fold increase in luciferase activity compared with promoterless vector (Figure 3-
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6A). MA binds to GC-rich regions in chromatin and interferes with the transcription of 
genes bearing GC-rich motifs in their promoter and also known as a major SP1 inhibitor, 
as SP1 recognises GC-rich sequences (Blume, et al., 1991). It drastically decreased CSE 
production in the presence of either 5 mM or 20 mM glucose (Figure 3-4C). Sp1 
knockdown also abolished a large portion of CSE protein production (Figure 3-5B), 
suggesting a critical role of SP1 in CSE production. A single Sp1 site mutation of Cse-
Sp1 vector completely abolished the promoter activity of Cse (Figure 3-5A), again 
suggesting the importance of Sp1 in the basal transcriptional activity of Cse. High-
glucose treatment significantly attenuated SP1 transactivation, which provided evidence 
that a glucose-responsive element is located within the proximal portion of the mouse 
Cse promoter (Figure 3-6 A, B).  
 Several reports have suggested the ubiquitously produced transcription factor SP1 
may provide a mechanism for glucose responsiveness (Li, et al., 2008; Schäfer, et al., 
1997). Changes in SP1 phosphorylation result in either facilitation or suppression of 
DNA binding, promoter activation (Schäfer, et al., 1997; Rohlff, et al., 1997; Merchant, 
et al.,1999) and gene transcription (Lam, et al.,2003; Ge, et al., 2003; Ko, et al., 2003). 
SP1 protein can be phosphorylated at various sites by different kinases including protein 
kinase A, protein kinase C, MAPK, casein kinases 1 and 2, and calmodulin kinases (Chu, 
et al., 2003). It was previously reported that glucose can de-phosphorylate SP1 and 
increase promoter binding activity on the Acc gene in adipose tissue (Daniel, et al., 1996). 
The phosphorylation status of SP1 appears to be cell- and gene-type dependent, which is 
also a major factor in mediating the effects of extracellular stimuli such as insulin 
(Samson, et al., 2002). 
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 In the present study, we examined possible signal-transduction pathways related 
to SP1 phosphorylation in high-glucose-induced downregulation of Cse expression. 
Exposure to high glucose has been reported to lead to the activation of various MAPK 
cascades in pancreatic beta cell lines (Frodin, et al., 1995; Khoo, et al., 1997). While p38 
MAPK phosphorylation became significant 15 min after high-glucose treatment (Figure 
3-4A), the decreased Cse mRNA and protein levels were detected 24 h later. Whether the 
downregulation of Cse mRNA expression actually occurred immediately after p38 
MAPK phosphorylation was not tested. It is reasoned that, however, p38 MAPK 
phosphorylation functions as a trigger and the decreased CSE production followed. This 
effect of high glucose is relatively specific as no significant difference was found in 
phospho-p44/42 MAPK level between 5 mM and 20 mM glucose treatments (data not 
shown). Inhibition of p38 MAPK phosphorylation by SB203580 or SB202190 at 20 mM 
glucose significantly decreased SP1 phosphorylation without changing the amount of 
total SP1 protein (Figure 3-5A), indicating that high glucose phosphorylates the existing 
SP1 protein through p38 MAPK. SB203580 and SB202190 but not SB202474 also 
completely reversed the inhibitory effect of high glucose on CSE production (Figure 3-
4C). Moreover, inhibition of SP1 phosphorylation by SB203580 or SB202190 abolished 
the inhibitive effect of glucose to CSE promoter activity (Figure 3-6B). These novel 
observations suggest that high glucose increases phosphorylation of SP1 via p38 MAPK 
activation in INS-1E cells, resulting in a decreased CSE promoter activity and reduced 
Cse transcription.  
 Kaneko et al. (Kaneko, et al., 2009) reported glucose-induced H2S production by 
observing stimulated CSE production after 18 h incubation with high glucose in mouse 
107 
 
islets and MIN6 cells. The discrepancies between the present study and the findings of 
Kaneko et al. may be resolved by considering that H2S level is not directly assayed in 
their study and glucose level in the pre-incubation before treatment was not indicated. 
The discrepancy may also be related to different responses of different cell types or 
animal species to H2S and other experimental conditions. The reported effects of 
CSE/H2S on the survival/apoptosis of pancreatic beta cells are not consistent either (Yang, 
et al., 2007; Kaneko, et al., 2009). We did not find any reduced cell viability after 
incubation with high glucose for 24 h compared with basal glucose (data not shown). Our 
observation was supported by another study in which high glucose promoted pancreatic 
islet beta cell survival through phosphoinositide-3-kinase/Akt signalling at 24 h 
(Srinivasan, et al., 2002). 
 Our study did not directly test whether the phosphorylation of SP1 at the Thr453 
leads to reduced SP-1 binding to the Cse promoter region. A reduced transcriptional or 
promoter activity is not always accompanied by reduced DNA binding (Chu, et al., 2005). 
Transcription activity could be regulated through changes in the interaction between SP1 
and other regulatory factors as a result of SP1 phosphorylation. Thus, altered Cse 
promoter activity associated with SP1 phosphorylation might be related to other 
transcription factors, whose activity has been modified via the phosphorylation of SP1. 
 In conclusion, we report a novel transcriptional mechanism of glucose-induced 
downregulation of CSE in which SP1 phosphorylation by p38 MAPK acts as one 
molecular link between glucose level and CSE production as outlined in Figure 3-8. A 
delicate interplay between glucose level and CSE/H2S in pancreatic beta cells would 
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potentially underlie the regulation of glucose metabolism and insulin secretion under both 
physiological and pathological situations.  
 
 
 
 
Figure 3-8. Schematic signal transduction pathways underlying glucose-repressed CSE     
          production 
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ABSTRACT 
 Mounting evidence has established hydrogen sulfide (H2S) as an important 
gasotransmitter with multifaceted physiological functions.  The aim of the present study 
was to investigate the role of H2S on glucose utilization, glycogen synthesis, as well as 
gluconeogenesis in both HepG2 cells and primary mouse hepatocytes.  Incubation with 
NaHS (a H2S donor) impaired glucose uptake and glycogen storage in HepG2 cells via 
decreasing glucokinase activity.  Adenovirus-mediated cystathionine gamma-lyase (CSE) 
overexpression increased endogenous H2S production and lowered glycogen content in 
HepG2 cells.  Glycogen content was significantly higher in liver tissues from CSE 
knockout (KO) mice compared to that from wild type (WT) mice in fed condition.  
Glucose consumption was less in primarily cultured hepatocytes isolated from WT mice 
than those from CSE KO mice, but more glucose was produced by hepatocytes via 
gluconeogenesis and glycogenolysis pathways in WT mice than in CSE KO mice.  NaHS 
treatment reduced the phosphorylation of AMPK, whereas stimulation of AMPK by 5-
aminoimidazole-4-carboxamide-1-β-d-ribofuranoside reversed H2S-impaired glucose 
uptake.  H2S increased glucose production was likely through increased 
phosphoenolpyruvate carboxykinase (PEPCK) activity.  In addition, insulin at the 
physiological range inhibited CSE expression, and H2S decreased insulin-stimulated 
phosphorylation of Akt in HepG2 cells.  CSE expression was, however, increased in 
insulin resistant state induced by exposing cells to high levels of insulin (500 nM) and 
glucose (33 mM) for 24 hours.  Taken together, these data suggest that the interaction of 
H2S and insulin in liver plays a pivotal role in regulating insulin sensitivity and glucose 
metabolism.  
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Abbreviations 
 
2-NBDG,2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-deoxy-D-glucose; 
AICAR, 5-aminoimidazole-4-carboxamide-1-β-d-ribofuranoside;  
AMPK, 5'-AMP-activated protein kinase;  
CSE, cystathionine gamma-lyase;  
Dex, dexamethasone; 
GK, glucokinase; 
IR, insulin resistance; 
KO, knockout; 
PEPCK, phosphoenolpyruvate carboxykinase; 
PPG, DL-propargylglycine; 
WT, wild-type. 
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INTRODUCTION 
 The liver has a central role in maintaining glucose homeostasis.  When plasma 
glucose and insulin levels are high, the liver takes up glucose, replenishes depleted 
glycogen stores, and synthesizes fatty acids (Pilkis, et al., 1992).  Type 2 diabetes is 
associated with the inability of hepatic control of glucose homeostasis.  The defects of 
insulin to trigger downstream actions in liver are defined as hepatic insulin resistance, 
including impaired glycogen synthesis, and failure to suppress endogenous glucose 
production (Kim, et al., 2003).  
 H2S, a gasotransmitter, has been implicated in the pathogenesis of diabetes.  
Gasotransmitters are a group of gaseous signalling molecules, which are generated and 
metabolized in our body.  Nitric oxide (NO), carbon monoxide (CO), and H2S are three 
known gasotransmitters  (Wang, 2012).  H2S formation in pancreases of Zucker diabetic 
fatty rats was significantly higher than that in non-diabetic Zucker fatty rats (Wu, et al., 
2009).  Compared with non-diabetic animals, streptozotocin-induced diabetic rats had 
higher H2S production rate in liver tissues (Yusuf, et al., 2005).  In addition, H2S has 
been reported to regulate glucose metabolism by interaction with methylglyoxal, an 
intermediate of glucose metabolism (Chang, et al., 2010) and is a novel insulin resistance 
regulator (Feng, et al., 2009).  Increased hepatic cystathionine gamma-lyase (CSE) 
activity and content in diabetic animals have been observed in different laboratories 
(Wijekioon, et al., 2005; Hargrove, et al., 1989).  CSE has been demonstrated to be the 
predominant H2S producing enzyme in rodent liver tissues (Kabil, et al., 2011; Mani, et 
al., 2011).  Given the importance of liver for the pathogenesis of diabetes and altered 
endogenous hepatic production of H2S in diabetes, it becomes imperative to understand 
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whether glucose metabolism in liver cells is regulated by H2S and to explore the 
underlying signalling cascade.  
 The present study was to determine whether H2S affects glucose metabolism and 
insulin signalling in the HepG2 human hepatoma cell line and primary hepatocytes 
isolated from wild-type (WT) and CSE knockout (KO) mice.  To test this hypothesis, we 
examined the basal and insulin stimulated glucose consumption and glucose production 
by measuring the glucose concentration in the medium after treatment with NaHS (a H2S 
donor) or DL-propargylglycine (PPG, a CSE inhibitor).  Glycogen content was also 
compared under fed and fasting conditions between CSE KO and WT mice. 
   
MATERIALS AND METHODS 
 
Animal preparation 
 CSE KO mice were generated as previously described (Yang, et al., 2008).  
Twelve week old male CSE KO mice and age-matched male WT littermates on 
C57BL/6J × 129SvEv background were used.  PCR-genotyping of CSE KO mice was 
performed using a three-primer assay in two reactions.  All animal experiments were 
conducted in compliance with the Guide for the Care and Use of Laboratory Animals 
published by the US National Institutes of Health (NIH Publication No. 85-23, revised 
1996) and approved by the Animal Care Committee of Lakehead University, Canada.  
All animals were maintained on standard rodent chow and had free access to food and 
water. 
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Cell culture and treatments 
 HepG2 human hepatoma cell line was obtained from American Type Culture 
Collection (Manassas,VA) and maintained in low glucose (5.5 mM) Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum, 100 units/mL 
penicillin, 100 μg/ml streptomycin and kept at 37 °C in a humidified atmosphere of 5% 
CO2.  Cells were grown upon reaching 70-80% confluence, and then preincubated in 
serum-free medium for 24 h before treatments.  The effects of NaHS and PPG on cell 
viability were assessed as the ability of the cells to reduce 3-[4,5-dimethyl-thiazol-2-yl]-
2,5-diphenyl-tetrazolium bromide (MTT).  For these assays, HepG2 cells were seeded in 
96 well plates, maintained with 5.5 mM glucose DMEM medium and treated with NaHS 
or PPG at different doses.   
 
Hepatocyte preparation 
 Hepatocytes were isolated from both CSE KO and WT mice as described before 
(Klaunig, et al., 1981) with slight modification.  In brief, livers of 8-12 week old mice 
were perfused through the inferior vena cava with a buffer consisting of (in mM) 140 
NaCl, 2.6 KCl, 0.28 Na2HPO4, 5 glucose, and 10 HEPES (pH 7.4).  The perfusion was 
first for 5 min with the buffer supplemented with 0.5 mM EGTA and then for 10 min 
with the buffer containing 5 mM CaCl2 and 100 U/ml collagenase type IV (Worthington, 
Lakewood, NJ).  All the solutions were prewarmed at 37°C incubator.  The isolated 
hepatocytes were filtered on nylon mesh (100 μm pore size), and selected by 
centrifugation in a 36% Percoll isodensity gradient and then seeded at 7.5×104 cells/per 
well in collagen coated 24 well plates in DMEM (5.5 mM glucose) containing 10% fetal 
115 
 
bovine serum.  The viability of hepatocytes was measured by Trypan blue staining.  The 
viability of all preparations was above 95%. 
 
Adenovirus-mediated CSE overexpression in HepG2 cells  
  Recombinant CSE adenovirus vector (Ad-CSE) was constructed as previously 
described (Yang, et al., 2005).  The recombinant adenovirus encoding bacterial β-
galactosidase (Ad-LacZ) derived from the same vector was used as a control.  For 
adenoviral infection, subconfluent HepG2 cells were incubated with Ad-CSE or Ad-LacZ 
in serum-free media.  After 4 h of incubation, media was removed, and cells were 
incubated in appropriate media for 48 h.  The transfection efficiency of adenoviral vector 
in HepG2 cells was determined by Western blotting of CSE protein.  At MOI 
(multiplicity of infection) = 100, a great increase of CSE expression was seen in Western 
blotting without significant loss in cell viability compared to Ad-LacZ transfected vector 
control.  Subsequent experiments were performed at MOI of 100.  To determine the cell 
viability after CSE overexpression, all cells were collected by trypsinization followed by 
centrifugation after transfection.  Cell viability was expressed as a percentage of cells 
excluding trypan blue out of the total cells.   
 
Measurement of glucose consumption and glucose uptake 
 HepG2 cells or primary hepatocytes from WT or CSE KO mice were plated onto 
24-well tissue culture plates at a concentration of 7.5×104 cells per well with some wells 
left blank and maintained in low glucose-DMEM (5.5 mM) medium.  Cells were starved 
in serum-free low glucose-DMEM medium for 24 h, and then subjected to various 
116 
 
concentrations of glucose in the presence of NaHS, and/or insulin (10 nM) for 6 or 24 h.  
After treatments, cell medium was collected for glucose measurement.  Glucose 
concentration was determined using a glucose assay kit II (Biovision, Mountain view, 
CA), since it is designed to be unaffected by reducing substances such as H2S, which is 
different from other suppliers offering oxidase-based kits 
(http://www.biovision.com/glucose-assay-kit-ii-3972.html).  Glucose level of the wells 
with cells was subtracted from that of the blank wells at the same treatment to obtain the 
amount of glucose consumption (Yin, et al., 2002). 
 Glucose uptake was determined by a nonradioactive method using a new 
fluorescent analog of D-glucose, 2-[N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl) amino]-2-
deoxy-D-glucose (2-NBDG) (Yoshioka, et al., 1996).  Different from the above glucose 
consumption method, this method detects transient glucose uptake which can be saturated 
in a short time.  2-NBDG was obtained from Molecular Probes (Invitrogen, Burlington, 
ON).  HepG2 cells were plated at 1×10
4/well in 96-well plates and used at subconfluence 
after 24 h preincubation.  For experiments, culture medium was removed from each well 
and replaced with 100 μL of glucose-free DMEM medium in the absence or presence of 
10 μM 2-NBDG with or without NaHS or PPG at the indicated concentrations for 1 hour.  
After treatment, the cells were washed in a modified balanced salt solution (MBSS) to 
stop the reaction before fluorescence analysis.  MBSS (pH 7.4) has an osmolarity of 300 
mOsm/L and contains (mM): 140 NaCl, 5.4 KCl, 0.5 MgCl2, 0.4 MgSO4, 3.3 NaHCO3, 
2.0 CaCl2, 10 HEPES, 5.5 glucose (O’Neil, et al., 2005).  Fluorescence intensity was 
detected by a FLUOstar OPTIMA microplate spectrophotometer (BMG LABTech, 
Offenburg, Germany) at 485 nm excitation and 544 nm emission wavelengths.  
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 Measurement of glycogen content 
 HepG2 cells were maintained in culture for 24 h after media change, and then 
exposed to NaHS and/or insulin (10 nM) or PPG for 6 h in medium glucose-DMEM 
(11.1 mM glucose) media.  In another experiment, the cells were transfected with Ad-
CSE or Ad-LacZ as a control vector for 48 h.  After that, the cells were collected to 
measure glycogen content.  For animal experiments, a liver biopsy was taken from WT or 
CSE KO mice under fed, 6 h fasting or overnight (16 h) fasting conditions.  After 
laparotomy, a 1- to 2-g piece of the liver was removed and immediately frozen in liquid 
N2 and then stored at -80°C.  Protein concentration was analyzed by Bradford reagent.  
Glycogen content was determined using a glycogen assay kit according to the 
manufacturer’s protocol (Biovision, Mountain view, CA) and normalized to total protein 
concentration determined from whole-cell lysates.  In this method, glucose is the sole 
substrate for glycogen synthesis. 
 
Hepatic glucose production 
 The effect of exogenous H2S on hepatic glucose production was measured by 
incubating HepG2 cells in 24-well plates at a density of 7.5×10
4/well at 37 °C in a 
humidified atmosphere (5% CO2).  To see the effect of endogenous H2S on glucose 
production, primary hepatocytes from WT and CSE KO mice were incubated at the same 
condition as HepG2 cells.  After 24 h of pre-culture, the HepG2 cells were treated with or 
without NaHS or PPG in serum-free low glucose medium (5.5 mM) for 6 h.  HepG2 cells 
or primary hepatocytes from WT and CSE KO mice were washed twice with phosphate 
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buffered saline (PBS) to remove glucose and then incubated for 3 h in glucose production 
assay medium (glucose and phenol red-free DMEM medium containing 2 mM sodium 
pyruvate, 20 mM sodium lactate, pH 7.4) stimulated by dibutyl-cAMP (100 μM) and 
dexamethasone (50 nM).  Three hundred microliter medium was sampled for 
measurement of glucose concentration.  Glucose concentration was normalized with 
cellular protein concentration.  The above method can represent the rate of 
gluconeogenesis since the substrates were supplied. 
 The effect of H2S on hepatic glycogenolysis was measured in vitro in HepG2 cells 
and primary hepatocytes from WT and CSE-KO mice.  Briefly, HepG2 cells or primary 
hepatocytes were pre-cultured in 24-well plates with high glucose-DMEM (25 mM) for 
24 hours.  Next day, cells were washed twice by PBS, and then incubated with 1 mL 
DMEM in the absence of glucose, glutamine and pyruvate but containing 0.24 mM 3-
isobutyl-1-methylxanthine (IBMX) in the presence or absence of NaHS (10 μM), PPG (1 
mM) or glucagon (10 nM).  IBMX was dissolved in dimethyl sulfoxide (DMSO) to a 
concentration in the medium that did not interfere with cell viability (maximally 0.1%, 
v/v).  Glycogenolysis was estimated by the rate of glucose appearance in the incubation 
as no gluconeogenic substrates were added.  Glucose content in the incubation medium 
was determined at 0, 10, 20 and 30 min of incubation.  The supernatant was removed, and 
cells were lysed to measure protein concentration by Bradford reagent.  The glucose 
content of the supernatant in the medium was measured using a glucose assay kit II 
(Biovision, Mountain view, CA).  Glucose concentrations were normalized to cellular 
protein concentration.   Different from the above assay measuring the rate of 
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gluconeogenesis from substrates, the assay of glycogenolysis measures glycogen 
breakdown from endogenous glycogen store within 30 mins. 
 
Establishment of insulin resistant HepG2 cell model  
 To develop a model of insulin resistance, HepG2 cells were incubated with 500 
nM insulin for 24 h with 33 mM glucose-DMEM medium.  In the normal control group, 
5.5 mM glucose-DMEM medium was used to culture cells for 24 h.  The cells in the 
normal control group and model group were washed twice with PBS, then treated with or 
without insulin (10 nM) for 24 h at medium glucose-DMEM (11.1 mM).  In another 
group, the insulin resistant model cells were washed and incubated with PPG (1 mM) in 
medium glucose-DMEM (11.1 mM) for 24 h.  Glucose consumption (with or without 
insulin stimulation), which represents the amount of glucose depleted from the culture 
medium (11.1 mM glucose) within 24 h, were determined to prove the successful 
establishment of insulin resistant cell model.   
 
Measurement of endogenous H2S production 
 H2S production rate was measured as previously described, which has been 
routinely used in our laboratory (Zhao, et al., 2001; Cheng, et al., 2004).  Briefly, cell 
lysates were incubated with L-cysteine (10 mM) for 90 min at 37°C water bath, and then 
trichloroacetic acid (TCA) was added to stop the reaction.  The level of methylene blue 
generated by the reaction of H2S with 20 mM N,N-dimethyl-p-phenylenediamine 
sulphate (DPD) was determined at 670 nm with a multicell spectrophotometer (Fisher 
Scientific, Ottawa, ON).  
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Western blotting  
 Cultured cells were harvested and lysed in a Tris-EDTA sucrose lysis buffer plus 
protease inhibitors as previously described (Yang, et al., 2005).  Protein extracts were 
separated by SDS-PAGE and blotted onto nitrocellulose membranes (Pall Corporation, 
Pensacola, USA).  Protein samples were analyzed with antibodies against CSE (Abnova, 
Taiwan), β-actin (Sigma), Phospho-Akt(Ser473), Akt, Phospho-AMPKα (Thr172), 
AMPKα (Cell Signaling Technology Inc., Beverly, MA).  Immunoreactions were 
visualized with a chemiluminescence reagent (GE healthcare, UK) and exposed to X-ray 
films (Amersham HyperfilmTM ECL, GE healthcare).  Each blot shown in the figures is 
representative of at least four experiments.  Protein quantification was performed by 
Alpha Digi Doctor software (Richardson, TX, USA), and the intensity values were 
normalized to the quantity of β-actin.   
 
Enzyme assays  
 The enzymatic activities of phosphoenolpyruvate carboxykinase (PEPCK) were 
determined by spectrophotometric assays as previously described (Chambers, et al., 
2010).  Enzyme activity of glucokinase (GK) was measured following a protocol in 
Sigma’s website 
http://www.sigmaaldrich.com/etc/medialib/docs/Sigma/Enzyme_Assay/glucokinase.Par.0
001.File.dat/glucokinase.pdf.  Briefly, for each assay, enzymatic activity was determined 
by the conversion of NADH to NAD+ measured by the change in absorbance at 340 nm 
over time.  Enzyme activity was measured in a multicell spectrophotometer (Fisher 
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Scientific, Ottawa, ON) and was expressed as per mili- international unit per minute per 
milligram (mIU/min/mg) of protein.  Results were normalized by protein concentration 
determined by Bradford method.  
 
Materials and data analysis  
 Chemicals were all obtained from Sigma-Aldrich (Oakville, ON) unless otherwise 
mentioned.  The data were expressed as mean ± SEM from at least four independent 
experiments.  Statistical analyses were performed using Student’s t test for paired data or 
one-way ANOVA.  Statistical significance was considered at p<0.05. 
 
 
RESULTS 
 
Effects of H2S on glucose consumption  
 The presence of glucose stimulated glucose consumption in HepG2 cells in a 
dose-dependent manner (Fig. 4-1A), and this effect does not appear to be due to the 
alteration of cell number (Fig. 4-1B).  When the glucose concentration was elevated from 
5.5 mM to 22.2 mM, glucose consumption was increased from 1.3 mM to 2.59 mM (Fig. 
4-1A).  Incubation of HepG2 cells with 100 μM NaHS for 24 h significantly decreased 
glucose consumption by 20-30% (p<0.05) (Fig. 4-1A).  The effect of NaHS was not due 
to a decrease in cell number.  At the concentration between 10 to 100 μM, NaHS had no 
effect on cell viability measured by MTT assay.  However, 300 μM NaHS started to 
decrease cell viability (Fig. 4-1C).  Similarly, NaHS at 10, 30, 100 μM significantly 
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decreased 2-NBDG uptake, but not at 300 μM, which is probably far beyond 
physiological range and has toxic effect (Fig. 4-1D).  NaHS also significantly reduced 
insulin-stimulated glucose consumption (Fig.4-1E).  PPG at 1 mM did not show any 
effect on glucose uptake (Fig. 4-1D) and glucose consumption (Fig. 4-1E) at the basal 
level.  Insulin stimulated-glucose consumption was not altered by PPG either (Fig. 4-1E).  
Primary hepatocytes from CSE-KO mice exhibited a two-fold increase in glucose 
consumption rate (25.52 ± 2.22 μM/mg protein) compared to that from WT mice (12.18 ± 
0.97 μM/mg protein) at 24 hours (Fig.4-1F). 
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Figure 4-1.  Effects of H2S on glucose consumption and uptake in HepG2 cells and 
hepatocytes.  
(A) Effects of NaHS on glucose consumption at various levels of glucose (5.5, 11.1, 16.7, 
and 22.2 mM) in HepG2 cells.  Glucose consumption was measured after 24 h incubation 
with or without 100 μM NaHS.  n=4 in each condition. * p<0.05 versus control.  (B) 
Effect of glucose on cell proliferation.  HepG2 cells were plated at 6-well plate in the 
density of 105/well and cultured in vitro under varying doses of glucose for 24 h.  Cell 
numbers were counted after trypsinization to reflect cell growth within 24 h.  n=4.  (C)  
Cell viability with NaHS or PPG treatment for 24 h.  HepG2 cells were seeded in 96 well 
plates, maintained with 5.5 mM glucose DMEM medium overnight upon reaching 70-
80% confluence, and then treated with NaHS or PPG at different concentrations in 
serum-free medium for 24 h.  Cell viability was assessed as the ability of the cells to 
reduce MTT.  n=5.  * p<0.05 versus control.  (D) Changes in glucose uptake in HepG2 
cells.  Glucose uptake was measured by incubating cells with 2-NBDG (10 μM) in the 
absence or presence of NaHS or PPG at indicated concentrations for 1 h.  n=4. * p<0.05.  
(E) Effects of NaHS or PPG on insulin stimulated-glucose consumption.  HepG2 cells 
were incubated with different doses of NaHS or PPG for 6 h at medium glucose DMEM 
(11.1 mM) with 10 nM insulin stimulation.  Glucose consumption was then measured as 
described in Methods.  n=4.  * p<0.05 versus control. # p<0.05 versus insulin alone group.  
(F) Glucose consumption over 24 hours by hepatocytes of CSE-KO or WT mice.  n=4, * 
p<0.05. 
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Effects of H2S on glycogen storage  
  Exposing HepG2 cells to 10, 30 and 100 μM NaHS for 6 h at medium glucose 
concentration (11.1 mM) resulted in a dose-dependent reduction in glycogen content (up 
to 42%) relative to control values (Fig. 4-2A), which remained constant until 24 h without 
or with insulin (Supplemental Fig. 4-1A and 4-1B, respectively).  PPG at 1 mM 
significantly improved glycogen storage (Fig. 4-2A). 
 We overexpressed CSE gene in HepG2 cells by using a highly effective 
replication-deficient adenovirus expression system.  CSE expression in Ad-CSE 
transfected cells was apparently higher than that in Ad-LacZ transfected cells or control 
cells (Fig. 4-2B).  The most significant expression was observed in cells after 48 h 
infection with Ad-CSE at 100 MOI (Fig. 4-2B).  Cells infected with Ad-CSE at 100 MOI 
also exhibited a marked increase in CSE activity as reflected by H2S production rate 
(27.0 ± 5.2 nmol/g/min) compared with Ad-LacZ infected cells (13.9 ± 1.0 nmol/g/min, 
p<0.05) or control cells (14.7 ± 0.8 nmol/g/min, p<0.05) (Fig. 4-2C).  These results 
indicated that infection with Ad-CSE drastically enhanced the amount of functional CSE 
protein in the transfected HepG2 cells.  Cell viability was not significantly different 
between Ad-CSE and Ad-LacZ transfected cells in the range of 25-100 MOI.  However, 
adenoviral infection significantly decreased cell viability at 100 MOI compared with the 
cells without transfection (0 MOI) (Fig. 4-2D).  As shown in Fig. 4-2E, CSE 
overexpression significantly reduced glycogen storage in HepG2 cells in comparison with 
the control cells or cells transfected with Ad-LacZ.  In addition, under both fed and 6 h 
fasting conditions, liver glycogen content was significantly higher in CSE KO mice 
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compared to that in WT mice (Fig. 4-2F).  After overnight fast, the glycogen level in both 
WT and CSE KO mice were essentially depleted, no difference was found between those 
groups (Fig. 4-2F). 

128 
 
 
 
Figure 4-2.  Effects of exogenous and endogenous H2S on glycogen storage.   
(A) Effects of increasing concentrations of NaHS or PPG on HepG2 glycogen content.  
The cells were maintained in culture for 24 h after media change, then exposed to NaHS 
or PPG for 6 h at medium glucose DMEM (11.1 mM) and washed.  Glycogen was 
extracted and quantitated as described in Methods.  n=4, * p<0.05 versus control.  (B) 
Ad-CSE mediated overexpression of CSE protein.  HepG2 cells were transfected either 
with the control adenovirus Ad-LacZ or Ad-CSE at 100 MOI for 48 h.  Cells were 
collected and subjected to Western blotting.  n=4.  (C) Increased H2S production rate in 
HepG2 cells by overexpressing CSE via adenovirus.  n=4, * p<0.05 versus control or Ad-
LacZ transfected cells.  (D) Cell viability after infection of adenovirus at different MOI.  
Various MOI were used to optimize the best transfection condition.  To determine the 
cell viability after transfection, cells were collected by trypsinization followed by 
centrifugation after transfection.  Cell viability was expressed as a percentage of cells 
excluding trypan blue out of the total cells.  n=4.  * p<0.05 versus control (0 MOI). (E) 
Decreased glycogen content in CSE-overexpressed HepG2 cells.  Glycogen was extracted 
and quantitated as described in Methods.  n=4, * p<0.05 versus control or Ad-LacZ-
transfected HepG2 cells.  (F) Glycogen content in liver tissues of WT and CSE KO mice.  
Glycogen content was measured in liver of 12 week-old mice (n=5-6) under fed, 6 hour 
fasting or overnight fasting conditions.  * p<0.05 versus wild type. 
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H2S-mediated changes in PEPCK and GK activity on glucose generation  
 Exposure to H2S significantly enhanced glucose production from substrates 
(pyruvate and lactate) in HepG2 cells (Fig. 4-4A), which represents the rate of 
gluconeogenesis.  Similarly, hepatocytes from CSE KO mice had a significantly 
decreased (23.18 ± 4.27 %) glucose production from substrates compared with WT mice 
(Fig.4-4B), due to markedly lower endogenous H2S production in liver tissues from CSE-
KO mice (Mani, et al., 2011).  NaHS rapidly increased IBMX-stimulated glycogenolysis 
(measured by glucose release through glycogen breakdown) within 30 min (Fig. 4-4C).  
The rate of glucose release (glycogenolysis) from these cells at basal state was 143.6 ± 
2.9 μg/mg protein/30 min, and increased to 266.0 ± 13.2 μg/mg protein/30 min with 10 
nM glucagon stimulation (Fig. 4-4C).  After treatment with 1 mM PPG, the glucose 
release (126.1 ± 8.3 nmol/mg protein/30 min) was comparable to control.  However, 10 
μM NaHS treatment significantly elevated glucose release at all the time points tested 
within 30 min compared to control state, which is comparable to glucagon treated cells 
(Fig. 4-4C).  Similarly, the rate of glucose release is higher in hepatocytes from WT mice 
than that from CSE KO mice in the presence or absence of 10 nM glucagon (Fig. 4-1D).   
 Treatment of HepG2 cells with NaHS (below 300 μM) for 6 h significantly 
enhanced PEPCK activity (Fig. 4-4E), but reduced GK activity (Fig. 4-4F) in comparison 
to untreated cells, whereas PPG treatment imposed the opposite effect.    
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Figure 4-4.  H2S-mediated glucose production and altered PEPCK and GK activities 
in hepatocytes.  
(A) Effects of NaHS and PPG on glucose production.  HepG2 cells were treated with 
NaHS or PPG for 6 h, washed twice with PBS, then incubated in glucose-free DMEM 
(pH 7.4), supplemented with 20 mM sodium lactate and 2 mM sodium pyruvate in the 
presence of Dex/cAMP.  Glucose concentration was measured in extracellular medium 
and values were normalized with protein concentration.  n=4, * p<0.05 versus control.  
(B) Glucose production from substrates via gluconeogenesis in primary hepatocytes from 
WT and CSE-KO mice.  n=4, * p<0.05.  (C) Effects of H2S, PPG or glucagon treatments 
for 30 mins on the rate of glucose release via glycogenolysis in HepG2 cells.  * p<0.05 
versus control.  (D) The rate of glucose release via glycogenolysis in hepatocytes from 
WT and CSE-KO mice in the presence or absence of glucagon.  n=4, * p<0.05 versus 
WT hepatocytes in the absence of glucagon; # p<0.05 versus WT hepatocytes with 
glucagon. (E, F) Enzymatic activities of PEPCK and GK under different treatment 
conditions.  HepG2 cells were treated with various concentrations of NaHS or PPG for 6 
h, and then the cells were harvested to quantify enzyme activity.  PEPCK and GK 
activities were determined by using a continuous spectrophotometric method.  n=4.  * 
p<0.05 versus control.   
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H2S induces insulin resistance in HepG2 cells  
 An insulin resistant cell model was established by incubating cells with high 
glucose (33 mM) and high insulin (500 nM) for 24 h.  Glucose consumption was 
determined with or without insulin stimulation.  Impaired insulin sensitivity in model 
cells was confirmed by significantly reduced insulin-stimulated glucose consumption 
during 24 hours (Fig. 4-5A).  Application of PPG at 1 mM markedly elevated glucose 
consumption in the insulin resistant model cells with or without insulin stimulation (Fig. 
4-5A). 
 Upon acute 100 nM insulin stimulation for 10 mins, the treatment of the cells in 
the state of hyperglycemia (33 mM) and hyperinsulinemia (500 nM) for 24 h clearly 
blocked the insulin-induced phosphorylation of Akt at Ser-473 (Fig. 4-5B).  In the range 
of 10-100 μM, NaHS induced a dose-dependent decrease in insulin-stimulated Akt 
phosphorylation compared to cells preincubated in low glucose (5.5 mM) with no insulin.  
NaHS at 300 μM was beyond the dose-dependent range, but still induced an impaired 
phosphorylation of Akt (Fig. 4-5B).   
 
Hormonal regulation of CSE expression and activity in HepG2 cells 
 Insulin and its counter regulatory hormones such as glucagon work synergistically 
to keep blood glucose concentrations normal.  To evaluate whether physiological 
concentration of insulin and glucagon exert a direct and specific effect on CSE 
expression and activity in liver cells, we treated HepG2 cells with insulin (10 nM and 100 
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nM) and glucagon (10 nM) at low glucose-DMEM (5.5 mM) for 24 h.  CSE expression 
was also checked under hyperglycemia (33 mM) and high insulin (500 nM) induced 
insulin resistance state.  As shown in Fig. 4-5C, physiological concentration of insulin 
decreased CSE expression, whereas glucagon has no effect to CSE protein level.  CSE 
expression was enhanced in the insulin-resistant state (Fig. 4-5C).  Additionally, CSE 
enzyme activity reflected by H2S production rate was elevated in HepG2 cells when 
stimulated with 10 nM glucagon for 24 h and lowered by 10 nM insulin for 24 h (Fig. 4-
5D). 
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Figure 4-5.  The effects of PPG and NaHS on insulin-resistance state of HepG2 cells   
(A) Amelioration of impaired glucose consumption by PPG (1 mM) in high glucose and 
high insulin-induced insulin-resistant HepG2 cells.  Incubation of HepG2 cells with 33 
mM glucose and 500 nM insulin for 24 h was used to establish an insulin resistant cell 
model.  Glucose consumption rate at 11.1 mM glucose medium during 24 h was then 
measured with or without 10 nM insulin stimulation using a glucose assay kit II.  n=4.  * 
p<0.05 versus low glucose alone group.  # p<0.05 versus insulin alone group.  (B) 
Phospho-AKT and total AKT expression in HepG2 cells under various treatments.  
HepG2 cells were pre-incubated with various doses of NaHS for 24 h, or exposed to high 
glucose (33 mM) and high insulin (500 nM) for 24 h to induce insulin resistance.  After 
treatments, cells were challenged by 100 nM insulin for 10 min.  Cell lysates were 
collected and phospho-Akt and total Akt were detected by Western blotting.  n=4, * 
p<0.05 versus control cells.  (C) Hormonal regulation of CSE expression.  HepG2 cells 
were incubated with physiological concentrations of insulin or glucagon for 24 h, or 
treated with 33 mM glucose and 500 nM insulin for 24 h to induce insulin resistance.  
Cell lysates were collected for Western blotting analysis of CSE and β-actin protein.  n=4, 
* p <0.05.  (D) Altered H2S production rate by insulin and glucagon.  HepG2 cells were 
incubated with 10 nM insulin or 10 nM glucagon for 24 h, and then H2S production rate 
in the cell lysates was measured by methylene blue method.  n=4, * p<0.05 versus control 
cells. 
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DISCUSSION 
 
 Strong experimental evidence implicates H2S as a pathophysiological factor in the 
pathogenesis of type 1 and type 2 diabetes and their complications observed in in vitro 
and in vivo.  Our previous study showed that H2S inhibited insulin secretion from islets 
and insulin-secreting β-cell lines (INS-1E cells) (Yang W, et al., 2005).  Elevated H2S 
level in pancreas (Wu, et al., 2009) and liver (Yusuf, et al., 2005) has been seen in 
different diabetic models.  Furthermore, H2S is endogenously produced in adipose tissues 
and inhibits glucose uptake by mature adipocytes (Feng, et al., 2009).  CSE/H2S system 
was found to be up-regulated in the adipose tissues of fructose-induced insulin resistant 
rat model (Feng, et al., 2009).  Adipose tissue has been traditionally considered as a 
major secretory and endocrine organ which mediates insulin resistance through a variety 
of factors released from adipose cells (Trujillo, et al., 2006).  These results strongly 
suggest that H2S might be a novel insulin resistance regulator.  Considering the important 
role of the liver in glucose disposal and glucose output upon fasting, which all contribute 
to insulin resistance, it becomes imperative to find the link between H2S and liver glucose 
metabolism.  In the present study, HepG2 cells were adopted to establish a hepatic insulin 
resistance cell model as reported in the literature (Zhang, et al., 2009; Lee, et al., 2010).  
It has to be noticed that, however, the in vitro cellular model used in our study only 
partially mimics high glucose- and high-insulin induced insulin resistance.  The one-day 
treatment of the cells with high levels of glucose and insulin would unlikely replicate the 
true situation of chronic insulin resistance in vivo.  The sophisticated homeostatic control 
of insulin and glucose metabolisms in the whole body involves both genetic and non-
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genetic factors with the participation of multiple organs and systems.  As such, our data 
should be cautiously interpreted as per the role of H2S as a regulator of insulin resistance.  
 The importance of  the liver in the glucose homeostasis is well known before 
(Pilkis, et al., 1992), but the endogenous factors governing the utilization of glucose by 
the liver remain unclear.  By using a colorimetric method (Zhang Z, et al., 2011), our 
results indicate H2S is a novel endogenous inhibitor for glucose consumption in liver.  
NaHS as low as 10 μM significantly lowered glucose consumption at the basal and 
insulin-stimulated state.  The underlying mechanism behind this might be associated with 
H2S-induced decreased GK activity in liver cells as observed (Fig. 4-4F). Normally, 
glucose enters hepatocytes by facilitated diffusion in an insulin independent way mainly 
via GLUT2 transporters (Pessin, et al., 1992).  In non-diabetic animals, GLUT2 provides 
glucose to hepatocytes much greater than the rate of phosphorylation by GK.  Thus, GK 
became key in the regulation of glucose utilization by hepatocytes.  Indeed, it is proved 
that GK is rate limiting enzyme for glucose utilization in the liver by using transgenic 
mice model (Ferre, et al., 1996).  Interestingly, PPG did not affect basal glucose uptake and 
glucose consumption in the absence of high glucose and high insulin treatment, but it 
significantly enhanced basal glucose consumption after exposure to high glucose and high insulin 
for one day to establish insulin resistant cell model.  Considering that CSE was overexpressed in 
the insulin resistant-model cells, the inhibitory effects of PPG on CSE activity and H2S 
production would be more obvious in these cells. 
 Glucose is stored in the liver in the form of glycogen and this process can be 
facilitated by insulin.  In our study, glycogen content in HepG2 cells was observed to be 
significantly diminished by exposure to H2S (both exogenous and endogenous) without 
being affected by loss of cell viability.  In our assay, we measured absolute glycogen 
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levels in HepG2 cells using a colorimetric method with glucose as sole substrate; however, 
many studies have determined the rate of glycogen synthesis by incorporation of 
radioactive glucose.  Due to our purpose, the radioisotope method was not adopted, as it 
does not consider effects of agents on endogenous glycogen stores.  In the present study, 
the reduction of glycogen content by H2S might be attributed to both decreased glucose 
consumption and increased glycogenolysis.  Most importantly, improved glycogen 
storage was observed in the liver of CSE knockout mice in both fed and 6 hour fasting 
conditions (Fig. 4-2F), supporting our hypothesis that glycogen content is elevated in the 
presence of inadequate H2S.   
 Gluconeogenesis is the process of glucose generation especially in the liver from 
non-carbohydrate carbon substrates such as lactate, glycerol, and gluconeogenic amino 
acids.  In our study, pyruvate and lactate were added as substrates to produce glucose and 
extracellular glucose production was measured from cell culture medium (Fig. 4-4A).  
The increased glucose production by H2S is mainly attributed to elevated 
gluconeogenesis from substrates in the above assay.  Interestingly, both WT and CSE KO 
mice were essentially depleted of glycogen upon fasting overnight (Fig. 4-2F).  No 
compensatory effect was observed.  In our previous study, we found that NaHS increased 
blood glucose levels only in non-fasting mice and in a rapid fashion (Yang, et al., 2011), 
which fits the properties of glycogenolysis.  Meanwhile, it is classically known that 
glycogen can be compensated through gluconeogenesis mainly in the liver upon long 
term fasting.  Therefore, it is assumed that H2S may play a bigger role in glycogenolysis 
than gluconeogenesis, which led to the induction of instant blood glucose elevation by 
H2S only seen in fed mice, but not in overnight fasting mice (Yang, et al., 2011). 
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 Altered glucose metabolism and impaired insulin sensitivity are two hallmarks for 
diabetes mellitus.  Our results indicate that physiological concentration of H2S 
significantly impairs basal and insulin-stimulated glucose uptake and glycogen storage, 
but enhances gluconeogenesis and glycogenolysis in HepG2 cells, all of which suggests a 
state of insulin resistance.  The activation of Akt via PI3-kinase is well known to be a 
central step in insulin signalling.  Insulin stimulated phosphorylation of Akt at serine 473 
was remarkably diminished in the H2S-treated cells (Fig. 4-5B).  These results in HepG2 
cells suggest that H2S plays a role in the hepatic regulation of glucose and glycogen 
metabolism dependent on the PI3-kinase/Akt signalling pathway.  Upstream or 
downstream of this signalling pathway (e.g., IRS-1, PI3-K, and glycogen synthase 
kinase-3) might also be affected by H2S, which merits further investigation.  We 
observed that insulin at physiological concentration (10 nM, 100 nM) downregulated 
CSE protein expression (Fig. 4-5C); however, in the high glucose and high insulin 
induced insulin-resistance state, this down-regulatory response is impaired, resulting in 
induced CSE overexpression (Fig. 4-5C).  In the insulin resistant cell model, we found 
that insulin-stimulated glucose consumption was impaired but the basal glucose 
consumption remained unchanged (Fig. 4-5A).  Insulin resistance is a state in which a 
given concentration of insulin produces a less-than-expected biological effect.  Therefore, 
insulin at physiological level may generate little effect on glucose consumption under 
insulin resistance status. 
 The AMP-activated protein kinase α2 catalytic subunit controls whole-body 
insulin sensitivity (Viollet B, et al., 2003).  These impairing effects of H2S have also been 
linked to AMPK inhibition, since the decreased expression of phospho-AMPK was 
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observed after H2S treatment (Fig. 4-3A) and AICAR (an AMPK activation reagent) 
completely reversed NaHS impaired glucose consumption (Fig. 4-3B).  Moreover, CSE 
overexpression by adenovirus displayed impaired glycogen storage (Fig. 4-2E).  CSE was 
demonstrated to be the predominant enzyme for H2S generation in liver cells, considering 
that H2S production is remarkably less in the liver of CSE KO mice (Mani, et al., 2011).  
Previous study from our lab also revealed that NaHS deteriorated glucose tolerance in 
mice and increased blood glucose level in nonfasting mice (Yang, et al., 2011).  PPG, a 
CSE inhibitor, significantly improved insulin-stimulated glucose consumption in the 
insulin resistant HepG2 cell model (Fig. 4-5A).  All these data suggest that CSE should be 
an important potential target for regulating insulin sensitivity.   
  It has been reported that liver glycogen stores gradually increase during fetal 
development and are pivotal for neonatal survival until gluconeogenesis is fully 
functional in the newborn liver (Girard, et al., 1992).  It is worth noting that development 
of CSE activity in human is dependent on the postnatal age, increasing rapidly after birth 
and reaching mature levels at about 3 months of age (Zlotkin, et al., 1982; Heinonen, 
1973).  It was recently shown that CSE can be induced in human fetal liver by agents 
such as dibutyryl cAMP, glucagon or dexamethasone (Heinonen, 1973) and protein 
synthesis is required for the increased activity.  All of these data strongly indicate the 
correlation between CSE and gluconeogenesis.  Due to the early discovery, none of them 
is able to link this phenomenon to H2S production.  In this study, we found H2S can 
induce hepatic gluconeogenesis, which may have a physiological role in fetal 
development, but exerts a pathological role during diabetes.  A very recent study 
supported our notion.  This laboratory reported H2S enhanced renal gluconeogenesis by 
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upregulating the gene expression level and gene transcriptional activity of peroxisome 
proliferator-activated receptor-γ (PGC)-1 α, a major regulator of gluconeogenesis by 
activating fructose-1,6-bisphosphatase (FBPase-1) and PEPCK.  And the activity of 
FBPase-1 is downregulated significantly in the kidneys of CSE KO mice (Untereiner, et 
al., 2011). 
 Insulin and glucagon are two important hormones for maintaining glucose 
homeostasis.  Physiological concentration of insulin can inhibit CSE expression and H2S 
production rate in HepG2 cells, whereas glucagon (10 nM) increased H2S production rate 
(Fig. 4-5C, 4-5D).  Glucagon is a well-known potent stimulator of hepatic 
gluconeogenesis via the activation of cAMP formation.  The addition of 10 nM glucagon 
increases H2S production rate (Fig. 4-5D), and H2S then enhances hepatic 
gluconeogenesis and glycogenolysis, suggesting that H2S may mediate glucagon effect. 
Indeed, CSE-KO mice displayed an impaired rate of glucagon stimulated glycogenolysis 
(Fig. 4-4D).  CSE expression was not altered by glucagon at 10 nM, indicating glucagon 
may only affect CSE activity by post-translational modification.   
 PEPCK is the key rate-limiting enzyme in hepatic gluconeogenesis.  It has been 
well established that GK is the major glucose-sensing enzyme in multiple metabolically 
active organs, such as liver, brain and pancreas (Schuit, et al., 2001).  In liver, GK 
activity is the rate-limiting enzyme for glucose utilization and glycogen synthesis (Ferre, 
et al., 1996).  We have observed that increased PEPCK activity, but decreased GK 
activity were induced by H2S at the physiological range.  It is hypothesized that H2S 
enhances gluconeogenesis pathway but shuts down glycolysis pathway at the same time.  
It has been known that activation of AMPK downregulates PEPCK gene expression via 
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the phosphorylation of a novel transcription factor referred to as AREBP (Inoue, et al., 
2006).  And glucose-6-phosphatase and PEPCK genes are both downregulated by 
activation of AMPK (Lochhead, et al., 2000).  Therefore, we speculate that H2S 
upregulated-PEPCK activity may go through decreased AMPK phophorylation. 
 Of note, H2S at concentration higher than physiological related level (above 100 
μM) fails to inhibit glucose uptake, and it even significantly increases GK activity.  This 
may be related to the toxicity and pro-apoptotic effect of H2S at high concentrations 
(Yang, et al., 2006).  Moreover, higher level of NaHS (donor of H2S) at 0.5 mM has been 
shown to deplete glutathione in isolated hepatocytes and inhibit ATP synthesis, leading to 
cytotoxicity (Truong, et al., 2006).  This observation is consistent with decreased cell 
viability in the presence of NaHS at concentrations of 300 μM and above. 
 Importantly, multiple evidences point to the role of CSE as the dominant H2S 
producing enzyme in the liver (Kabil, et al., 2011; Mani, et al., 2011).  CSE protein levels 
were shown to be 60 times higher than cystathionine-β-synthase (CBS) in murine liver.  
It is estimated that only 3% of H2S production was attributed to CBS in liver at 
physiologically relevant concentrations of substrate through transsulfuration pathway 
(Kabil, et al., 2011).  To examine the effect of endogenous H2S on hepatic glucose 
metabolism, primary hepatocytes were isolated from WT and CSE-KO mice.  CSE gene 
deficiency plays a critical role in β cell function (Yang, et al., 2011).  We found 
previously that CSE KO mice exhibited a delayed onset of diabetes status and a lower 
diabetic incidence after challenged with STZ compared to WT mice.  Improved islet 
insulin release was also seen in CSE KO mice compared to WT mice (Yang, et al., 2011).  
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Our current work further confirms that CSE/H2S system is involved in glucose 
metabolism in hepatocytes.  
In summary, H2S downregulated glucose uptake and glycogen storage was 
mediated by decreased AMPK activation.  At the mean while, enhanced activity of 
gluconeogenic enzyme PEPCK was responsible for H2S increased glucose production 
(Fig. 4-6).  The total effect of decreased glucose input and enhanced glucose output will 
contribute to hyperglycemia, which is a major symptom of insulin resistance.  Insulin 
resistance, manifested by decreased glucose peripheral uptake, increased hepatic glucose 
production, diminished insulin secretion and reduced insulin sensitivity, has been well 
established to play a central role in the development of type 2 diabetes (Guillausseau, et 
al., 2008).  All our data suggest that H2S may play an important role in hepatic insulin 
resistance, and is further involved in the pathogenesis of type 2 diabetes.  Inhibition of 
hepatic H2S biosynthesis or CSE activity may emerge as a potential organ-specific 
approach to protect against the development of insulin resistance. 
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GENERAL DISCUSSION 
 Since the discussion related to specific results has been given in chapter 3-4, the 
general discussion of the results, therefore, is presented in this chapter.  
The involvement of H2S in pathophysiology and development of type 1 diabetes 
(T1DM) (Yang, et al., 2011) and type 2 diabetes (T2DM) (Wu, et al., 2009) was widely 
investigated in our lab. Our results implicated H2S overproduction as a causative factor in 
the pathogenesis of β-cell death in T1DM (Yang, et al., 2011) and the development of 
insulin resistance in T2DM (Wu, et al., 2009). H2S from adipose tissue has been 
postulated to contribute to the pathogenesis of insulin resistance (Feng, et al., 2009). 
However, very little is known about the regulatory mechanisms of CSE gene, a major 
H2S-producing enzyme in β cells as well as some other tissues (such as liver) important 
for glucose homeostasis, during the development of diabetes.  
In the present study, we demonstrated that H2S release was markedly inhibited 
when pancreatic β cell lines and freshly isolated rat pancreatic islets were incubated with 
high glucose compared to those treated with basal glucose. High glucose not only 
decreased CSE activity, but also significantly reduced CSE mRNA and protein 
expression. Pyruvate and 2-deoxy-D-glucose, as glucose metabolites, similarly down-
regulated CSE protein expression. However, the inhibitive effect of high glucose on CSE 
expression was not mimicked by its analogue (L-glucose), osmosis control (mannitol) or 
membrane depolarization reagent (KCl).  
 To further explore the mechanism, we demonstrated the involvement of a Sp1 
binding sequence in glucose regulated CSE activity, which is located in the core CSE 
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promoter. It is concluded that glucose stimulates the phosphorylation of Sp1 via p38 
MAPK activation, which leads to decreased binding of Sp1 to the CSE promoter and 
down-regulation of the CSE gene expression.  
 We also tested the effect and functions of CSE/H2S system to hepatic glucose 
metabolism. CSE is demonstrated to be the dominant H2S producing enzyme in the liver. 
In the present study, we found that H2S significantly impaired glucose uptake and 
glycogen storage (from glucose as the sole substrate) at basal or insulin stimulated 
condition in HepG2 cells, which might be mediated by decreased glucokinase (GK) 
activity. Adenovirus-mediated CSE overexpression increased endogenous H2S 
production and lowered glycogen synthesis in HepG2 cells. Glycogen content was found 
to be significantly higher in liver tissues of CSE knockout mice compared to that from 
wild type mice in both fed and 6 hour fasting conditions. NaHS induced reduction of 
AMPK phosphorylation was shown to mediate NaHS-impaired glucose uptake. 
Furthermore, H2S increases glucose production likely through increased 
phosphoenolpyruvate carboxykinase (PEPCK) activity. In addition, insulin at the 
physiological range inhibited CSE expression and H2S production, meanwhile H2S 
diminished insulin-stimulated phosphorylation of Akt (a marker of insulin resistance) in 
HepG2 cells. However, CSE expression was induced in insulin resistant HepG2 cells. In a 
nutshell, the interaction of H2S and insulin in liver is suggested to play an important role 
in regulating insulin sensitivity and glucose metabolism. 
1. H2S and insulin secretion 
Insulin release is regulated by physiological substances including various 
hormones, autacoids, neurotransmitters, and nutrients. Most of these substances regulate 
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insulin release by modulating their intracellular signalling molecules. Until now, an 
endogenous signalling molecule directly inhibiting insulin release has not been explored 
in detail (Kaneko, et al., 2006; Sharp, et al., 1996). From this perspective, H2S is a novel 
signalling molecule which plays a suppressive role in insulin release from pancreatic β 
cells. Therefore, it becomes imperative to investigate the involvement of H2S in the 
mechanism of insulin release in the physiological or diabetic status. 
 Our lab and other groups have reported that H2S and L-cysteine exert a 
physiological inhibitory role on insulin secretion from insulin-secreting β cell line (INS-
1E, MIN6 and HIT-T15 cells) and isolated rat islets (Yang, et al., 2005; Kaneko, et al., 
2006; Ali, et al., 2007). However, this inhibition was shown to occur via varied 
mechanisms, such as opening of KATP channels (Yang, et al., 2005), a KATP independent 
mechanism (Kaneko, et al., 2006), regulation of intracellular Ca2+ concentration (Ali, et 
al., 2007) and direct inhibition of VDCC in pancreatic β cells (our unpublished data). 
Therefore, the relative portion of each specific mechanism remains to be investigated in 
great detail. The above evidence clearly shows that H2S suppresses insulin secretion from 
pancreatic islets. It is reasoned that that elevation of the H2S levels derived from L-
cysteine metabolism is possibly involved in a vicious cycle of impaired insulin secretion 
under diabetic status, since the activities of H2S-producing enzymes (CBS and CSE) were 
reported to become higher in diabetic animals and patients (Veldman, et al., 2005; 
Wijekoon, et al., 2005; Ratnam, et al., 2002; Hargrove, et al., 1989). 
 Our data suggested that high glucose suppressed CSE gene transcription, CSE 
protein expression and activity in the physiological condition, further inhibited H2S 
production (mainly from CSE) in pancreatic β cells. Considering the inhibitory role of 
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(STZ)-induced Type 1 diabetic models, hepatic or pancreatic activities of CBS and CSE 
were significantly up-regulated and were associated with decreased plasma homocysteine 
levels (Wijekoon, et al., 2005; Ratnam, et al., 2002). The above studies relevant to CBS 
or CSE mainly focus on altered homocysteine metabolism with altered H2S metabolism 
being largely neglected. 
 Moore’s lab (Yusuf, et al., 2005) reported that giving insulin to STZ-injected rats 
reversed the increase in H2S synthesizing activity by a direct effect of insulin on CSE 
expression or activity (Ratnam, et al., 2002). H2S can reduce β-cell mass (Yang, et al., 
2007) and increase KATP channels activities (Yang, et al., 2005) in pancreatic β cells, both 
of which are associated with the development of diabetes. In our studies (Yang, et al., 
2011), we examined the effects of genetic and pharmacologic ablation of CSE (a major 
H2S-producing enzyme in pancreatic β cells) on β-cell functions and their correlation 
with STZ-induced diabetes. Mice deficient of CSE gene exhibited a delayed onset of 
diabetic status including less apoptotic death in β cells and improved glucose tolerance 
after injections of STZ. Administration of PPG to inhibit CSE activity similarly protected 
WT mice from STZ-induced hyperglycemia and hypoinsulinemia. Injection of NaHS as a 
H2S donor instantly increased blood glucose level, decreased plasma insulin, and 
deteriorated glucose tolerance in mice.  
 To summarize, our results provide evidence that STZ induces intra-islet H2S 
production, and then contributes to the β cell death in type 1 diabetes. Previously, the 
translation of basic science findings into the clinical settings (bench to bed studies) has 
demonstrated the therapeutic potential of gaseous signalling molecules like NO (Griffiths, 
et al., 2005). Our data suggested a potential therapeutic possiblity to protect β cell 
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function in type 1 diabetics by specifically inhibiting CSE in pancreatic β cells. The 
simplified relationship between CSE/H2S system and type 1 diabetes has been outlined in 
Figure 5-2. 
 
 
Figure 5-2. Schematic diagram of the pathogenic role of CSE/H2S system in type 1 
diabetes. STZ-induced diabetes is largely mediated by the effect of pancreatic produced 
H2S on β cell apoptosis and KATP channel activity, which lead to hyperglycemia and 
hypoinsulinemia, both of them are typical symptoms of type 1 diabetes. 
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3. Role of H2S in insulin resistance and metabolic syndrome 
 Insulin resistance (IR) is a condition when the regular amount of hormone insulin 
becomes less effective at lowering blood glucose levels. Insulin resistance in muscle and 
adipose cells impairs glucose uptake (and also local storage of glucose as glycogen and 
triglycerides, respectively), whereas insulin resistance in hepatocytes results in reduced 
glycogen synthesis and storage and a failure to suppress glucose production and release 
into the circulation (Le Roith, et al., 2001). Previously, CSE/H2S system was identified in 
both rat adipocytes and pre-adipocytes and it is indicated that adipose could secret H2S 
and act as an autocoid to inhibit basal and insulin-stimulated glucose uptake and affect 
the pathogenesis of insulin resistance (Feng, et al., 2009). H2S induced hepatic insulin 
resistance was demonstrated in our present study (Chapter 4). As a marker of insulin 
resistance, impaired phosphorylation of AKT was seen after exposure to H2S. Impaired 
glucose uptake, glycogen storage, and increased gluconeogenesis in hepatocytes were 
also observed after treatment of H2S, which are symptoms of hepatic insulin resistance. 
Taken together, H2S is considered as “a novel insulin resistance regulator”. 
 The metabolic syndrome is a group of disorders that cause the high risk of 
developing cardiovascular events and type 2 diabetes and is featured by the symptoms 
including central obesity, increased blood triglycerides, reduced plasma HDL, elevated 
blood glucose and hypertension (Aschner, et al., 2010; Mottillo, et al., 2010; Weiss, et al., 
2010). The pathogenesis of the metabolic syndrome is controversial, but it is normally 
considered that insulin resistance is the central reason. However, up to now there is 
barely any investigation on the role of H2 S in the development of lipogenesis induced by 
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high lipid and carbohydrate diet. Sulfide poisoning has been indicated to induce 
metabolic syndrome (Wang, 2012). The role of H2S in the pathogenesis of hypertension 
and diabetes has been elaborated in the literature review part, which are two 
abnormalities of metabolic syndrome. Obesity is another part of metabolic syndrome, and 
the development of obesity is possibly linked to H2S metabolism. Indeed, lower plasma 
H2S level in obese people has been previously shown (Whiteman, et al., 2010). Recently, 
a great review has covered many aspects of H2S effect in various targets of metabolic 
syndrome, including the relationship of H2S with pancreatic function and insulin 
secretion, interplays between H2S and methylglyoxal, plasma glucose, obesity and 
hyperlipidemia, as well as hypertension (Desai, et al., 2011). However, all these reports 
deal with the specific conditions of hypertension, obesity and diabetes solely and they are 
only limited to the effects of H2S administrations in cultured cells and animal models. 
Obviously, more efforts need to be spent before a big picture of the role of H2S in the 
metabolic syndrome emerges. Whether the altered H2S metabolism is the cause or the 
consequence of obesity and insulin resistance is not yet understood. 
4. Limitations of study 
 For the limitations of H2S study generally, several laboratories are investigating the 
role of H2S in the pathogenesis of diabetes mellitus besides our group. Researchers 
around the globe have thrown themselves enthusiastically into the task of probing the 
roles of this novel biologically active gas in both physiological and pathological 
conditions. However, several fundamental issues remained obscure, such as these: What 
is the effective and physiological concentration range of endogenous H2S? To what 
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extent can H2S effect be mimicked by NaHS and other donors? How does this gas work 
exactly at the cellular level? 
 It’s still a controversy if circulating H2S level is decreased or increased in diabetic 
patients. Until now, most of the studies were done in rodents. Moore et al. demonstrated 
the induction of H2S-producing enzyme CBS in the pancreas of animals treated with β 
cell toxin streptozotocin (Yusuf, et al., 2005). In addition, CSE protein expression in 
pancreatic islets and serum H2S level of ZDF rats (a type 2 diabetes model) was 
significantly higher than that of age-matched ZL and ZF rats (Wu, et al., 2009). However, 
it seems like H2S in the plasma was lower in diabetic conditions in various diabetes 
model used (Brancaleone, et al., 2008), as well as a small amount of human data. 
Considering the biggest controversy exist in the methodology of measuring H2S level in 
extracellular fluids or in plasma, additional work should be done to determine the 
absolute value of free forms of H2S in the circulation of diabetics compared to that of 
normal control. Ideally, measurement of exhaled H2S can be a feasible approach to 
differentiate diabetics and non-diabetics. Future studies need to be conducted to examine 
the specific role of obesity in the circulating H2S level of diabetics. A recent investigation 
suggests adiposity (Whiteman, et al., 2010) is an independent factor contributing to the 
low level of H2S in diabetes. 
 There are also clear contradictory results as to whether H2S exerts cytoprotective 
or cytotoxic effect. There is a trend that low concentrations of H2S is cytoprotective, 
whereas high level of H2S starts to induce toxic effect. Cytoprotective mechanisms of 
H2S include direct and indirect antioxidant/redox based mechanism (Jha, et al., 2008), 
upregulation of antioxidant pathway proteins such as thioredoxin (Jha, et al., 2008) and 
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Hsp90 (Yang Z, et al., 2011). Cytotoxic mechanisms include the depletion of antioxidants 
(Truong, et al., 2007), pro-oxidative response (Eghbal, et al., 2004), modulation of 
ERK1/2 phosphorylation and p21Cip/WAK-1(Yang, et al., 2004a), induction of DNA 
injury and alterations in apoptotic gene expression (Baskar, et al., 2007). However, 
concerning the varied effects of H2S in pancreatic β cells, only the concentration 
differences is not enough to explain the contrasting results. As our lab reported before, 
endogenous H2S inhibits insulin secretion (Yang, et al., 2005) and induces endoplasmic-
reticulum stress response (Yang, et al., 2007), which results in apoptosis of insulin-
secreting β cells. Meanwhile, another group observed that L-cysteine and NaHS 
increased glutathione content and exerted cytoprotective roles in MIN6 cells. Therefore, 
cell type differences, cell culture conditions, length of exposure, different H2S donor, and 
future studies have to be all considered to answer the bigger question: does H2S in vivo, 
even in human pancreatic β cells, exert cytoprotective or cytotoxic role? 
 For the limitation of our pancreas study (Chapter 3), we adopted insulin secreting 
cell line INS-1E (from rat) and rat pancreatic islets cultured in vitro to do our study. It is 
important to state that in vivo intact islet structures (comprising α, β and δ-cells, which 
secrete glucagon, insulin and somatostatin respectively) are required to maintain 
appropriate and pulsatile hormone secretion in response to nutrient stimuli. Therefore, we 
are not clear if H2S can modulate the whole hormone system in vivo including the 
proportion of glucagon, insulin or other hormone (like leptin), which may indirectly 
suppress insulin secretion. 
 For the limitation of our liver study (Chapter 4), we measured absolute glycogen 
levels in HepG2 cells by a colorimetric method with glucose as sole substrate; however, 
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many studies have determined the effects of chemicals on glycogen as incorporation of 
radioactive glucose, which is more direct. Due to our purpose and limitation of our lab 
condition, the radioisotope method was not adopted for our study, as it does not consider 
effects of agents on endogenous glycogen stores. In our study, the reduction of glycogen 
content by H2S might be explained by both decreased glucose consumption and increased 
glycogenolysis. Similarly for the assay of gluconeogenesis, pyruvate and lactate were 
added as substrates in our studies to produce glucose and we measured glucose 
production from cell culture medium. The increased glucose production by H2S is 
probably associated with both elevated gluconeogenesis from substrates and increased 
glycogenolysis from glycogen breakdown. 
 Considering all the literatures reported so far and our own studies, it seems that 
the inhibition of pancreatic and hepatic H2S biosynthesis is beneficial for diabetes, 
whereas supplementation of H2S emerges as a therapeutic approach for diabetic 
complications in cardiovascular systems (Suzuki, et al., 2011). Clearly, more 
investigations are needed to develop a valid therapeutic approach to diabetes related to 
H2S biosynthesis.  
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CONCLUSIONS 
 
 Our studies demonstrated the important role of CSE/H2S system in glucose 
homeostasis. Therefore, high glucose would offer two different effects: down-regulating 
CSE expression and inhibiting CSE activity. The latter may function as a physiological 
response responsible for glucose induced insulin secretion. The reduced H2S production 
would lead to increased insulin release in pancreatic β-cells since H2S itself can open 
KATP channels and hyperpolarize the membrane to inhibit insulin release. 
 In the hormone level of whole body, insulin was observed to decrease CSE 
expression and H2S production in liver cells. Considering that H2S itself increased 
glycogenolysis and gluconeogenesis, but inhibited glucose utilization in liver cells, 
decreased H2S affected by insulin will improve glucose utilization, decrease glucose 
production from liver, thereby glucose level will go back to normal. It is a circle of 
physiological regulation. This theory has been summarized in Figure 5-3. However, 
imbalanced overproduction of H2S in the liver or pancreatic β cells would exert the 
opposite effect and might constitute one of pathogenic mechanisms for diabetes related to 
H2S.  
 In this context, a hypothetic model of ‘sweetened rotten egg (H2S)’ for 
physiological regulation of pancreatic and liver function is proposed. This model 
integrates the role of pancreas and liver in regulation of ‘sweet’ glucose metabolism and 
inhibitory role of the ‘rotten egg’ gas H2S in insulin release and glucose utilization. As 
abnormal insulin release from pancreas and impaired insulin action in liver are ubiquitous 
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for many disorders of insulin resistance syndrome, including obesity and hypertension, a 
critical evaluation of the role of H2S as a ‘sweetened rotten egg’ in pancreas and liver will 
shed light on understanding of pathogenesis and management of these disorders.  
 
 
 
Figure 5-3. Summarized mechanism of the role of CSE/H2S system in glucose   
          homeostasis 
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SIGNIFICANCE OF THE STUDY  
 
 Diabetes is one of the fastest growing and most costly metabolic disorders 
worldwide, it’s more common in developed countries, but now its incidence is also 
increasing rapidly in developing countries due to urbanization and lifestyle changes. Until 
now, the mechanisms of its pathogenesis have not been fully understood (Mathis, et al., 
2001).  
 Approximately, 285 million people worldwide are affected by diabetes. With 7 
million more people developing diabetes annually, this number is expected to reach 438 
million by 2030. Among them, more than 9 million are Canadians suffering from 
diabetes or prediabetes. An estimated 90% of diabetic patients are T2DM due to a 
number of factors including sedentary life style, aging and obesity, et al. The personal 
costs of diabetes are largely due to the increased likelihood of complications such as 
diabetic neuropathy, nephropathy, cardiovascular disease, retinopathy, stroke, amputation 
and erectile dysfunction. Almost 80% of people with diabetes will die as a result of 
cardiovascular emergency. Overall, diabetes is a contributing factor of deaths of over 41, 
500 Canadians each year. Furthermore, the financial burden of diabetes and its 
complications is huge. The direct cost for each diabetic patient for medication and 
equipments ranges from $1,000 to $15,000 per year. It is estimated that the Canadian 
healthcare system will spend $16.9 billion a year on diabetes by 2020 (Canadian Diabetes 
Association, http://www.diabetes.ca/diabetes-and-you/what/prevalence/). 
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 Clinical therapeutic targets based on the current mechanisms have not achieved as 
much as expected. Diabetes still mystifies and fascinates both practitioners and 
investigators due to its elusive causes and multitudes of symptoms. As a novel 
gasotransmitter, H2S has been shown to contribute to or be involved in the development 
and progression of diabetes (Wu, et al., 2009; Yang, et al., 2011). However, very little is 
known about the molecular regulatory mechanisms of CSE gene, a major H2S-producing 
enzyme in β cells as well as some other insulin sensitive tissues (such as liver), during the 
development of diabetes. The novelty of our experiments is that for the first time, we 
have displayed the interaction between glucose metabolism and CSE gene expression and 
H2S production in both pancreatic β cells and liver cells, and unveiled the underlying 
molecular mechanisms.  Clarifying the role of CSE/H2S system in glucose homeostasis 
and the development of diabetes is meaningful and may lead to discoveries of new 
protective interventions or therapeutic treatment for diabetes and associated 
complications. The derived novel discoveries can either be transformed to pharmaceutical 
anti-diabetic drugs or to new diagnostic methods for early diagnosis and follow-up the 
progression of diabetes. 
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FUTURE DIRECTION 
 
 To extend and expand our findings reported in this thesis, we are planning to 
carry out the following experiments in the future: 
 1. To further investigate the mechanism of H2S affected glucose catabolism. The 
expressions and activities of glucose metabolism-related genes glucose-6-phosphatease 
(G-6-P), fructose-1,6-bisphosphatease (FBP), hexokinase (HK), glucokinase (GK), 
pyruvate kinase (PK) and pyruvate carboxylase (PC) in islets, liver, adipose tissue and/or 
skeletal muscle will be determined. Inflammation (TNF-α, IL-1β, IL-6, monocyte 
chemotactic protein-1) and apoptosis (caspase-3, CHOP, and SREBP-1c)-related genes in 
islets and hepatocytes will be detected by real-time PCR, Western blots, and/or ELISA. 
The activities and expression levels (mRNA and protein) of different enzymes involved 
in glucose metabolism will be determined and quantified using Real-Time PCR and 
Western blot analysis. 
 2. To elucidate the correlation between CSE deficiency, H2S production and high 
fat diet (HFD)-induced metabolic syndrome, which lead to central obesity, fasting 
hyperglycemia, hypercholesteremia and insulin resistance. Briefly, age-matched male 
CSE WT mice and CSE KO mice will be fed ad libitum a low- or high-fat diet (LFD or 
HFD), with 10% or 45% kcal from fat, respectively (Research Diets, New Brunswick, 
NJ). The possible mechanisms for the role of CSE deficiency will be explored. 
 3. To investigate the possibility of H2S modulated enzyme activity important for 
glucose catabolism through sulfhydration. Hexokinase (HK), glucokinase (GK), pyruvate 
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kinase (PK), phosphoenolpyruvate carboxykinase (PEPCK) and pyruvate carboxylase 
(PC) enzyme activity after H2S treatment will be measured and sulfhydration of these 
enzyme protein will be assayed by biotin switch method.   
 4. To develop new assays to detect free H2S in real time. The capability to 
measure free H2S generated within cells at low concentrations in real time would be a 
significant advance to H2S research. 
 5. To get a clearer idea of the plasma/serum/tissue concentration of H2S and its 
physiological significance in terms of predicting the biological relevance of endogenous 
and exogenous H2S provided by slow- and fast-releasing donor drugs. 
 6. To develop H2S releasing drugs at different rates in a wide range. A better 
understanding of their precise cellular and intracellular sites of action/breakdown will be 
of benefit in establishing whether this mediator can be targeted with drugs for therapeutic 
benefit. 
 7. To get greater insights into the mechanism of the cell signalling activity of H2S. 
It is critical to determine the relative contributions of redox mechanisms and intracellular 
protein S-sulfhydration and their interconnection with the known effects of this gaseous 
signalling molecule on ion channels, transcription factors, and kinases, which seem to be 
the major molecular targets of H2S. 
 8. To clarify the role of H2S in diabetes caused inflammation and explore 
potential treatment strategy 
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